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Abstract  
 
Staphylococcus aureus is an opportunist human pathogen that colonises the anterior nares 
and is shed onto skin.  The bacterium is most frequently a cause of skin and soft-tissue 
infections, yet is also a major cause of respiratory, urinary tract, bone, eye and brain 
infections.  Evolution of the bacterium has selected strains that are more antibiotic resistant, 
particularly in the hospital environment and more recently in the community. The pathogen 
has the capacity for secreting a wide range of proteins that contribute to survival from host 
immunity and competing microflora.  
 
The bacterial cell wall is a vital structural polymer serving mechanical roles to protect 
bacteria from osmotic challenges and it serves as a scaffold for the attachment of many 
anchored proteins and anionic polymers for interaction with extracellular components.  
Peptidoglycan of S. aureus is modified by enzyme catalysed decoration of N-acetyl muramic 
acid with teichoic acid and O-acetylation which promotes lysozyme resistance. Further 
modification of teichoic acid engenders properties linked to colonisation and survival during 
the life-cycle. 
 
This research study sought to assign roles of S. aureus secreted proteins of unknown 
function using bioinformatics. From this approach the study identified a peptidoglycan 
deacetylase (Pgd) and this enzyme catalyses a reduction in acetylation of N-acetyl 
glucosamine in biosynthesis of the cell wall. An allelic replacement mutant revealed altered 
muropeptide composition that was consistent with its proposed N-deacetylase activity, and 
transmission electron microscopy (TEM) revealed a reduction in cell wall thickness. 
 
S. aureus pgd exhibited increased surface charge to influence a range of phenotypes, 
including autolysis, resistance and biofilm formation. Resistance was increased to lysozyme, 
and most notably there was rescue of the lysozyme sensitivity phenotype of an oatA mutant 
(lacking peptidoglycan O-acetyltransferase [oatA] activity). Hydrodynamic flow biofilm 
assay revealed that both S. aureus pgd and oatA mutants exhibited negligible biofilm 
formation on a glass surface; treatment of the surface with plasma fluid increased biofilm 
capability. Biofilms of S. aureus pgd cultured in static conditions revealed an opposite 
phenotype with a thicker, but loosely adherent biofilm. Confocal laser scanning microscopy 
(CSLM) combined with viability staining it was revealed that in the biofilm, there were 
increased dead cells compared with wild-type. 
 
An increased lag phase of growth of S. aureus pgd was identified, and quantitative label free 
proteomics was used to determine that multiple metabolism and cell wall proteins were 
differentially expressed, compared with the wild-type strain. The proteome analysis revealed 
that the pgd mutant expressed increased levels of the lytic transglycosylase, IsaA and this 
might explain the biofilm phenotype.  Further contributions to the biofilm phenotype could 
be due to decreased expression of protein A and reduced pyruvate metabolism enzymes. 
 
S. aureus pgd was killed more rapidly in an opsonophagocytosis assay compared with its 
isogenic parent but showed equivalent levels of complement deposition and serum survival. 
Infection models of pneumonia and bacteraemia were tested and revealed reduced bacterial 
loads for lung and kidney, respectively. 
 
The S. aureus pgd mutant phenotype requires further study and it should provide insights 
into cell wall structure and function.  Pgd could represent a future candidate vaccine antigen 
due to its likely cell surface exposure and contribution to key cellular processes. 
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CHAPTER 1 	
1.1. Introduction 	
1.1.1. Overview of Staphylococcus aureus and its clinical importance  	
Staphylococcus aureus is a Gram-positive bacterium that belongs to the 
Staphylococcaceae family.  The species is found as part of microbial flora of the 
human body as commensal organism; it persistently colonises around 20-30% of the 
general population asymptomatically, especially in nostrils, pharynx, axillae, vagina, 
and it is shed onto the skin surface. Notably, it has the capacity to be a harmful 
pathogen and causes several infections as an opportunist (Lazarevic et al., 2011a; 
Sibbald et al., 2006)  
 
As an opportunistic pathogen, the invasion of S. aureus can lead to a wide range of 
infections across the human body, ranging from superficial skin and soft tissue 
infections to systemic or chronic infections in different organs. The diversity of 
disease ranges in severity from the most frequent presenting pathology of skin and 
soft tissue infections (impetigo, furuncles, folliculitis, fasciitis, and abscesses),to 
invasive infections of the bloodstream (bacteraemia), heart (endocarditis) and 
respiratory system (pneumonia) disease, bone (septic arthritis and osteomyelitis) and 
brain (meningitis) infection. The mechanisms involved with the switch between 
carriage of commensal S. aureus to life-threatening infections are only partly known.  
In most cases this switch follows the breakage of a key barrier of skin or mucosa, for 
example from a wound, intravascular device or surgery (Rasmussen et al., 2011). 
		 2	
This access opportunity allows bacteria to establish locally by adherence and/or 
spread to tissues from access to the bloodstream. Infection severity and patient 
outcomes are dependent on the balance between bacterial virulence properties and 
the immune response efficiency (Lowy, 1998). 	
 
This ability of S. aureus to infect organs under different environmental conditions 
such as, supply of blood, immune defences, oxygen, local pH, is a key challenge in 
the study of this bacterium. This must be combined with a rigorous understanding of 
the physiology of the bacteria combined with informed use of experimental models. 
S. aureus is frequently described as being multifaceted, versatile, flexible and 
adaptable as commentary to reflect its environmental interactions and responses to 
changes (Archer, 1998).  S. aureus isolates variably encode a wide range of toxins 
that contribute to the diversity and severity of diseases. (Francois et al., 2010; 
Gittelman et al., 1991; Lazarevic et al., 2011b; Lew and Waldvogel, 2004; Sibbald et 
al., 2006). The majority of these toxins will be discussed later.  
 
A clinically-relevant feature of S. aureus is its capability to adhere to and colonise 
different synthetic materials to form structured biofilms. These structures are 
important in the lifestyle of bacterial communities and develop from a coordinated 
sequence of events, including initial attachment, microcolony formation, maturation 
and detachment. Biofilm formation provides significant protection from defences 
from host responses and antibiotics during colonisation and infection. Most common 
infections due to biofilm-associated infection are reported to be nosocomial 
infections arising from medical devices such as, heart valves, bone prostheses, or 
implanted catheters (Otto, 2013). 
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Although adequate and prolonged antibiotic therapy can be successfully used against 
this bacterium, many infections can be difficult to eliminate and often relapse, 
suggesting S. aureus adapts itself to environmental changes by producing effective 
survival responses (Lazarevic et al., 2011b; Powers et al., 1990). The continued 
emergence of S. aureus resistance thwarts the effectiveness of antimicrobial drugs. 
The emergence of antibiotic resistance in S. aureus was reported first in the mid-
1940s when bacteria became resistant to penicillin by producing beta-lactamase to 
degrade penicillin antibiotic.  Subsequently, a semi-synthetic penicillin (called 
methicillin) was developed to overcome the resistance. This antibiotic was effective 
against penicillin-resistant S. aureus, since it was not affected by beta-lactamase. 
However, shortly after the introduction of methicillin, the first reports in 1961 
indicated that S. aureus had evolved resistance. 20 years later, it was found that 
certain S. aureus strains harboured the specific gene, mecA that encodes the low 
affinity penicillin binding protein (called PBP2a) responsible for the methicillin-
resistance and this was rapidly horizontally transferred reducing its clinical 
effectiveness for treatment (Chambers and Deleo, 2009).  
 
In recent years, there have been reports of MRSA isolates with reduced susceptibility 
to vancomycin and isolated instances of vancomycin resistant strains. MRSA strains 
have spread worldwide and are now endemic in hospitals of most countries. The 
strains that are known causes of nosocomial infections are described as hospital-
acquired MRSA (HA-MRSA) and are characteristically multiply resistant to a range 
of antibiotics.  The recent emergence of community-associated MRSA (CA-MRSA) 
has seen the rise of successful clonal groups that remain susceptible to many 
antibiotics classes, but have apparently increased virulence and frequently encode 
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different toxins such as, exfoliatin A, and Panton-Valentine leukocidin (PVL) 
(Lazarevic et al., 2011b). Genetically, it is possible to distinguish between these two 
groups of strains by the variability in many genetic regions. For example, HA-MRSA 
strains generally carry a large cassette mec element (SCCmec) in their chromosome 
accounting for their resistance, including to several non-β-lactam antimicrobials, 
while CA-MRSA carries a smaller SCCmec element resulting in resistance to fewer 
non-β-lactam classes (David and Daum, 2010). Whether MRSA strains are more 
virulent than methicillin- susceptible strain (MSSA) is still debated. Nevertheless, 
HA-MRSA are reported to cause bacteremias with high mortality rate. In recent 
years, CA-MRSA and particularly the clonal group of isolates named as USA300 
were reported to be spread outside of hospitals causing infections especially in close 
contact between people such as in schools, sports teams and military recruits (David 
and Daum, 2010; DeLeo et al., 2010). Typically CA-MRSA, especially USA300 
isolates, carry important previously infrequently identified genes lukS/lukF-PV, 
encoding the PVL toxin and causing serious necrotising pneumonias and many skin 
infections. The specific role of PVL toxin in pathogenicity of CA-MRSA is still the 
subject of much debate, but CA-MRSA strains are reported without this toxin 
(DeLeo et al., 2010). A general upregulation of toxin synthesis and numerous 
uncharacterised genome SNPs are likely to explain the emergence and alternative 
virulence and pathology of these strains.  These strains are now circulating in 
hospitals leading to blurred distinctions between CA-MRSA and HA-MRSA in the 
USA (DeLeo et al., 2010).  Taken together, this rapid evolution combined with an 
expanded virulence determinant repertoire highlights S. aureus as a versatile and 
problematic opportunist pathogen that will remain a challenge for clinical teams and 
researchers.   
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1.1.2 Virulence of S. aureus 	
This ability of S. aureus to cause several infections is due largely to secreted 
virulence factors that engender specific virulence strategies. These proteins are 
collectively named the exoproteome or secretome (Lazarevic et al., 2011b; Sibbald 
et al., 2006). To be able to cause disease in host niches, S. aureus needs to 
differentially express virulence factors; some of these are displayed at the bacterial 
surface inserted into the membrane or either covalently or ionically attached to the 
cell wall, while others are released from the cell to cause pathology or inhibit host 
processes (Sibbald et al., 2006).  	
Infection by S. aureus is frequently described to follow from sequential steps: 
adherence to host (either cell surfaces or host components), evasion from immune 
defence, and finally spreading and tissue invasion (Fournier, 2008; Holbrook and 
Lowy, 1998). Each step requires coordinated expression of virulence factors, 
therefore, these factors are often divided into different classes based on their role 
during the process of infection. A proportion are anchored to the cell wall of bacteria 
as adherence factors (e.g. protein A and fibronectin binding protein, Fnb), whereas 
others are secreted as extracellular proteins (e.g. alpha toxin and PVL) required for 
the cell damage, dissemination and spreading (Arvidson and Tegmark, 2001). Many 
membrane-anchored and surface-located secreted proteins are most highly expressed 
early during infection when cell density is low. This initial expression phase is 
followed by secreted toxins and enzymes being most highly expressed later in 
infection, when cell surface-attached proteins are downregulated (Arvidson and 
Tegmark, 2001; Cheung et al., 2008), (Fig 1.1). This pattern of protein expression is 
under the control of the quorum-sensing system, agr, the master regulator of 
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virulence gene expression. The agr density signalling mechanism is activated by the 
accumulation of extracellularly secreted auto-inducing peptide during exponential 
growth phase (Novick, 2003). This system is discussed in more detail later.  
 
 
Fig. 1.1 Schematic of growth and secreted protein production of S. aureus. Initial 
adaptation of bacteria occurs during the lag phase, followed by cells multiplying and 
synthesising necessary surface proteins for growth, adhesion and cell division during 
exponential phase. The majority of S. aureus exoproteins including toxins are 
produced during late exponential phase due to activation of density-dependent 
signalling via Agr. Adapted from (Harris et al., 2002). 
 
Virulence factors can be divided into groups based on their functions; (i) proteins 
participating in invasion and adhesion of host cells, (ii) secreted proteins and toxins 
and (iii)	proteins that circumvent host immune defence (Hecker et al., 2010; Sibbald 
et al., 2006).  In addition to these groups, there are many proteins required for 
nutrient acquisition from the host, which are not discussed further here. However, 
!
 
Fig. 1. 1. Model structure of growth and virulence factor production of S. 
aureus. Initial growth and infection of bacteria during Lag phase, following by 
multiplying and synthesising necessary surface proteins for the growth, adhesion and 
cell division during exponential phase. Eexoproteins including toxins productions 
occurred during post-exponential phase as result of crowding activities and sensing 
mechanism. Adapted from [L.G. Harris et al., 2002]. !!!!
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there is not always a clear distinction between many virulence factors that reveal 
overlapping functions that can act individually or together (Dinges et al., 2000; 
Foster and Hook, 1998; Lowy, 1998). A subset of key virulence proteins is listed in 
(Table 1.1). 
 
1.1.2.1. Surface proteins participating in adhesion to host cells. 	
 A key group of proteins required for host adhesion belong to the family of Microbial 
Surface Components Recognising Adhesive Matrix Molecules (MSCRAMMs) 
proteins.  S. aureus isolates express up to twenty different MSCRAMMs which are 
directed to the cell surface after secretion during the exponential growth phase (Fig. 
1.1). MSCRAMMs are covalently attached to peptidoglycan via their C-terminal 
sorting signal catalysed by the specific transpeptidase enzymes, sortase (SrtA and B). 
These adhesins assist with the initiation of infection by adhering to, or interacting 
with host matrix components, including collagen, fibronectin, vitronectin, fibrinogen 
and bone sialoprotein. Adhesion is mediated by among others, clumping factors A 
and B, collagen adhesion (Cna), fibronectin-binding proteins (FnbA and B), serine-
aspartate repeat proteins (SdrC-E) and the iron-regulated adhesin IsdA (Dreisbach et 
al., 2011; Foster and Hook, 1998; Fournier, 2008). In addition to adherence 
functions, MSCRAMMs have roles in colonisation, prevention of 
opsonophagocytosis, and several mediate uptake into host cells (Massey et al., 2001; 
Palmqvist et al., 2004). Development of vaccines against this family of 
MSCRAMMS proteins has been actively pursued (Rivas et al., 2004). 
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Table 1.1.  Selected virulence factors produced by S. aureus.  
 
Secretome Description Virulence Role Functions 
FnbA, FnbB, IsdA, 
SdrC-E, ClfA, ClfB 
Surface protein 
adhesin 
Colonise host tissues  Adhesion, fibrinogen- or 
fibronectin- binding 
proteins 
Coa, ClfA, ClfB, 
Spa,  
Surface protein Immunological 
modulation and 
disguise 
Coagulase, clumping 
factors A and B, protein 
A 
Staphyloxanthin, 
KatA 
Biochemical 
compounds  
Survival inside 
phagocytes 
Antioxidant pigments, 
Catalase production  
Hla, b, HlgA-C, 
Geh, HysA, LukD to 
F, LukS, Lip, Nuc 
Toxins, invasins, 
damaging 
membrane 
To lysis cell 
membrane of host and 
spread bacteria  
Leukotoxin, lipases, 
emolysine, 
hyaluronidase 
Spa, 
Efb,  
Surface-factors To inhibit 
phagocytosis 
Protein A,  
Efb blocks the C3 and 
C5 convertases 
SEA to G, TSST-1, 
Eta, Etb 
Exotoxins Lead to cause signs of 
septic shock 
Cytotoxicity 
VanA, MecA, BlaZ Resistance  As resistance factors 
used to antimicrobial 
agents 
Resistance to both 
Vancomycin and 
Methicillin. 
This data was adapted from [Hecker et al., 2010; Sibbald et al., 2006].   	
 
1.1.2.2. Exoproteins 	
The excreted group of proteins includes those able to cause pathology and promote 
the spreading of this bacterium through host tissues, including leukocidins and 
hyaluronidase. S. aureus isolates secrete multiple enzymes such as proteases, 
coagulase, hemolysins and lipases that act upon tissue of the host. The α-hemolysin 
(alpha-toxin) can lyse both leucocytes and erythrocytes (Verdon et al., 2009). 
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Leucocidins act to form holes in the membrane of target cells. The Panton-Valentine 
leucocidin (PVL) toxin, consisting of two components encoded by lukF-PV and  
lukS-PV, is able to lyse monocytes and neutrophils. PVL was first identified many 
years ago, but recently was reported associated with S. aureus CA-MRSA isolates, 
particularly those with SCCmec type IV, and was reported to cause several 
dermatological diseases such as, necrotising of skin and abscesses, and also involved 
in pneumonia infections (DeLeo et al., 2010). Moreover, S. aureus can express 
superantigens such as exfoliatin A and B toxins, toxic shock syndrome toxin-1 
(TSST-1) and several enterotoxins are responsible for food poisoning (Schlievert, 
1993).  
 
 1.1.2.3. Immune evasion proteins 	
This group of secreted proteins includes a diverse set of structures and modes of 
action. These proteins range from Protein A and Sbi, which are surface attached and 
facilitate antibody and complement evasion, to OatA and TagO which catalyse the 
addition of acetyl groups and teichoic acids to peptidoglycan.  These diverse proteins 
act collectively as virulence factors that enable the bacterium to limit 
opsonophagocytosis (Hecker et al., 2010; Sibbald et al., 2006; Smith et al., 2011b).  
  
1.1.2.4. Peptidoglycan modification for immune escape 	
Lysozyme is a cationic enzyme produced in various locations of human and animal 
hosts as part of their innate immunity, where it acts as a key antimicrobial peptide 
activity against invading bacteria.  The enzyme catalyses cleavage of β-1,4 
glycosidic bounds between disaccharides units, N-acetylmuramic acid (NAM) and N-
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acetylglucosamine (NAG), of peptidoglycan (PG) leading to membrane damage and 
cell lysis. S. aureus isolates are highly resistant to lysozyme which mainly arises 
from two enzyme catalysed PG modifications: O-acetylation and teichoic acid (TA) 
addition. Both surface changes protect the bacterial surface from lysozyme binding 
by steric inhibition of its active site to the sugar backbone. The O-acetylation of PG 
promotes resistance against the bacteriolytic activity of lysozyme with the teichoic 
acid acting in concert. Mediated by the products of the dlt operon, teichoic acid can 
also be modified structurally with D-alanine, which increases positive charge to 
further limit interaction with cationic lysozyme (Neuhaus and Baddiley, 2003).   
 
1.1.2.5.  Protein A (Spa) and Immunoglobulin-binding Protein (Sbi)  	
Both Spa and Sbi have domains for immunoglobulin G (IgG)-binding and have roles 
in the virulence of S. aureus. These proteins bind the Fc region of IgG to prevent 
complement fixation and thus recognition by the neutrophil FcγR receptor which 
limits opsonophagocytosis (Smith et al., 2011b), (see section: 6. 3. 5.). 
 
1.1.2.6.  Staphylococci avoidance from complement attacks. 
The innate immune system is a primary defence against all microbes. This system 
comprises three effector mechanisms that allow rapid and efficient killing. First, 
diverse antimicrobial peptides recognise bacterial structures and lyse the membrane 
of bacteria, leading to rapid killing provided the concentration of peptides is effective 
and granules of neutrophils contain a high concentration of these peptides.    
 
Second, the complement system promotes killing upon its activation by multiple 
foreign microbial molecules that differ in their interaction.  Each stimulus leads to 
the cleavage of C3 and generation of a C3 convertase that generates chemoattractant 
and opsonin components, C3a and C3b (Fig. 1.2.). The C3b acts as a surface-
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targetting opsonin that increases neutrophil phagocytosis through enhanced 
recognition.  
 
Third, phagocytic cells, mostly neutrophils and macrophages, ingest and kill 
microbes within a few seconds. Bacterial infection produces several chemoattractants 
including chemokine interleukin-8 (IL-8) and complement C5a. These 
chemoattractants are sensed by neutrophils, leading to induced cellular activity and 
receptor expression. Nearby endothelial cells also express specific receptors to allow 
neutrophil egress across the endothelium guided by chemotactic gradients (e.g. IL-8) 
(Phillipson and Kubes, 2011). Neutrophils migrate towards the site of infection by 
detecting the activated complement and chemokines and upon phagocytosis their 
cytosol activates granules that contain neutrophil serine proteases (NSPs), 
myeloperoxidase, and antimicrobial peptides, that direct killing of bacteria 
(Rooijakkers et al., 2005).  
 
  
Once at the site of infection, neutrophils kill bacteria using multiple mechanisms. 
After phagocytosis the neutrophils engulf opsonised bacteria once they recognise 
either C3b- or IgG-bound bacteria. Once the plasma membrane of the neutrophil 
surrounds the bacterium to complete the uptake process the release of antimicrobial 
peptides from granules promotes lysis (van Kessel et al., 2014); This process is 
called degranulation (Korkmaz et al., 2010), which also releases NADPH oxidase 
that catalyses production of superoxide, leading to production of further reactive 
oxygen plus nitrogen intermediates and the generation of hypochlorous acid.  A final 
mechanism of neutrophil killing targets extracellular bacteria via the extrusion of 
chromatin loaded with histones, and the proteases cathepsin and elastase, all of 
which are antimicrobial.  These neutrophil extracellular traps (NETs) trap and kill 
bacteria (Remijsen et al., 2011).  
 
In addition to capsule proteins, Sbi and MSCRAMMS including Spa, there is a suite 
of secreted proteins that are important for inhibiting complement activation and 
opsonisation of the bacterial surface.  These proteins include staphylokinase (SAK), 
Extracellular fibrinogen-binding (Efb), and staphylococcal complement inhibitor 
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(SCIN) proteins. The latter protein (SCIN) is able to block C3 convertase activities 
(C3bBb and C4b2A) that cleave of C3 protein into C3a and C3b. The C3b fragment 
functions as a surface-bound opsonin, increasing neutrophil phagocytosis when 
bound to the surface of S. aureus and SCIN prevents C3b formation (Fig.1.2.), 
(Rooijakkers et al., 2005). S. aureus surface proteins act as plasminogen (PLG) 
receptors that enable PLG to become activated by SAK which releases plasmin (PL).  
PL functions to proteolyse several activating molecules of the complement cascade, 
particularly C3b, and IgG via removal of the Fc region (required for C1q-mediated 
activation via the classical pathway). Extracellular fibrinogen-binding (Efb) of S. 
aureus binds to C3 and this blocks cleavage by C3 convertases to limit generation of 
C3b; Efb targets a central point of the cascade, blocking each form of activation, 
classical, alternative and lectin (Fig.1.2), (Foster, 2009; Rooijakkers et al., 2006). 
Chemotaxis inhibitory protein of staphylococci (CHIPS) binds to the neutrophil C5a 
receptor to block its recognition of the proteolysed C5 protein, an activity that limits 
neutrophil recruitment (Rooijakkers et al., 2006; Rooijakkers et al., 2005). 
Staphylococcal superantigen-like-protein 7 (SSL-7) binds IgA1-2 and C5, to control 
the immune response during infections (Fig.1.2) (Foster, 2009; Fournier, 2008).   
 
Furthermore, S. aureus has microcapsular polysaccharides, particularly serotype 5 
and 8 involved in several infections, allowing bacteria to escape from immune 
response such as, activation of complement systems (Watts et al., 2005). Most S. 
aureus strains can produce polysaccharide intercellular adhesin (PIA) encoded by the 
ica operon, which directs cell-cell adhesion and biofilm formation, making networks 
able to stabilize cells and reducing phagocytosis (section 5.3.6.) (Cramton et al., 
1999).     
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Fig. 1.2 S. aureus inhibition of complement activation. The complement system has three 
pathways directing formation of surface-bound C3 convertases that cleave C3 to release C3b 
for surface deposition and formation of C5 convertases. The surface-detecting activators 
[C1q, Fic (ficolins), MBL (mannose-binding lectin)] and protease components [M-2 (MASP-
2), C1r and C1s] of the classical and lectin pathway are indicated. Several complement 
components (C2 and C4) and factors (fB and fD) form, respectively, the C3 convertases 
C4b2a and C3bBb that cleave C3 protein resulting in microbe-bound C3b. As opsonisation 
with C3b increases there is formation of C5 convertases (C4b2a3b and C3bBb3b) leading to 
C5b-9-mediated lysis and release of the chemoattractant C5a. Secreted S. aureus factors 
(orange) help to evade complement system: staphylokinase (Sak), extracellular fibrinogen-
binding (Efb), staphylococcal complement inhibitor (SCIN), protein A (pro-A), chemotaxis 
inhibitory protein of staphylococci (CHIPS) and staphylococcal superantigen-like-protein 7 
(SSL-7) are indicated at the stage they interfere with the complement cascade. (Adapted 
from (Rooijakkers et al., 2005). 
!!!!!
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1.1.3. The cell wall and peptidoglycan structure 	
Peptidoglycan (PG) is a polymer serving mechanical roles to protect bacteria from 
osmotic challenges and surrounds S. aureus with a thickness of around 30 nm. PG is 
a scaffold that provides sites for the attachment of anchored-surface proteins and 
anionic polymers for interaction with extracellular matrices. PG has key roles in 
bacterial growth, morphogenesis and separation, pathogenesis, interaction with the 
environment, biofilm formation and homeostasis (Sharif et al., 2009; Typas et al., 
2012). Teichoic acids are anionic polymers, which are covalently anchored to the PG 
layer in the cell wall, as wall teichoic acid (WTA), or attached to the lipid of the 
cytoplasmic membrane as lipoteichoic acid (LTA), (Fig. 1.3.) (Madigan et al., 2003).  
 
1.1.3.1. Peptidoglycan synthesis 	
Peptidoglycan is composed of disaccharide glycan units cross-linked by short stem 
peptides producing a structure that surrounds the inner or cytoplasmic membrane in 
Gram-negative or Gram-positive bacteria, respectively (Frankel and Schneewind, 
2012; Typas et al., 2012). The disaccharide units N-acetylmuramic acid and N-
acetylglucosamine are conserved in the PG of all bacteria (Fig. 1.4), however, both 
bridge and stem differ in their structures between organisms. In S. aureus, there is a 
pentaglycyl (L-Gly)5 cross-linking bridge, while the stem peptide is a pentapeptide 
comprising L-Ala-D-Gln-L-lys-D-Ala-D-Ala (Sharif et al., 2009). The structure of 
peptidoglycan is shown in Fig. 1.3.  
 
The synthesis of PG occurs through three main steps (Fig.1.4). Firstly, there is a 
soluble biosynthetic step in the cytoplasm where the precursor UDP-N-
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acetylmuramyl and UDP-N-acetylglucosamine pentapeptides are synthesised. These 
precursors are next linked with undecaprenyl phosphate (carrier bactoprenol) at the 
inner membrane, producing a lipid II subunit (lipid-anchored-disaccharide-
pentapeptide-monomer), which are then are flipped within the membrane to become 
outward-facing. The third step occurs when the lipid II subunit is polymerised by a 
transglycosylation reaction to release undecaprenyl pyrophosphate and disaccharide 
glycan chains are inserted into PG the growing structure (Frankel and Schneewind, 
2012; Typas et al., 2012). Final assembly of the PG structure requires 
transpeptidation activity, including two essential enzymes located at the cytoplasmic 
membrane, DD-transpeptidase (TPase) and glycosyltransferase (GTase).  The GTase 
catalyses the formation of a β−1,4 glycosidic bond between the glycan units, 
resulting in a polymerised glycan chain. TPase (also called penicillin-binding 
protein) acts in the creation of a cross-linking bridge, a peptide bond between glycine 
of the pentaglycyl segment (L-Gly) 5 and a neighbouring stem pentapeptide L-Ala. 
The final three-dimensional PG structure serves as a lattice, which encapsulates the 
whole surface of the bacterium (Sharif et al., 2009; Typas et al., 2012).  
 
PG polymerisation, therefore, is achieved by the coordinated activities of two types 
of enzymatic reactions: transglycosylation (the formation of linear disaccharide 
glycan chains), and transpeptidation (the formation of peptide cross bridges between 
glycan strands. There are five different PBPs (PBP1-5) of S. aureus and these 
membrane-bound enzymes catalyse both transpeptidase and carboxypeptidase 
reactions. β-lactam antibiotics block cell wall synthesis by binding to enzymatic sites 
of PBP proteins (Chambers and Miick, 1992; Waxman and Strominger, 1983). The 
resulting growth inhibition is circumvented in S. aureus MRSA isolates, whereby an 
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alternative penicillin-binding protein (PBP2a) is expressed from the mecA gene, and 
this has reduced affinity for binding β-lactam antibiotics (Baek et al., 2014). All 
PBPs possess transpeptidase activity, however PBP2 possesses an additional 
transglycosylation activity. Two monofunctional transglycosylases (MGT), SgtA and 
SgtB identified in S. aureus have been confirmed to have transglycosylase activity in 
vitro. Curiously these proteins are not essential in S. aureus but, in the absence of 
PBP2 activity, SgtB is essential for bacterial viability, suggesting the bacteria need a 
single transglycosylases, either SgtB or PBP2 for their survival (Kuroda et al., 2003; 
Reed et al., 2011).  
 
Supplementing those activities outlined, in S. aureus there are additional genes for 
peptidoglycan synthesis including murA and murZ (also called murAB or murA2). 
MurA is a UDP-GlcNAc enolpyruvyl transferase enzyme that catalyses reaction of 
UDP-GlcNAc (UDP-N-acetylglucosamine) with phosphoenolpyruvate (PEP) as a 
committed stage for peptidoglycan biosynthesis. The key reaction product, UDP-
GlcNAc enolpyruvate is subsequently reduced to UDP-MurNAc (UDP-N-
acetylmuramic acid) as a PG biosynthesis precursor. The murA gene is conserved 
across the bacteria but Gram-positive bacteria harbour a murZ gene encoding UDP-
GlcNAc enolpyruvyl transferase enzyme (MurZ). The specific role of MurZ is 
unknown, though its expression was observed to increased when S.aureus was 
exposed to inhibitors of PG biosynthesis, indicating a potential contributory role in 
PG synthesis.  
 
Purification and characterisation has indicated that both MurA and MurZ enzymes 
are very similar biochemically. Both are essential genes in S. aureus, but during the 
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exponential phase, the expression level of MurA was observed to be higher than 
MurZ expression (Blake et al., 2009). Both PBP2 and MurZ expressions are 
controlled by the signal transduction system VraSR (Depardieu et al., 2007), which 
is discussed later.  
 
1.1.3.2 Peptidoglycan (PG) hydrolases 	
The activity of hydrolases is required to attach new peptides transferred by 
transpeptidases into the layers of PG. The PG requires cleavage of covalent bonds 
during its growth to allow newly attached peptide to insert between glycan layers 
without affecting its thickness. In addition, cleavage of PG is required for reductive 
cell separation. From studies of bacteria it is known that the hydrolases are necessary 
during cell division for separation of the daughter cells, and after this is completed, 
they sculpt the shape, thickness of PG and determine bacterial size (Typas et al., 
2012). The majority of PG synthesis takes place at the cross-wall peptidoglycan 
(mid-cell) that separates daughter cells during cell division (Frankel and 
Schneewind, 2012). Cell autolysis is directed by proteins with PG hydrolysis activity 
that are located at the cell wall of Gram-positive bacteria like S. aureus, including 
muramidase, endopeptidase, amidase and glucosaminidase activities (Fig. 1.3) 
Amidases have an important role in septum cleavage, and lytic endopeptidases and 
transglycosylases also contribute to cell separation (Typas et al., 2012). Three 
autolysins were identified in staphylococci that are responsible for hydrolysis of the 
cross-wall for separation of the daughter cells; Atl, Sle1 and LytN genes (Frankel 
and Schneewind, 2012).  
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Autolysin activity must be controlled to prevent cell lysis. Covalent modifications of 
the PG control the activities of autolysins. In a wide range of bacterial species, de-N-
acetylation, O-acetylation and N-acetylation of peptidoglycan are described as 
important for conferring intrinsic resistance to PG hydrolysis (Dupont and Clarke, 
1991; Raymond et al., 2005; Vollmer and Tomasz, 2000).   
 
1.1.4. Biofilm formation  	
Biofilm formation protects bacteria from disruptive environmental conditions 
including antimicrobial compounds and clearance mechanisms of host immune 
defence. The development of a biofilm structure is a complex process including three 
steps: initial attachment, accumulation (maturation) and dispersal (detachment). The 
initial bacterial attachment to a surface of metal (e.g. indwelling medical device) or 
plastic is dependent on bacterial surface components and the physicochemical 
properties of the surfaces. For example, initial attachment of S. aureus to these 
abiotic surfaces is governed by surface proteins; including autolysins (AtlA and 
AtlB), accumulation-associated protein (Aap) and teichoic acids (WTA and LTA) 
(Speziale et al., 2014). Contrastingly, attachment to a biotic surface or synthetic 
surface coated with host plasma proteins (e.g. fibrinogen, fibronectin) are controlled 
by cell wall-anchored (CWA) proteins of S. aureus (section: 5.3.6.). Bacterial 
communities in a biofilm structure (matrix) produce or release a wide range of 
contributory factors, including extracellular DNA (eDNA), proteins, and 
exopolysaccharides or other polymers. Clumping factor (ClfA), surface proteins 
SasC and SasG and serine aspartate repeat protein SdrC all contribute to biofilm 
formation either individually or together (Speziale et al., 2014).  
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Fig. 1.3. Cell wall structure of S. aureus and other Gram-positive bacteria. The 
major structural components; peptidoglycan (PG), periplasmic space, cell membrane 
and cytoplasm are indicated, except the polysaccharide layer above the PG. Both 
teichoic acids (LTA, WTA) are indicated. Synthesis of a new peptidoglycan strand 
begins when a precursor is synthesised in the cytoplasm, linked to the transport lipid 
(bactoprenol phosphate), and then flipped across the cell membrane. A lipid II 
subunit is polymerised by glycosyltransferase (GTase) to release undecaprenyl 
pyrophosphate and disaccharide glycan chains and attachment of a new chain of PG 
by a DD-transpeptidase (TPase). Adapted from (Madigan et al., 2003; Typas et al., 
2012). 
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Fig. 1.4. Schematic of peptidoglycan (PG) structure of S. aureus (left) and other 
bacteria, Gram-positive bacilli and Gram-negative bacteria (right). The activity 
of each enzyme (muramidase, endopeptidase, amidase and glucosaminidase) is 
indicated by a dashed arrow (Fournier and Philpott, 2005).  
 
 
 
strand is crucial for cytokine production, whereas stem peptide
structure does not seem to be critical for the inflammatory
activities of peptidoglycan.
Although peptidoglycan by itself promot s a weak induction
of cytokines, it shows synergistic effects with LTA or LPS
(221). Indeed, intravenous administration of staphylococcal
peptidoglycan or LTA alone cannot cause shock, whereas co-
administration of peptidoglycan with LTA in rats induces the
production of TNF-! and IFN-" in a synergistic way and pro-
vokes septic shock and multiple organ failure (31, 83, 188).
Furthermore, although intranasally inoculated LTA does not
synergize with peptidoglycan to induce the production of
TNF-! and the chemoattractants MIP-2 and keratinocyte che-
moattractant, these staphy ococcal components act n synergy
to elicit recruitment of PMNs into mouse lung (97).
Peptidoglycan of S. aureus also synergizes with low doses of
LPS to cause multiple organ failure (188). Furthermore, coin-
jection of peptidoglycan with LPS induces synergistic produc-
tion of TNF-! and IL-6 in the blood. Surprisingly, the release
of IL-10 was not modified by the coadministration of pepti-
FIG. 2. Structure of peptidoglycan of S. aureus and several other bacteria. The peptidoglycan of gram-negative bacteria and gram-positive
bacilli is indicated on the right. Digestion by different enzymes (glucosaminidase, muramidase, amidase, and endopeptidase) is shown by dotted
arrows. MDP structure is indicated in the dotted square. NAG, N-acetylglucosamine; NAM, N-acetylmuramic acid; m-DAP, m-diaminopimelic
acid.
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1.1.5. Regulation of virulence genes 	
Host infections reflect the coordinated expression of virulence genes. How S. aureus 
achieves this is only partly understood. Research has identified multiple global 
regulators that that hierarchically control S. aureus virulence factor expression, 
however a limitation of the experiments means it remains to be discovered exactly 
how all the regulatory proteins control specific responses to multiple environmental 
and nutrient conditions. Many genes that encode virulence proteins are regulated by 
multiple global regulators producing a response to the different signals that arise 
from the extra- and intracellular conditions (Dunman et al., 2001). Two major 
response networks most intensively studied to date coordinate expression of many 
virulence factors; the two-component signal transduction system (TCSTS) accessory 
gene regulator (agr) and staphylococcal accessory regulator (sarA) (Cheung et al., 
2008). These major regulatory pathways and the others that interactively control 
virulence are described in detail below.  
 
1.1.6. Quorum-sensing system (QS) 	
Bacterial communication is achieved by two types of signals; signals sensed by 
bacteria that are produced in adaptation to the environment, and signals directed by 
some bacteria for conjugation. In S. aureus, the small, secreted auto-inducing peptide 
(AIP) is used for signaling and communication is coordinated by the TCST system 
collectively called Agr. 
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1.1.6.1. The agrBDCA locus and its regulation  	
As previously described, in S. aureus there is growth phase-dependent expression of 
virulence factors (Arvidson and Tegmark, 2001; Cheung et al., 2008; Novick and 
Geisinger, 2008). The agr system is a TCSTS that enables S. aureus to adapt to its 
own population size then increase and decrease subsets of virulence proteins, in 
response to density governed by sensing the extracellular level of auto-inducing 
peptide (AIP), a small thiolactone ring peptide (Dunman et al., 2001; Lyon and 
Novick, 2004).  
 
The unique specificity of this QS system in staphylococci is that the major effector is 
RNAIII, a complex regulatory RNA, instead of the transcription factor response 
typically observed with other genera. This agr/RNAIII mechanism up-regulates 
secreted virulence proteins and toxins while concomitantly it down-regulates many 
virulence factors associated with the cell surface (Arvidson and Tegmark, 2001; 
Dunman et al., 2001; Novick and Geisinger, 2008; Recsei et al., 1986).  
 
The agr locus is a four gene operon, agrBDCA, with two divergent promoters, P2 
and P3 (Fig.1.5). The P2 promoter drives expression of the agrBDCA transcript 
(RNAII) and the P3 promoter is responsible for the RNAIII transcript.  AgrD is a 
propeptide whereby the N-terminus is used for membrane attachment and the C-
terminus interacts with AgrB, a transporter endopeptidase. The AgrD propeptide is 
processed by AgrB into a thiolactone peptide (AIP) and secreted (the mechanism of 
secretion still unknown).   The increasing concentration of AIP in the environment 
due to cell number will eventually stimulate the activation of the AgrC sensor by 
autophosphorylation on the membrane surface. The AgrC sensor transfers the 
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phosphate to AgrA enabling AgrA to bind to the intergenic region of agr P2-P3. 
AgrA thus produces upregulation of agrBDCA and RNAIII transcripts. The P2 
promoter acts in an autoactivation circuit so the RNAIII molecule serves as a 
regulatory effector of agr system via the P2 promoter (Dunman et al., 2001; Novick 
and Geisinger, 2008). This process will lead to amplifying AIP production. RNAIII 
is responsible for the major upregulation and downregulation of exoprotein 
production and surface proteins transcription respectively, during postexponential 
and stationary growth phases. 
 
1.1.6.2. RNAIII 	
RNAII is a 514 nucleotide riboregulator acting as the agr regulon effector. RNAIII 
folds as a stable, complex structure with regulatory RNA function; it also encodes a 
peptide of 24 amino acids (delta-hemolysin). The general structure of RNAIII is 
conserved across staphylococcal species. Functional analysis of the structure 
revealed that the 3’ end of RNAIII is required and essential for repressing the 
transcription of cell wall protein genes, such as protein A gene (spa), while both sub-
regions, 5’ and 3’ are active-independently and able to stimulate alpha-hemolysin 
gene (hla) transcription (Novick and Geisinger, 2008). Mechanistically, RNAIII 
binding to protein A (Spa) transcript sequence creates a substrate for RNase III to 
accelerate spa mRNA digestion (Morrison et al., 2012). RNAIII directs upregulated 
expression of alpha-hemolysin by interaction with secondary structure in the hla 
mRNA. Activation of the agr system also leads to stimulate and repress another 
TCST called SaeRS as well as the SarA-like repressor, Rot, by the same mechanism 
of its RNAIII interaction. At least two loops in the RNAIII structure is predicted to 
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interact with the rot mRNA transcript to prevent ribosome binding and translation 
(Cheung et al., 2004; Novick and Geisinger, 2008).  
 
 
 
 
Fig 1.5. The S. aureus agr system. The products of the Agr system: AgrA (response 
regulator), AgrD, AgrB and AgrC (sensor kinase) are indicated. Thiolactone peptide 
(AIP) induces a surface signal via the AgrC sensor, leading to transfer of a 
phosphoryl group to AgrA which activates agr system. The P3 promoter acts on an 
autoactivation circuit for transcription of RNAIII, which serves as the regulatory 
effector of agr system. Partially adapted from Novic and Geisinger (2008).(Novick 
and Geisinger, 2008).  
interact with the rot mRNA transcript to prevent ribosome binding and translation 
[Cheung et al., 2004; Novick and Ge singer, 2008].  
 
 
 
AgrA 
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1.1.7. Accessory sigma factor B (σB) 	
The alternative σ factors of S. aureus include σH, σB and σS (Bischoff et al., 2004). 
Of these, σB has the best-understood role in cell biology of the organism. A total of 
198 genes are regulated by activity of σB, including several adherence and virulence-
associated genes that are up-regulated, whereas transcription of multiple toxins and 
exoproteins are repressed. This identified that σB can act conversely to the agr 
operon effector, RNAIII. σB activates upregulated expression of genes associated 
with peptidoglycan synthesis and hydrolysis activity together with genes for cell 
surface proteins such as, clumping factor (clfA), fibronectin-binding protein (fnbA), 
UDP-N-acetylglucosamine transferase (murA), holin-like proteins (lrgA and IrgB) 
and peptidoglycan hydrolase (lytM). In addition, the virulence regulator genes sarA, 
sarS and RNAIII are up-regulated by σB (Bischoff et al., 2004). Regulation of the S. 
aureus crtOPQMN operon encoding enzymes for biosynthesis of the C30 triterpenoid 
carotenoid that is the characteristic golden pigment of the species occurs solely by 
σB-dependent transcription (Lan et al., 2010).  
 
1.1.8. Rot   	
The transcription factor Rot (repressor of toxins), has an opposite role to RNAIII by 
down-regulating expression of secreted proteins, as when repressed by RNAIII, and 
up-regulating the expression of the cell surface proteins such as protein A (Spa). 
(Morfeldt et al., 1995; Novick and Geisinger, 2008).  
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1.1.9. SarA family of transcriptional regulators  	
In additional to the agr system, S. aureus expresses various other regulatory proteins 
to control virulence factor production during growth and infection. The sarA family 
of proteins is involved with the regulation of many virulence proteins either directly 
or in coordination with agr.  
 
The 1.2 kb sarA locus, is transcribed as three overlapping transcripts: sarP1 (0.58 
kb), sarP3 (0.84 kb) and sarP2 (1.15 kb) that are under temporal control during the 
growth cycle. The 3’ end sequences of these transcripts are identical, but driven by 
three independent promoters (P1, P3 and P2) overlapping transcripts are produced, 
each of which encodes the main 372-bp sarA gene that yields a 14.5-kDa SarA 
protein (Bayer et al., 1996; Manna and Cheung, 2001). The prototypic member of 
the SarA family is central for the regulation of virulence factors productions (Cheung 
et al., 2008; Liu et al., 2006).  In contrast to RNAIII, SarA is constitutively 
expressed during S. aureus growth phases, however, the complement of sarA 
transcripts differs during growth phases. Both sarP1 and sarP3 are initially 
transcribed within exponential growth phase, while sarP2 is expressed throughout 
stationary growth phase (Manna et al., 1998; Morrison et al., 2012).   
 
In contrast with the agr locus, SarA activates the expression of exoproteins (e.g. α, β 
and δ toxins, proteases) and cell surface proteins (e.g. Spa, FnbA), either directly or 
via upregulation of the agr locus. SarA binds to the promoters of a range of genes, 
including spa, hla, fnbA, agr, cna (collagen adhesin) and the ica operon (for biofilm), 
(Cheung et al., 2004; Didier et al., 2010; Manna and Cheung, 2001) (Table 1.2). 
Studies indicated that SarA regulates expression of its target genes by directly 
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binding to promoters of target genes, or by stabilising mRNA, or indirectly through 
downstream effectors (e.g. SarA binds agr promoter to modulate RNAIII) (Cheung 
et al., 2008; Manna and Cheung, 2001). In addition, SarA binds to the promoters of 
further SarA-like regulators such as sarS and sarV (Didier et al., 2010).  Valle and 
colleagues discovered that SarA was able to bind to the ica operon, responsible for 
expression of polysaccharide intercellular adhesin PIA, and improved biofilm 
formation (Ruch et al., 2003). Biofilm formation and related effects are described in 
(section 5.3.6).  
 
From Table 1.2, it is clear that SarA has regulatory activities to repress and stimulate 
its target genes. In vitro, the maximum level of the separate sarA transcripts was 
observed during postexponential growth phase.  Each transcript in the sarA locus is 
repressed multiply; by the SarR protein (generally binding sarP1 transcript 
promoter), by SigmaB (binding central of P3), and by its product, the SarA protein 
(binding to P1 and P3) (Cheung et al., 2008; Manna et al., 1998). Whether total SarA 
production alters during growth cycle and the significance of this amount on 
bacterial physiology is debatable (Manna and Cheung, 2001). Didier and co-workers 
found that phosphorylation of SarA was the key effected upon its capacity to bind 
DNA. Phosphorylation of SarA was observed in vivo, as a step of post-translation 
modification, but it was not reported in vitro (Didier et al., 2010) and may be related 
to environmental cues. 
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Table 1.2 Virulence factors regulated by agr and sarA up to 2004. Adapted from 
(Cheung et al., 2004) 
 
Virulence factors																																																																																						Strains		 	agr	 sarA	
Aureolysin (Metalloprotease)  +	 -	
Enterotoxin B +	 +	
Enterotoxin C +	 Unknown	
K-hemolysin  +	 +	
L-hemolysin +	 +	
N-hemolysin +	 +	
Q-hemolysin +	 +	
exfoliatins A and B +	 Unknown	
Fatty acid modifying enzyme FemA  +	 +	
FemA	 Unknown	 +	
FemB +	 Unknown	
HysA (hyaluronate lyase) +	 Unknown	
Lipase +	 -	
Phospholipase C +	 Unknown	
Set8 (exotoxin) +	 Unknown	
Set9 (exotoxin) Unknown	 +	
SplA, B, D and F (proteases)  +	 +	
SspB (cysteine protease) Unknown	 -	
Staphylokinase +	 Unknown	
TSST-1 +	 +	
V8 protease (SspA) +	 -	
Clumping factor A No	effect	 Unknown	
Clumping factor B No	effect	 +	
Coagulase -	 +	
Collagen-binding protein  ±	 -	
Capsular polysaccharide (type 5) +	 +	
Fibronectin-binding protein A -	 +	
Fibronectin-binding protein B -	 +	
GyrA -	 Unknown	
LrgAB +	 +	
PBP3 Unknown	 -	
Protein A -	 -	
SdrC Unknown	 +	
Vitronectin-binding protein  -	 Unknown	
 * (+) Up-regulated and (-) Down-regulated (±) in certain strain up-regulated 
while others down-regulated  
		 		
 
 
Although SarA is the best studied member of the SarA family, there are ten SarA-
like proteins reported, six of which are partially described: SarS, R, T, U, V, and 
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MgrA (Rat) (Liu et al., 2006). Several of these SarA homology proteins are 
described briefly as they are outside the scope of this study (Cheung et al., 2004; 
Cheung et al., 2008; Manna and Cheung, 2001).  
 
1.1.10. SarA homologues  
1.1.10.1 SarS and SarT 	
Activation of the requlatory systems agr, SaeRS, and Rot, leads to downregulation of 
two gene products, SarS and SarT. The SarT protein is a single domain SarA 
homologue (118 amino acids) that is usually repressed by Agr and SarA. The 
expression of sarT leads to upregulated production of SarS (250 amino acids) that in 
turn upregulates spa expression and down-regulates alpha toxin (hla)  (Cheung et al., 
2004; Cheung et al., 2008). It was proposed RNAIII may repress the expression of 
the spa gene indirectly by downregulation of sarT production that would reduce sarS 
production.  SarA represses sarT to upregulate alpha-toxin production (Cheung et al., 
2004; Cheung et al., 2008). SarT can act as repressor of both RNAIII and hla 
transcription highlighting a complex network (Schmidt et al., 2001).  
 
1.1.10.2. SarU  	
The expression of sarU (247 amino acids) is controlled by SarT production. It was 
observed that SarU can regulate RNAIII and contributes to the expression of the 
majority of virulence factors that are controlled as part of the agr regulon (Cheung et 
al., 2008; Manna et al., 2004).  
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1.1.10.3. SarV  	
sarV encodes a 116-residue transcription factor of the SarA family that is expressed 
at a low level under in vitro conditions; sarV is expressed significantly more highly 
in both sarA and mgrA mutants (Cheung et al., 2004; Novick, 2003), with both gene 
products being determined to be sarV gene repressors. Similar to those genes 
involved in virulence and autolysis controlled by sarA and mgrA (Table 1.2) SarV 
regulates the same virulence factors, and additional genes for autolysis (atl, scdA, 
irgB) and protease (splA) (Cheung et al., 2004; Novick, 2003). In contrast to the 
effect with sarA and mgrA mutations, the inactivation of sarV led to increased 
resistance to both penicillin-and Triton X-100-induced lysis, compared with its 
parent strain; Overexpression of sarV decreased autolysis, suggesting that SarV acts 
to control selective genes concerned with lysis (Manna et al., 2004).  
 
1.1.11. MgrA 	
MgrA (also named Rat) is a global regulatory member of the SarA protein family. 
MgrA is a key regulator of autolytic activity in S. aureus (section 5.3.4) and 
inactivation of mgrA produced a growth defect and also increased penicillin and 
Triton X-100-induced autolysis (Ingavale et al., 2003). MgrA modulates expression 
of virulence genes and mutation also increased expression of both sarS and spa, with 
downregulation of agr, RNAIII and hla. Despite both agr and SarA upregulating hla 
and downregulating spa transcription, sarA transcription was unaffected by mgrA 
mutation, indicating a direct role for MgrA in regulation of both spa and hla genes in 
a SarA-independent manner. MgrA binds promoters of both sarS and hla to 
modulate expression, highlighting the complex interaction between MgrA and other 
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regulators, SarS, SarT and agr as an interconnected virulence regulatory network 
(Ingavale et al., 2005). S. aureus resistance to methicillin and vancomycin. are 
reported to be associated with oxacillin, ciprofloxacin and vancomycin resistance, 
particularly in MRSA isolates (Didier et al., 2010).  
 
1.1.12. SarR 	
SarR is a further SarA family DNA-binding protein (115 amino acids) that can 
repress expression of sarA gene. Inactivation of sarR affects regulatory gene 
expression (e.g. agr system) (Cheung et al., 2008). In addition inactivation of both 
sarR and sarA together revealed that during early growth phase both genes 
contributed to regulating expression of agr. SarR has potential to bind the same 
region as SarA on the agr promoter meaning they work together as key regulators of 
agr activity. (Manna and Cheung, 2006). SarR has a key role in regulating virulence 
genes, such as sspA (V8 serine protease) and aur (metalloprotease aureolysin) 
(Gustafsson and Oscarsson, 2008). Tamber and colleagues identified a repressor of 
SarR transcription called the rsr locus (Tamber et al., 2010).  
 
1.1.13. Two-component signal transduction systems (TCSTS) 	
The TCSTS play an essential role in bacterial adaption, virulence and survival by 
sensing external environmental changes and modulating expression of genes in 
response to a wide range of stimuli (Zhu et al., 2010). TCSTS pathways comprise a 
phosphotransfer reaction that occurs between two conserved components, a histidine 
kinase (HK) and a response regulator (RR) (Gao and Stock, 2009). The HK is 
characteristically the input element of the signal pathway, which is designed to sense 
		 32	
the external stimulus to input into the signalling pathway. The RR is 
characteristically the output of the system, controlled by the HK component to effect 
the cellular response. The HK component auto-phosphorylates at a coserved histidine 
generating a phosphoryl group that is subsequently transferred onto aspartate of the 
RR, which activates it to obtain a response. This activation of the RR component will 
lead to regulated expression of the target regulon (Gao and Stock, 2009).   
 
TCSTS systems are involved with most biological networks of the microbe, 
including regulation of virulence factors (Martin et al., 1999). Several fundamental 
TCSTS have been described among bacterial species involved in key bacterial 
processes. For example, in the bacterium Caulobacter crescentus, the ctrA gene 
encodes a RR required for restriction of DNA replication and regulation of 
membrane protein expression, whereas the resDE system genes regulate expression 
associated with respiration and oxygen availability (Martin et al., 1999). The genome 
of S. aureus includes sixteen TCSTS systems and one additional system located on 
the island SCCmec (staphylococcal cassette chromosome mec). The agr system 
(previously described) contains a TCS in its locus encoded by agrCA genes 
(Fig.1.4.). Other relevant systems for this study include those encoded by saeRS, 
srrAB, arlSR, yycFG and lytSR (Kuroda et al., 2003; Martin et al., 1999; Novick, 
2003).  
 
1.1.13.1. SaeRS TCSTS 	
Staphylococcal accessory element (Sae) locus is central to the regulation of many 
secreted virulence factors upregulating hla, coa and hld genes and downregulating 
spa and sspA genes (Giraudo et al., 1999; Giraudo et al., 1997). The sae locus 
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contains saeR and saeS genes, encoding the two-component system RR and HK, 
respectively. Inactivation of sae leads to reduced levels of alpha -and beta-
hemolysin, coagulase and DNase with it having a cntral role for expression of 
exoproteins (Giraudo et al., 1999). SaeRS is proposed to be concerned with 
coordinating the environmental signalling via the quorum-sensing agr system 
(Novick, 2003). Of note, the wild-type strain Newman, commonly used for virulence 
assays, has a proline (Pro18) instead of leucine (Leu18) in its SaeS domain compared 
with other staphylococcal strains.  This single change in SaeS is responsible for 
increasing the phosphorylation level of SaeR, leading to increased expression of 
some virulence proteins. It is believed that the expression of target genes is 
dependent on the extent of SaeR phosphorylation. For example, a high level of SaeR 
phosphorylation is necessary for expression of class1 genes, including sbi (IgG 
biding protein, Sbi), fnbA (fibronectin binding protein A), fib (fibrinogen binding 
protein Fib), efb (fibrinogen binding protein Efb), coa (coagulase), eap (extracellular 
adherence protein, EAP), sae genes. A low level of SaeR phosphorylation, occurring 
independent of sensory SaeS, is sufficient to express the class II genes, including hla  
and hlb genes. Finally, in some strains the transcription of the sae locus is activated 
by the agr system, while sigB and rot contribute to repression (Mainiero et al., 
2010).  
 
1.1.13.2. SrrAB 	
The staphylococcal respiratory response system (SrrAB) is a TCSTS that regulates 
energy transduction based on the oxygen levels (Pragman et al., 2007; Pragman et 
al., 2004). SrrA is a 28-kDa response regulator located in the cytoplasm of S. aureus, 
whereas, SrrB is a 66-kDa histidine kinase located to the membrane (Pragman et al., 
		 34	
2004). SrrAB is required for expression of spa, icaR (transcriptional repressor of 
icaADBC) and tst genes by binding to region of promoters under aerobic condition. 
Thus, SrrA can act to increase production of both Spa and TSST-1, to enhance 
virulence factor expression in an environment supplemented with oxygen, whereas 
modukating the IcaR level alters the ica locus expression for biofilm formation. 
Overexpression of SrrAB was reported to decrease virulence in an animal model of 
infection and reduce biofilm formation in microtitre plates. SrrAB regulates genes 
controlling metabolism including enzymes such as, aconitase and fumarase (Throup 
et al., 2001).  
 
1.1.13.3. ArlSR 	
Autolysis-related locus (ArlSR) is a TCSTS involved in cell wall regulation together 
with several virulence genes. Inactivation of either arlS or arlR increased the 
production of Spa, V8 serine protease, Coa, Hla, and lipase, indicating that arlSR 
down-regulates the transcription of their cognate genes (Fournier et al., 2001). In 
addition, inactivation of arlSR causes decreased sarA transcription, but increases the 
level of RNAII and RNAIII transcripts. Finally, this system was not reported to be 
auto-regulated however, the expression of arlSR locus was stimulated by sarA and 
agr systems, indicating their interaction (Fournier et al., 2001). Its role in regulation 
of virulence factors expression remains to be investigated including its mechanisms. 
ArlRS was reported to be involved in biofilm formation of S. aureus on a 
polystyrene plate (Zhu et al., 2010). 
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1.1.13.4. VraSR 	
The exposure of S. aureus to inhibitors of cell wall synthesis immediately affects the 
transcription of many genes associated with cell wall biosynthesis, such as pbp2, 
sgtB, murZ and vraSR; these genes are part of a cell wall stimulon (Gardete et al., 
2006). In this study, transcription of 139 genes was upregulated by vancomycin 
challenge, with 46 of these not induced in a vraSR mutant indicating a TCSTS 
regulon associated with peptidoglycan synthesis: pencillin-binding protein 2 (PBP2), 
UDP-N-acetylglucosamine enolpyruvyl transferase (MurZ) and monofunctional 
glycosyltransferase (SgtB). The VraS HK responds to fragments of damaged 
peptidoglycan when cell wall synthesis is inhibited. VraSR is an important positive 
regulator in the biosynthesis of peptidoglycan and significantly increases bacterial 
resistance to antibiotics such as glycopeptides and β-lactams (Kuroda et al., 2003). 
Research has proposed that peptidoglycan damage is the main source activating this 
TCSTS from responses of the VraS phosphorylation state. This system therefore 
appears to serve as a sentinel with the capability of sensing damages in the cell wall 
peptidoglycan to rapidly coordinate responses to generate a resistance phenotype in 
S. aureus (Belcheva and Golemi-Kotra, 2008).  
 
1.1.13.5. LytSR 	
In S. aureus, cells of a lytS mutant form aggregates in liquid culture and display an 
increased rate of autolysis when challenged with either penicillin or Triton X-100 
inducers. On this basis it was proposed that the LytSR TCSTS participates in either 
modulation of murein hydrolase activities or gene expression. A lytS mutant also 
exhibited greater biofilm formation in a microtitre plate assay (Zhu et al., 2010). 
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The expression of two genes lrgA and lrgB regulated by LytSR, together with Agr 
and SarA in S. aureus in particular is involved in blocking murein hydrolases in 
peptidoglycan (Groicher et al., 2000; Zhu et al., 2010). The LytSR TCSTS serves to 
sense damage in cell peptidoglycan and induce the expression of lrgAB operon to 
limit damage. A lytSR mutation limits lrgAB expression and induces autolysis by 
increasing susceptibility to Triton X-100, supporting this TCSTS having an 
important role in the regulation of hydrolase activity (Lehman et al., 2015; Zhu et al., 
2010). Overexpression of LytR (RR) increased lrgAB promoter activity during 
growth and changed morphology of biofilm (Lehman et al., 2015).  
 
1.1.13.6. WalKR  	
The WalKR (also called YycG/YycF) two-component system was first identified in 
Bacillus subtilis as encoding an essential TCSTS.  This system (WalKR) is 
conserved among Gram-positive bacteria, including Streptococcus pneumoniae and 
S. aureus. The auto-phosphorylation of WalK (HK) leads to transfer of its 
phosphoryl group to the cytoplasmic WalR protein (RR) (Dubrac and Msadek, 
2004).  WalR regulates transcription of multiple genes associated with peptidoglycan 
biosynthesis and modification that accounts for the essential requirement of this 
TCSTS in the viability of many Gram-positive bacteria, including S. aureus (Dubrac 
and Msadek, 2004; Martin et al., 1999). The walkR locus is expressed during the 
exponential phase and then turned off at the beginning of stationary phase, indicating 
that this TCSTS has its important role during the exponential growth phase (Dubrac 
and Msadek, 2004). Dubrac and colleagues examined the essential role of WalKR in 
S. aureus strain ST1000, constructed as an IPTG-dependent inducible walkR 
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expression. Fluorescence microscopy combined with viability stains indicated that in 
the absence of IPTG >90% of bacterial cells were dead and had tended to aggregate 
but no cells lysis was detected.  The presence of IPTG maintained 100% viability 
(Dubrac et al., 2007). Cells become more resistant to lysostaphin under WalkR 
depletion (Dubrac et al., 2007), indicating its role in cell wall structure and function.  
Initial study by the same group indicated that WalkR regulates the expression of 
genes associated with cell wall hydrolysis, including lytM (Dubrac and Msadek, 
2004). Subsequent study confirmed that nine cell wall function genes, lytM, ssaA, 
isaA, atlA, sceD and four ssaA-homologous genes involved in different steps of 
bacterial cell wall homeostasis were regulated by WalKR. LytM and AtlA comprise 
the major autolysin activities of S. aureus.  
 
When peptidoglycan structure was analysed under conditions of WalkR depletion the 
length of the glycan chain and cross-linking of peptidoglycan were significantly 
increased.  The observed increase in length of glycans could result from a lack of 
SceD and IsaA muramidase activities. The disaccharide N- acetylglucosamine-β-
(1,4)-N-acetylmuramic acid disappeared when WalkR transcription was limited 
implying an arrest of peptidoglycan synthesis and indicating this system is required 
for the turnover of cell wall by regulating both degradation and biosynthesis of 
peptidoglycan (Dubrac et al., 2007). Strains producing high levels of the WalR 
response regulator, exhibited reduced virulence and this was proposed to be due to 
increased levels of released peptidoglycan fragments being recognised early by the 
host immune system, and implying this system controls autolytic activity in vivo 
(Delaune et al., 2012).  
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Peptidoglycan integrity is critical for the cell viability and cell wall metabolism 
genes are tightly regulated. WalKR is a TCSTS identified as positively regulating 
peptidoglycan hydrolase synthesis, with three regulatory systems acting to repress 
peptidoglycan hydrolytic activities: LytSR ArlSR, and MgrA, all described above 
(Brunskill and Bayles, 1996; Fournier et al., 2001; Ingavale et al., 2003). Cell wall 
metabolism contributes to many phenotypes including sensitivity to many 
compounds that target the bacterial cell wall, especially antibiotics. A defect in 
autolysins leads to the tendency of single cell suspension to aggregate, notably 
observed with an atlA mutant (Dubrac et al., 2007). The WalKR TCSTS is indirectly 
involved in biofilm formation of S. aureus. Depletion of this TCSTS causes a defect 
in primary adherence and impairs biofilm formation (Dubrac et al., 2007).  
 
The dynamics of peptidoglycan play an important role in pathogenicity of S. aureus; 
specifically, the anchored display of cell-wall-anchored molecules (e.g. WTA, Sbi, 
Spa, FnbA), the maintenance of cell shape, and the controlled degradation of 
peptidoglycan to limit release fragments of muropeptides, which are powerful 
virulence effectors and immune alarmones.  
 
1.2.Thesis aims 	
S. aureus is responsible for a wide variety of infections and can survive in multiple 
niches. The success of this bacterium is attributed to its capacity to secrete many 
surface proteins that modify, protect and maintain cell wall structure from 
environmental pressures. S. aureus is often described as being multifaceted, flexible 
and adaptable in its interactions, especially in its response to environmental changes.  
In this context, there remain secreted proteins that have unknown function and a 
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description of their roles will help to better understand the lifecycle of this 
opportunist pathogen and the potential opportunities for design of new therapies. 
 
The main aim of this study was to use bioinformatics methods to investigate S. 
aureus secreted proteins of unknown function to determine potential functions from 
their primary sequences by comparison with described motifs and homologous 
structures.  These studies would inform potential biochemical functions of the 
proteins that would be tested experimentally. 
 
From the bioinformatics predictions, laboratory investigations were planned to use a 
variety of molecular and biochemical studies of the purified proteins and inactivation 
of the cognate genes in S. aureus. It was anticipated that results from these studies 
may shed light on the molecular mechanisms that the target proteins had in specific 
infection and survival pathways such as immune evasion, metabolism, antimicrobial 
resistance or survival on the host. 
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CHAPTER 2 
 
2. Bioinformatics analysis  
 
 
2.1. Introduction  
 
Significant changes in S. aureus epidemiology reported in recent years demonstrate 
that S. aureus, and most remarked its methicillin-resistant form, is evolving as a 
global pathogen causing both hospital and community-acquired infections 
(Vandenesch et al., 2003; Voyich et al., 2005). Since the first genome sequences of 
two S. aureus strains (N315 and Mu50) were published (Kuroda et al., 2001), many 
additional virulence factors have been demonstrated. In one study, analysis of the 
proteome using 2D gels and mass spectrometry revealed that nearly 1000 out of 2600 
proteins were still of unknown function [Hecker et al., 2010]. This study also 
demonstrated that particular secreted proteins of unknown functions were expressed 
in specific conditions. The experimental characterisation for each protein is 
expensive and time consuming {Watson and Thornton, 2009}, resulting in large gaps 
in our understanding of staphylococcal biology. 
 
2.1.1. Signal peptide mediated protein secretion 
 
Investigations of secreted protein functions and their cognate secretion systems in 
Gram-positive bacteria are increasingly important with some, e.g. bacilli, 
staphylococcal streptococci, of medical interest and high commercial value. The 
study of different protein secretion systems and their functions directly contribute to 
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increasing the knowledge required to facilitate the rational design of novel drugs 
(Oudega, 2003). 
 
In eukaryotic and prokaryotic cells, most proteins destined to be exported from the 
cytosol (the exoproteome), to become part of the cell surface interface or the 
extracellular milieu contain a specific targeting signal sequence within the protein 
sequence, called the signal peptide (SP) (Sibbald et al., 2006; Vonheijne, 1990). 
Most exoproteins are synthesized as preproteins (precursors) with an N-terminal 
signal peptide (SP) and these precursors are initially recognized by soluble factors 
that target them into the translocation system at the cell membrane. Subsequently, the 
preprotein is transported via a proteinaceous channel that acts as a translocation 
motor. The SP is then removed which releases the final protein from the membrane 
and immediately the mature protein folds into its native conformation (Tjalsma et al., 
2004) 
 
Although signal peptides play an important role in directing proteins to their correct 
cellular compartments, they share no sequence homology (Paetzel et al., 2002). In 
general, each SP consists of three distinct domains: a positively charged amino-
terminal region (N-region); a hydrophobic region (H-region); and a carboxy-terminal 
domain (C-region) that is polar (Vonheijne, 1990). In bacteria, the N-region typically 
contains positively charged arginine (R) or lysine (K) amino acids that are proposed 
to interact with both the negatively charged phospholipids of the lipid bilayer and the 
translocation system (Akita et al., 1990; Vonheijne, 1990). The H-region formed by 
hydrophobic residues can adopt an α-helical structure in the membrane. In the centre 
of the hydrophobic region, helix-breaking proline or glycine residues are usually 
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present to allow the formation of a hairpin-like structure that has ability to insert into 
the cell membrane (Tjalsma et al., 2004). Following this region, the C-domain has a 
small sequence motif at the end, in forms Ala-X-Ala.  This motif acts as a 
recognition sequence for the enzyme signal peptidase  (SPase) that cleaves this SP 
immediately after translocation (Wooldridge, 2009)  
 
Prokaryotic SPs are categorised by the modification and transport pathways into 
which SPs direct proteins. Currently, four distinct types of SP are known that share a 
common structure but differ in other details (Fig. 2.1.). Two SP types target the Sec 
pathway: the secretory signal peptide (Sec-type) and lipoprotein signal peptide.  The 
other two SPs, the type IV (pseudopilin) SP and twin-arginine SP, use different 
pathways, namely the pseudopilin export and tat pathways, respectively. All 
preproteins with these SPs are processed by various signal peptidases (SPases) and 
are directed to various cellular destinations (Sibbald et al., 2006). In general, 
preproteins with a twin-arginine SP are processed by type I SPase and directed to the 
cell wall or released extracellularly(Tjalsma et al., 2004). Preproteins with a type IV 
SP are processed by type IV pseudopilin SPase (ComC) and are proposed to localise 
to the membrane or cell wall. However, these proteins represent the smallest group 
of secreted proteins compared with the majority of secreted proteins labelled with 
either lipoprotein or sec-type SPs (Antelmann et al., 2001; Tjalsma et al., 2000)    
 
Similarly in S. aureus, preproteins that contain sec-type SPs are processed by type I 
SPase (SpsB) and are targeted to the cell wall or extracellular milieu. However, 
preproteins containing a lipoprotein SP are firstly lipid modified by phosphatidyl 
glycerol diacylglyceryl transferase (Lgt) then processed by the type II SPase (LspA). 
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Prolipoproteins originally thought to be retained to the cell membrane for interacting 
with the milieu (Antelmann et al., 2001; Sibbald et al., 2006).  
 
 
 
 
Fig. 2.1. General properties and classification of signal peptides of S. aureus.  
The four described SP features: sec-type (A), twin-arginine (B), lipoprotein (C) and 
prepilin  (D).  Figure modified from (Paetzel et al., 2002; Sibbald et al., 2006). 
%%%%%%%%%%%% %%%%%%%%%%%%%%%%%%%%%%
+N:region! H-region     C-region   AXA +1 A   H-region 
+N:region! H-region     C-region   AXA +1 A    H-region 
+N:region! H-region     C-region   LXX +1 C     H-region 
+N:region!XA! +1 F                          H-region 
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2.1.2. Predicted protein function 
     
Despite infections with S. aureus being common worldwide, the key processes 
causing the different disease stages of colonization, invasion of host cell and 
persistence in tissues or other environments of host are not fully understood 
(Francois et al., 2010). During the last decade, advancing methods led to sequencing 
of entire genomes of numerous pathogenic bacteria. The sequencing of S. aureus 
genomes revealed a high heterogeneity among different strains within the accessory 
genome, with around 75% of the sequences being conserved and thus representing 
the core genome. The studies also revealed several virulence factor-associated genes 
belong to this core part of the sequence in addition to housekeeping genes (Lindsay, 
2008; Peacock et al., 2002).  
 
From the first genome sequences of S. aureus (strains N315 and Mu50) (Kuroda et 
al., 2001), it was found that S. aureus codes for 2600 - 2700 proteins.  Rapidly this 
revealed ~1000 of these proteins were of unknown function (Hecker et al., 2010). 
Although the primary protein sequence presents valuable information, predicting 
function is known as one of the difficulties in biology. More recently functions have 
been predicted from distant homologies with bioinformatics tools such as HHpred 
(based on HHsearch and HHblits) together with predicted structures generated by 
homology modelling to infer a general function for a target protein (Rigden, 2009). 
In the study of bacterial pathogenesis proteins of unknown function that contain a SP 
make obvious targets for initial study since they have the greatest potential for host 
interaction (Lazarevic et al., 2011b; Sibbald et al., 2006). 
 
Several bioinformatics tools have been developed for protein function prediction 
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with different degrees of success.  Since molecular experimental study to 
characterise protein function is expensive and time-consuming, bioinformatics 
methods help address the prediction of protein function from sequence and structure 
data  (Watson and Thornton, 2009). Combining the signatures of active site, catalytic 
site and motifs can be used predict the function from the primary sequence of a 
protein (unknown function). This approach, using database of several protein 
families, including homologues domain and motifs to predict a function for a 
unknown protein function (Whisstock and Lesk, 2003). In addition, the meta-PPISP 
server was used for predicting possible protein-protein interaction sites (Qin and 
Zhou, 2007).  
 
2.2. Chapter aims  
 
To identify potential functions in the exoproteome of S. aureus bioinformatic 
methods will be applied to determine the proteins with signal peptides to direct them 
through sec-pathway. This dataset will be refined by analysing the sequences of 
these proteins with bioinformatics approaches together with their metadata to 
separate unknown function proteins for further investigation. Finally, advanced 
bioinformatics will be used on a small subset of 3-4 proteins to predict function, 
which could involve modelling template structures with the query proteins.  
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2.3. Bioinformatics Methods  
  
2.3.1 Determining the exoproteome of S. aureus 	
2.3.1.1 Identification of proteins with a signal peptide (SP) 	
 To identify the signal peptide-bearing proteins of S. aureus Newman, the complete 
annotated proteome sequence comprising 2583 proteins was obtained from the 
UniProtKB database (Magrane and Consortium, 2011), (http://www.uniprot.org/). 
This dataset was interpreted locally using the prediction program SignalP 4.0 
(Petersen et al., 2011) to determine the secreted protein fraction. This program is a 
convenient tool to distinguish between non-signal peptides and signal peptides and 
identify cleavage sites (Petersen et al., 2011). Additionaly, PRED-LIPO method 
(Bagos et al., 2008), was used in this study for prediction of lipoprotein signal 
peptide of S. aureus proteins.   
 
2.3.1.2. Predicting function of uncharacterised proteins 
 
Multiple Sequence Alignment (MSAs) and homology detection are basic elements of 
bioinformatics methods and, with many applications, can be used to predict function, 
three-dimensional structure of a protein. Highly sensitive tools can identify and align 
distantly similar sequences that may provide information about a predicted protein, 
such as function, type of structure or evolution. Many programs have been developed 
to predict function this way, such as the HH-suite methods that are sensitive and 
accurate because of their ability to identify evolutionary relatives between different 
protein families; this is done by distinguishing between non-conserved and 
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conserved positions of residues among members of the family (Soding et al., 2005). 
HH-suite methods were used in this study. 
 
The HH-suite software package was used locally in this project. The open source 
software is used for sensitive sequence searching based on the pairwise alignment of 
Hidden Markov Models (HMMs); it contains rapid iterative protein sequence and 
search tools (Remmert et al., 2012). HHblits is a faster and more sensitive tool 
compared with methods such as HMMER3 and PSI-BLAST. A build of multiple 
sequence alignments (MSAs) is converted to a HMM by adding pseudocounts of 
amino acids that are similar to the amino acids in the query sequence. HHsearch is 
used as a powerful implementation of the HMM comparison to find regions of 
uncharacterised proteins that match either known domains (e.g. in Pfam) or 
structures (in PDB) (Berman et al., 2000; Punta et al., 2012).  
        
2.3.1.3 Modelling structure  
 
This study predicted the potential structure for a subset of target proteins. Depending 
on whether homologous proteins having been identified, prediction methods that can 
be used for protein structure are divided into two types.  First, if the target protein is 
similar to the structure of a matched protein (template), the model is built by copying 
the framework of this template; this is called template-based modelling (TBM) or 
homology modelling.  Second, if there are not available templates, modelling of 
structure is used to build 3-dimensional structures from scratch; this procedure is 
called ‘ab initio modelling’ and is only applicable to small protein < 150 residues 
(Rigden, 2009).  
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2.4 Bioinformatics results and analyses methods 	
2.4.1. Identifying sec-dependent secreted proteins of S. aureus. 
 
The described bioinformatics methods were used to analyse the encoded 2583 
proteins of S. aureus Newman strain.  Each of the proteins that harboured an N-
terminal sequence signal peptide (SP) motif was identified and collated.  The 
analysis using SignalP 4.0 and PRED-LIPO programs indicated that the S. aureus 
Newman encodes 169 proteins that are apparently secreted through the sec pathway. 
Based upon bioinformatics methods, including HHpred and an analysis of metadata 
and information collected from databases and literature sources, it was determined 
that 56 (33%) of these secreted proteins were still regarded as hypothetical or being 
of unknown function. Of these unknown function proteins, 24 (43%) harboured the 
feature sequence of lipoproteins or lipobox sequence, with many containing motifs 
associated with enzymatic functions (Table 2. 1.).   
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Table 2. 1. SignalP 4.0 and HHpred analysis of S. aureus Newman proteins of 
uncertain function. Protein sequence matches to databases are listed with > 80% 
probability.  
 
 Gene ID 
Protein sequence HHpred-homologous Note 
Protein ID Length 
(aa) 
SP 
Type Functional information 
 
1 NWMN_0022 A6QD62 772 Sig. 5'-nucleotidase; metallophosphatase  
2 NWMN_0181 A6QDM1 92 Sig. PTS system, galactitol-specific IIB component; 
Escherichia coli 
 
3 NWMN_1863 A6QIF3 280 Sig. DUF4097:  Domain of unknown function  
4 NWMN_1649 A6QHT9 2186 Sig. Hypothetical protein  
5 NWMN_0161 A6QDK1 322 Lipo. Putative iron-uptake ABC transport  
6 NWMN_0087 A6QDC7 514 Sig. Family: ThuA (PF06283)  
7 NWMN_0078 A6QDB8 241 Sig. Receptor tyrosine kinase  
8 NWMN_2392 A6QJY2 1501 Sig. PF07501- G5:  G5 domain  
9 NWMN_0152 A6QDJ2 423 Lipo. Solute-binding protein; various sugars.  
10 NWMN_0245 A6QDT5 124 Lipo. Type II secretory pathway pseudopilin  
11 NWMN_2356 A6QJU6 151 Lipo. DUF1307:  Protein of unknown function  
12 NWMN_2270 A6QJL0 209 Lipo. (PF12262) Lipase_bact_N  
13 NWMN_0724 A6QF64 279 Sig. CHAP domain protein. * 
14 NWMN_0753 A6QF93 242 Lipo. Uncharacterised protein  
15 NWMN_0925 A6QFR5 405 Sig. LytR_cpsA_psr:  Cell envelope-related 
transcriptional attenuator domain 
* 
16 NWMN_0931 A6QFS1 105 Sig. Bacillolysin; solution structure, cell wall 
hydrolase, peptidoglycan-anchor; NMR; Bacillus 
cereus  
 
17 NWMN_1066 A6QG56 109 Sig. Efb-homologous protein * 
18 NWMN_1690 A6QHY0 208 Lipo. PF13670) PepSY_2:  Peptidase propeptide  
19 NWMN_0336 A6QE26 284  
Lipo. 
Peptidase_M75:  Imelysin or Algp7; Alginate-
binding protein or EfeO, involved in iron uptake. 
 
20 NWMN_0368 A6QE58 130  Uncharacterised protein  
21 NWMN_2538 A6QKC8 152 Sig. Uncharacterised protein  
22 NWMN_0402 A6QE92 105 Sig. Staphylococcal complement inhibitor SCIN * 
23 NWMN_1077 A6QG67 241 Sig. Staphylococcal toxin SSL5 * 
24 
NWMN_1396 
A6QH36 305 Lipo. Protein of unknown function (DUF1672)  
25 NWMN_2579 A6QKG9 374 Lipo. Polysacc_deac_1:  Polysaccharide deacetylase.  
26 NWMN_0369 A6QE59 208 Lipo. Uncharacterised protein  
27 NWMN_0646 A6QEY6 131 Lipo. Uncharacterised protein  
28 NWMN_1435 A6QH75 193 Lipo. YkyA:  Putative cell-wall binding  !
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From analysis of the various bioinformatics predictions methods it was determined 
that three of the 56 proteins of unknown function (A6QKG9, A6QD62 and A6QE26) 
were of particular interest.  Each of these proteins matched the database significantly, 
with more than 99% probability and having identity ≥ 27% with another described 
protein.  These three query proteins were selected, as they seemed to have interesting 
functions, for further characterisation based on these strong similarities of primary 
sequence, motifs, domains and amino acid conservation with homologous protein 
sequences of the pfam and/or PDB databases.  
The available homology structure template was used to compare with modelling 
structure of queries proteins in order to visualize the position of active sites, motifs, 
conserved amino acids, plus charge and hydrophobicity of the target surface. Each of 
the three query proteins possessed features of an enzyme catalytic site, making them 
attractive to investigate by further study using more advanced bioinformatics 
methods to investigate their biological roles in S. aureus.   
 
2.4.2. Analysis of predicted protein A6QE26 sequence. 
 
The full-length protein sequence A6QE26 contains 284 residues. The PRED-LIPO 
server predicted a SP, with the N-terminal region containing a lipobox motif (IAAC) 
bearing a cleavage site between residues 17 and 18 (MKKLTTLLLASTLLIAA-C). 
This motif matched the lipoprotein signal peptide signature of Gram-positive bacteria 
that typically comprises one or more positively charged amino acids, followed by a 
region of hydrophobic amino acids and the lipobox motif including an invariant 
cysteine (C). Generally, the first position after the cysteine (C) residue, in the 
protein, is glycine (G) (Juncker et al., 2003). 
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Analysis with HH-suite revealed that the A6QE26 sequence matched one Pfam 
domain, PF09375, present in the peptidase family M75 (Imelysin). A6QE26 
resembled the homologous structures of four proteins: 1) protein 3at7 (39%), the 
AlgP7 protein of a Sphingomonas sp, 2) protein 3oyv (21%), imelysin from 
Bacteroides ovatus (PIBO), 3) protein 4ecg (24%), a putative iron-regulated protein 
from Parabacteroides distasonis, and 4) protein 3pf0 (12%), an imelysin-like protein 
from Psychrobacter arcticus. The sequence of these proteins, including A6QE26 
sequence, presented a HXXE motif that was reported to be a metal binding, as a Zn-
binding site. However, while the query proteins each harboured a HXXE motif, they 
had different reported functional annotation. For example, LruB protein from 
Leptospira interrogans is homologous to imelysin protein and, although it has the 
motif HXXE, it has a confirmed role in iron uptake (Xu et al., 2011a). A HXXE 
motif is present in the EfeO protein sequence of E. coli O157:H7 and in the Algp7 
protein sequence of Sphingomonas sp (Maruyama et al., 2011). EfeO functions in 
iron uptake, while Algp7 functions as a concentrator of polysaccharide in a cell-
surface pit (Maruyama et al., 2011). Thus, this study suggests that A6QE26 protein 
maybe has direct or indirect role in iron uptake since the HXXE motif of LruB and 
EfeO is involved in iron uptake, or in polysaccharide binding as a homologue of 
AlgP7. 
 
2.4.2.1. T-coffee alignments 
 
To investigate function further, the T-coffee tool (Notredame et al., 2000), was used, 
which is known to be an accurate method for making multiple sequence alignments 
(Poirot et al., 2003). Using the data that was collected from using the HH-Suite 
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together with the literature-based information, all homologous proteins were aligned 
with the A6QE26 sequence again to compare their similarities so any conserved or 
related motifs aid with predicting function. The A6QE26 sequence contains 
conserved His126 and Glu129 residues that occur associated with the motif HKIE (as 
HxxE) that is located centrally in the sequence (Fig 2. 2.). The motif is present in two 
protein families, M75 and M14 (Marchler-Bauer et al., 2015). The peptidase family 
M75 contains metallopeptidase activity, while peptidase family M14 contains 
metallocarboxypeptidase. Imelysin or ‘insulin-cleaving membrane peptidase’ from 
P. aeruginosa is a member of the M75 peptidase family, which harbours the motif 
HxxE, and is located at the outer membrane. Alignment of the sequences revealed 
the HxxE motif is located in the middle and relative position in the sequence of 
proteins A6QE26, EfeO and LurB, but this motif appears towards the C-terminus of 
PIBO protein sequence (Fig 2.2). The A6QE26 protein shares 14% sequence identity 
with LurB and 22% with Efe0.  
 
The EfeUOB is an iron-transporter system, which is involved in Fe2+ transport at 
lower pH. It was reported that the EfeO is an essential component in this system but, 
its biochemical function is not clear yet. EfeO sequence contains N-terminal 
cupredoxin (CUP) domain, probably for binding iron, and C-terminal M75-like 
imelysin domain containing the GxHxxE motif (Xu et al., 2011a). In general, this 
motif (HxxE) is known to be metal-binding, as a Zn-binding site for 
metallopeptidase M75. The sequence is also highly conserved among the EfeUOB 
family, suggesting this motif in EfeO might be acting as part of a metal (Fe2+)-
binding site enabling iron transfer to the EfeU protein to transport iron as part of the 
iron uptake process (Rajasekaran et al., 2010). In contrast, the CUP domain is not 
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fully conserved among members of the EfeO family or essential for function, despite 
its role in ferrous ion transport (Xu et al., 2011a). 
 
Based upon the current annotation of the S. aureus strain Newman genome in THE 
SEED and NCBI databases, the gene (ID: NWMN_0336) encoding A6QE26 protein 
is located in an operon similar to that of E. coli EfeUOB.  This operon encodes a 
ferrous ion uptake transporter (data not shown), supporting a role in iron import. 
 
Fig. 2.2. Possible functional site in A6QE26. The most highly conserved region 
within a multiple sequence alignments (represented by different colours) of A6QE26 
and several partially characterised homologues. The residue numbering for A6QE26 
is shown at the top. Each of the proteins (AlgP7, PIBO, EfeO and LurB) have 
positionally-conserved amino acids, including a HxxE motif (black box with arrow).  
 
 
Using seaview  !!!
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!!!!!!!
Alignment: /Users/send2me0/Desktop/Bioinformatics-analysis-3-proteins/first and second report/teplate.aln
Seaview [blocks=13 fontsize=13 A4] on Wed Dec  2 17:04:07 2015
        1
A6QE26  TKAYDKYTDEQLN EFLKGTEKFALYP KVRMYYERSEPVA EAFGDEEKKEKEW
AlgP7   ISDYKIYVSENLQ TLVRDTREFKLFA STRMSYERIEPIA ELFSDKAEKDPAF
PIBO    ---YNLYKAGNTE EALYAVESWDAWI TAREPWEKSEA-- FLFGPAVESAQNV
EfeO    ITAYKAYVMAETT QLVTDTKAFALYA PTRQHYERIEPIA ELFSDQKAADPKF
LruB    ------------- ---------NLYV VARASYLTTEAFR FSSGPQDDETALT
       53
A6QE26  SGYHKIEKALYED KKIDDVTVDLLNE VATSKITGEEEIY SHTDLYDFKANVE
AlgP7   FGFHRIEYGLFAQ NSAKGLAAVLMEE VAATKISGEEDRY SHTDLWDFQANFE
PIBO    RGFHTLEFLLYKN GEPRKVQ------ ------------- -------------
EfeO    TGFHRLEKALFGD NTTKGMDAGLIEE VAASKISGEEDRY SHTDLWDFQANVE
LruB    VGWHAIEYILWGQ DLFNGGIRAYMKA VTDGLNPDAAVTY IFQGLGKFIAGEW
      105
A6QE26  GAQKIYDLFKPIL EKKDKKLSD
AlgP7   GAKKIVDLFRPLV VKDNRAFAD
PIBO    ------------- ---------
EfeO    GSQKIVDLLRPQL QKANPELLA
LruB    GGERLTGTFGGQQ EEEHSCFSDAlignment: /Users/send2me0/Desktop/Bioinformatics-analysis-3-proteins/first and second report/A6QE26/teplate.alnSeaview [blocks=13 fontsize=13 A4] on Thu Dec  3 16:23:06 2015
        1
A6QE26  TKAYDKYTDEQLN EFLKGTEKFALYP KVRMYYERSEPVA EAFGDEEKKEKEW
AlgP7   ISDYKIYVSENLQ TLVRDTREFKLFA STRMSYERIEPIA ELFSDKAEKDPAF
PIBO    ---YNLYKAGNTE EALYAVESWDAWI TAREPWEKSEA-- FLFGPAVESAQNV
EfeO    ITAYKAYVMAETT QLVTDTKAFALYA PTRQHYERIEPIA ELFSDQKAADPKF
LruB    ------------- ---------NLYV VARASYLTTEAFR FSSGPQDDETALT
       53
A6QE26  SGYHKIEKALYED KKIDDVTVDLLNE VATSKITGEEEIY SHTDLYDFKANVE
AlgP7   FGFHRIEYGLFAQ NSAKGLAAVLMEE VAATKISGEEDRY SHTDLWDFQANFE
PIBO    RGFHTLEFLLYKN GEPRKVQ------ ------------- -------------
EfeO    TGFHRLEKALFGD NTTKGMDAGLIEE VAASKISGEEDRY SHTDLWDFQANVE
LruB    VGWHAIEYILWGQ DLFNGGIRAYMKA VTDGLNPDAAVTY IFQGLGKFIAGEW
      105
A6QE26  GAQKIYDLFKPIL EKKDKKLSD
AlgP7   GAKKIVDLFRPLV VKDNRAFAD
PIBO    ------------- ---------
EfeO    GSQKIVDLLRPQL QKANPELLA
LruB    GGERLTGTFGGQQ EEEHSCFSD
45 80 115 
175 123 186 201 
212 229  
HxxE sequence motif!
HxxE sequence motif!
45 80 115 
123 175 186 201 
212  229 
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2.4.2.2. Modeling the structure of A6QE26  
 
No EfeO protein structure was available in the PDB database for comparison. A 
model structure of the query A6QE26 was constructed based on homologous 
structures of AlgP7, which is available from PDB, using the Modeller program on 
the HHpred server (Soding, 2005; Soding et al., 2005). The A6QE26 model structure 
was loaded to the Pymol program locally (PyMOL Molecular Graphics System, 
Version 1.8 Schrödinger, LLC.), and was aligned with the AlgP7 structure available 
from PDB (Fig. 3.3.) 
 
2.4.2.3. Overall structure and comparison 
 
The modelled structure of A6QE26, based on AlgP7, (Fig. 2. 3.) indicates that 
A6QE26 consists of two bundles, each of which includes four major alpha-helices. 
Bundle one (B1) comprises four major ∝- helices (H1, residues 32-66; H2, 69-92; 
H3a, 95-101; H3c, 118-129, with a (HKIE) metal-binding motif region (red colour), 
and H4, 135-156). The helix (H3) divided into three helices (H3a, b and c), with loop 
regions inserted between them. Bundle two includes four major ∝- helices (H5, 
residues 161-179; H6, 190-215; H7, 218-238; H9, 253-277). The helix H8 (248-250) 
is included in bundle B2. From the A6QE26 model structure, 75% of all amino acids 
are appeared in alpha- helices, while the others were found in the turns and coils, 
revealing similarity with Algp7, which might extend to function.  
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2.4.2.4. Location of metal-binding motif (HxxE) 
 
The model structure of A6QE26 (Fig. 2.4.) contains a metal-binding motif 
120HxxE123, which is situated in H3c of bundle B1.  By comparing the same side 
(Side 1) of both A6QE26 and Algp7 structures, there is a loop containing hydrogen 
bond and electrostatic networks that is in front of the metal-binding motif of Algp7 
(Maruyama et al., 2011) but, this loop is not in front of the metal-binding motif in 
the A6QE26 model, where the motif is present on the surface of A6QE26 to 
potentially bind metal. Similarly, the other side of both structures (side 2), a motif is 
present with the same arrangement (Fig. 2.4.). These observations support that 
A6QE26 may harbour peptidase activity, using binding zinc or this motif involved in 
binding a metal ion, such as iron that could be exchanged with another protein e.g. 
EfeU for iron utilisation. 
 
2.4.2.5. Analysis using ConSurf and Meta-PPISP tools 
 
As a further bioinformatics analysis the consurf tool (Glaser et al., 2003), was used, 
since it is effective for estimating the evolutionary conservation of amino acid 
positions in a protein in relation to phylogenetic distance between homologous 
sequences. The model structure of A6QE26 was analysed by ConSurf server (Fig. 2. 
5.) and revealed that most of the conserved amino acids are presented on one side of 
structure (side 1), with fewer on side 2, which were clustered around the motif, and 
possibly indicating a binding site (Fig. 2. 5A). The meta-PPISP server provided 
further support for interaction with another protein via side 1 (Fig. 2. 5C), possibly 
relevant to an interaction with another protein during iron uptake.     
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During the course of cloning work carried out in the lab (gene deletion, insertion for 
complementation and gene expression), a paper was published describing a function 
role for protein A6QE26, and was named FepA (Turlin et al., 2013). The protein was 
shown to be involved in heme iron utilisation confirming the predictions from 
bioinformatics methods in this study, but making it less interesting for further study.   
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Fig. 2. 3. Structural fold prediction visualised using Pymol. A, B: overall 
structure of A6QE26 template and AlgP7 (PDB ID: 3AT7) respectively. The two 
bundles B.1 and B.2 are coloured orange and yellow, respectively. Homology loops 
between structures is coloured in pink. Metal-binding motif HxxE is coloured red. 
C1, C2, structural alignment of A6QE26 (green) with AlgP7 (cyan). 
 
Modelling the structure of A6QE26. 
EfeO protein has not structure available in database (PDB) to compare with our 
query. However, A model structure of the query A6QE26 was successfully built 
based on the homologous structures, using the Modeller program as implemented at 
the HHpred server. Query A6QE26 model structure was loaded to the Pymol program 
locally, and was aligned with the AlgP7 structure available from PDB (fig.5).   
!
 
!
!!!!!!!!!
!!!!A.!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!B.!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!!!! !!!!!!!!!!!
C.1!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!C.2!
!!!! !
!
!
Figure!5.!Structure!fold.!!(A!and!B)!Overall!structures!of!A6QE26!template!and!Algp7!respectively.! !The! two!bundles!B.1! and!B.2!are! colored! orange! and!yellow.! !MetalF!binding! motif! HxxE! is! colored! red.! B.! AlgP7! structure! (PDB! ID:! 3AT7)! from!
Sphingomonase, sp., C.1! and! C.2! AligningFA6QE26! (green)! to! Algp7! (cyan),! the!structure!of!query!A6QE26!was!homologous!with!AlgP7.!!
H1!
H2!
H3a!
H3c!H4!
Motif!
H5!
H6!
H7!
H8!
H9!
Motif!
B1!
B2!
B1!
B2!
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Fig. 2. 4. Comparing HxxE motif locations.  The HxxE motif (red) is present on 
the surface of (A) A6QE26 and (B) Algp7. A loop (yellow) sits in front of the motif 
of Algp7, viewed from both sides (1 and 2); (B1) bundle 1 and (B2) bundle 2. 
 
 
 
structure, it was found that there is a loop containing hydrogen bond and electrostatic networks that 
is in front of metal-binding motif of Algp7 structure [Maruyama et al., 2011]. In contrast, this loop 
was not in front of the metal-binding motif in the A6QE26 model, which means the motif is present 
on the surface of A6QE26 to bind metals.  On side 2 of both structures a motif is present with the 
same arrangement (Fig. 3. 6.). These observations support that A6QE26 may harbour peptidase 
activity and by bind a metal ion such as zinc or iron and could exchange the metal ion with another 
protein e.g. EfeU for iron utilisation. 
 
 
 
 
 
 
 
 
Comparing*two*sides*of*each*A6QE26*and*Algp7**
A.#Side#1##################################################################A.#Side#2#####################
***** **
B.#Side#1##################################################################B.#Side#2#####################
* **** **************
Fig. 3. 6. Comparing the location of a HxxE motif (red color) in both 
surface of (A) A6QE26 and (B) Algp7. A loop (cyan color) presented in 
front of a motif of Algp7, in both side (1 and 2), while that not observed 
with A6QE26 otif. (B1) bundle 1 and (B2) bundle 2.#
HxxE$
motif$
HxxE$
motif$
HxxE$
motif$
Loop$
Loop$
Loop$
Loop$
HxxE$
motif$
B2$
B2$ B2$
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B1$ B1$
B2$
		 60	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fi
g.
 2
. 5
. E
vo
lu
tio
na
ry
 c
on
se
rv
at
io
n 
of
 a
m
in
o 
ac
id
s i
n 
a 
m
od
el
 o
f A
6Q
E2
6 
us
in
g 
C
on
Su
rf
.  
(A
) A
 p
re
di
ct
ed
 fu
nc
tio
na
l r
eg
io
n 
in
 si
de
 1
 o
f A
6Q
E2
6,
 w
hi
ch
 is
 h
ig
hl
y 
co
ns
er
ve
d 
(r
es
id
ue
 c
ol
ou
re
d 
bl
ue
). 
(B
) F
ew
er
 c
on
se
rv
ed
 a
m
in
o 
ac
id
s i
n 
si
de
 2
, b
ut
 th
e 
gr
oo
ve
 
is
 s
tro
ng
ly
 c
on
se
rv
ed
 (r
es
id
ue
s 
bl
ue
) b
es
id
e 
th
e 
H
xx
E 
m
ot
if.
 (C
) S
id
e 
1 
sh
ow
s 
th
e 
in
te
rf
ac
e 
ar
ea
 o
f s
ev
en
 c
on
se
rv
ed
 a
m
in
o 
ac
id
s, 
po
ss
ib
ly
 se
rv
in
g 
as
 p
ro
te
in
-p
ro
te
in
 in
te
ra
ct
io
n 
si
te
, w
er
e 
de
te
ct
ed
 u
si
ng
 m
et
a-
PP
IS
P.
 
		 61	
2.4.3. Bioinformatics analysis of predicted protein A6QD62 
 
A second protein investigated, A6QD62, has a sequence length of 772 amino acids 
bearing an N-terminal signal peptide (SP) with a likely cleavage site between SNA27 
and 28AE residues, as determined by using the SignalP 4.0 program.  The A6QD62 
protein does not contain a lipoprotein motif, however an LPxTG motif was detected, 
which is located in the C-terminus between residues 739 and 752 (Fig. 2.6.). This 
motif is used for sortase-directed covalent attachment to the peptidoglycan, an 
activity detected in most Gram-positive bacteria (Sibbald et al., 2006). 
 
The HH-Suite program revealed that A6QD62 was homologous to structures of 5’-
nucleotidases (5’-NTs).  Three homologous structures from PDB with different 
shared % sequence identities were found: 5’-nucleotidase from CD73 protein of 
human 29% (code 4h1s), 5’-nucleotidase from Thermus thermophilus 31% (code 
2z1a), and UshA protein from E. coli 28% (code 1hp1), as well as a Pfam domain 
match to 5’-nucleotidase with 39% identity (code PF02872). Thus, these data 
indicated that A6QD62 could harbour the same activity of 5’-nucleotidase.  
 
2.4.3.1. T-coffee alignments 
 
The T-coffee was used to align three sequences, query A6QD62, bacterial 5’-
nucleotidase (E.coli, UshA protein) and human 5’-nucleotidase (5’NT protein), 
which were obtained from UniProtKB database.  Alignment shows that the primary 
sequences of both A6QD62 and UshA share low (~15%) overall sequence identity 
with human 5’NT but revealed several clusters of highly conserved amino acids (Fig. 
2. 6.). This observation was similarly reported by other alignment study between 
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human 5’-nucleotidase (5’NT protein) and bacterial 5’-nucleotidase (5’-NTs), 
including E. coli UshA protein (Knofel and Strater, 1999). However, the clusters in 
these sequences, includes A6QD62, (Fig. 2. 6.) contain typically active-site residues 
such as, Histidine (His) and aspartic acids (Asp). It was reported that the main 
requirements for catalysis are dimetal clusters with its ligands and catalytic Asp-His 
dyad. For example, in UshA sequence, the catalytic His117 and Asp120 dyad is an 
essential player in the catalytic mechanism of 5’-nucleotidase activity (Knofel and 
Strater, 1999). 
 
 T-coffee alignments revealed two signature motifs that occur as HxxD, and are 
conserved between all sequences (Fig. 2. 6.), indicating possible similarity function 
between these proteins. For example, these motifs consist of His93-Asp96 and 
His164-Asp167 in A6QD62 sequence,. These motifs also conserved across the 
Haemophilus influenza, Archaeoglobus fulgidus and Boophilus microplus sequences 
(Knofel and Strater, 1999). However, only the A6QD62 sequence presented a motif 
LPXTG in the end of C-terminal, indicating this protein is surface-attached at the cell 
wall membrane.  
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2.4.3.2 Modelling structure of A6QD62 	
2.4.3.2.1 Overall structure and comparison 
 
The model structure of A6QD62 (Fig. 2.7. A,B,C) contains two domains linked by 
loops. The overall query structure conformation is similar to the 5’NTs fold of E. coli 
UshA (Fig. 2.7. D&E), and CD73 of human. The N-terminal domain (residues 27-
352) consists of a mixture of eleven strands and seven helices, whereas the C-
terminal domain (residues 385-753) contains 9-helices and 7-sheets, bordered by a 
large signal peptide and the LPxTG motif. 
 
Compared with the E. coli 5’NT (UshA) the C-terminal domain of A6QD62 also 
contains additional residues (Phe479 and Phe563), which were reported to be 
involved for the catalytic step of N-terminal domain by binding substrate, such as the 
adenosine group (Knofel and Strater, 1999). 
 
2.4.3.2.2. Location of catalytic residues on structure  
 
The catalytic Asp-His dyad and di-metal centre that are known as important for the 
catalytic step are located at the interface in the cleft and between the two domains in 
the model structure of query protein. Moreover, these catalytic sites or residues are 
present in the N-terminal domain sequence (Fig. 2.7. A, B, C) 
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2.4.3.2.3. Consurf and Metal-PPISP tools 
 
The catalytic site is located in a region that has a positive electrostatic potential, 
which potentially attracts the negatively charged substrate, such as phosphoesters 
(Knofel and Strater, 1999). The PPISP output indicates that 5 conserved residues 
between the query and 5’NTs of human might participate in protein-protein 
interactions (data not shown) however, these amino acids are present after the 
LPxTG motif (Fig. 2. 6), and may be important for other interactions. 
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Fig. 2. 7. Modelled structure of A6QD62 showing a catalytic site similar to 5’NT 
of E. coli. A, N-terminal and C-terminal domains are coloured in green and light 
pink, respectively, with yellow sheets in both domains. Both domains are linked 
together by a loop mediated by alpha helix (orange). B, Active-site region that 
contains core catalytic His164-Asp167 and other catalytic residues. C, the surface of 
A6QD62 model was coloured using pymol for its electrostatic potential (deep cleft 
with positively-charged residues at the catalytic region). Surface with positively 
charged residues in blue, and with negatively charged residues in red colour. D, 
structure of 5’NT of E. coli shows a deep cleft for the di-zinc centre. E,display of 
active site region within the surface electrostatic potential, as described by (Knofel 
and Strater, 1999). 
!!!!! !!!!!!!!!!!
 
 
 
 
 
 
 
 
 
 
 
!
 
Annotation of the gene cluster.  
          The Seed and NCBI databases reveal that the gene (ID: NWMN_0022 and size 
2319bp) encoding A6QD62 is conserved across strains of S. aureus but there is no co-
localisation of other genes among different genera (fig 13). The S. aureus protein is 
annotated as a virulence-associated cell wall-anchored protein (surface associated 
staphylococcal protein H, SasH). During this work, a paper was found, which 
described this protein as adenosine synthase (AdsA), an enzyme converting adenosine 
!
!!
Fig.%14%!
A""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""B"""""""""""""""""""""""""""""""""""""""C"
!!!!! !!!!!!! !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
"""""""""""""D""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""E"
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!
!!!!!!!!!!!!!!!!!!!!!!!! !
!
Figure" 14.! (A," B" and" C)! Overall! modeling! structure! fold! of! A6QD62! and!catalytic! site! similar! to! (D" AND" E)! 5’NTs! structures! of! E.coli.! A,! NAterminal!domains! are! colored! in! green! and! light! pink! respectively! and! ! yellow!sheets! in! both! domains.! The! domains! linked! with! ∝Ahelix! at! the! loop! in!orange.! ! B,! ActiveAsite! region! that! contains! all! residues! are! important! for!catalysis.! (all! catalytic! residues! were! display! in! fig! 12).! ! C,! the! surface! of!qu ry!m del! is!colored!by!pymo !fo !electrostatic!potential! (Deep!cleft!with!positively! charged! residues! in! the! same! catalytic! region).! !D,! structure! of!5’NTs!E.coli!sows!a!!deep!cleft!for!diAzinc!center,!and!E,!display!this!activity!region!in!the!surface!electrostatic!possible,!which!calculated!by!DELPHI!!(Knofel!and!Strater,!1999).!
 B C 
D E
Active site 
Active site Active site  
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Numerous phosphotransferases and phosphatases use a ‘two-metal-ion’ mechanism 
to catalyse phosphoryl transfer. The 5’nucleotidases (5’-NTs) contain di-metal sites, 
and are members of a large superfamily of metallophosphatases. This superfamily 
includes phosphatases with various substrate specificities, e.g. protein phosphatases, 
nucleases and nucleotidases (Knofel and Strater, 1999). 
 
5’-nucleotidases have also described to be involved in UDP-sugar hydrolase activity  
(Knofel and Strater, 1999). 5’NT of animal cells, which is located at the cell surface, 
can play an important role in the hydrolysis of extracellular nucleotides, such as 
ATP, ADP, UTP or the diadenosine polyphosphates that were identified to act as 
extracellular messengers. Membrane bound extracellular nucleotidases 
(ectonucleotidases), including 5’nucleotidase (5’-NTs), apyrases, and ATPase can 
degrade ATP, for example to dephosphorylate ATP to ADP, AMP and adenosine. 
This enzymatic function was found to terminate the ATP actions of neurotransmitter 
in the brain and periphery (Knofel and Strater, 1999; Zimmermann, 1996), and 
5’NTs were implicated in cell-cell and cell-matrix interactions and trans-membrane 
signalling (Knofel and Strater, 1999). 
  
Bacterial 5’nucleotidases (5’-NTs) are found to be highly homologous to 5’-NT 
proteins of animals. For example, the gene ushA from E. coli encodes an enzyme 
with zinc-binding sites, and is reported to possess activities of 5’-nucleotidase and 
UDP-sugar hydrolase (Knofel and Strater, 2001). This secreted enzyme is located in 
the periplasmic space and can degrade the imported UDP-glucose to uridine, 
phosphate and glucose 1-phosphate (via an unknown mechanism) for utilisation by 
the cell  (Burns and Beacham, 1986; Knofel and Strater, 1999).  
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2.4.3.3. Annotation of the gene cluster 
 
The Seed server (data not shown) and NCBI databases reveal that the gene (ID: 
NWMN_0022 and size 2319bp) encoding A6QD62 is conserved across strains of S. 
aureus but there is no gene colocalisation with other genes across different genera. 
The S. aureus protein is annotated as a virulence-associated cell wall-anchored 
protein (surface associated staphylococcal protein H, SasH). During this work, a 
paper was found, in which it was described as adenosine synthase, renamed AdsA, 
an enzyme converting adenosine monophosphate into adenosine that is used to 
escape phagocytic clearance (Thammavongsa et al., 2009).  
 
Despite this finding, which considerably reduced interest in continued study, there 
was no activity study of the protein for hydrolysis of extracellular UDP-glucose to 
serve as a carbon source, an activity regulated by oxygen levels (Burns and 
Beacham, 1986). The adsA gene may be involved in increasing bacterial survival, 
similar to the AdsA homologue NudP of Streptococcus agalactiae, which contributes 
to survival in blood (Firon et al., 2014). From bioinformatics analysis, this protein 
could harbour multiple functions that would be achieved by the active site located on 
the surface. 
 
In summary, the SasH/AdsA protein potentially contains a di-zinc centre that might 
hydrolyse UDP-sugar, as described in Salmonella and E. coli (Knofel and Strater, 
2001). In addition to the nucleotidase activity reported recently. The protein could be 
involved in degrading UDP-glucose to extra uridine, phosphate and glucose 1-
phosphate in order to be used as an important carbon source as indicated by (Glaser 
et al., 1967).  
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2.4.4. Bioinformatic analysis of predicted protein A6QKG9 
 
A third exoprotein investigated was A6QKG9, which contains 374 amino acids 
bearing an N-terminal signal peptide (SP) with a likely cleavage site between EKA28 
and 29QN residues, determined with the SignalP 4.0 program. In addition, A6QKG9 
sequence contains a lipobox motif for sorting. The motif cleavage site was predicted 
to be S20/21CSK, using the PRED-LIPO server (Fig 2. 8).  Thus, this protein can be 
recognized, during translocation, by both signal peptidases for cleaving its sites 
(SPase1 and SPase2), meaning that its location needs confirming during 
investigations. 
 
HH-Suite results indicated that A6QKG9 contained a domain that matched 
polysaccharide deacetylase (PF01522) in the pfam database, with 27% identity 
(Table 2. 2.). This domain is found in a family of polysaccharide deacetylases. This 
family includes the nodulation protein B (NodB) from Rhizobium sp., which is a 
chitooligosaccharide deacetylase, and the family includes yeast chitin deacetylases. 
Chitin deacetylases sit within a family of 4-carbohydrate esterases (CE4) in the 
Carbohydrate-Active Enzymes (CAZY) database, which is specialized in enzymes 
that breakdown and/or build complex glycoconjugates and carbohydrates (Cantarel 
et al., 2009)        
 
Numerous bacterial members of the CE4 family are involved in evading lysis by host 
glycosidases, by catalysing the N- or O-deacetylation of substrates, for example, de-
N-acetylating sugar amino acids on cell wall peptidoglycan (Urch et al., 2009). This 
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action allows degradation and remodelling of the surface of bacteria, which avoids 
recognition by mammalian host enzymes like lysozyme (Oberbarnscheidt et al., 
2007). 
 
With further investigation using HHpred server, it was found that the sequence of 
A6QKG9 matched four structures from PDB with different identities: (1) SpPgdA 
20% from Streptococcus pneumoniae (PDB code 2c1i), which is a peptidoglycan 
deacetylase; (2) SmPgdA 16% from Streptococcus mutans (PDB code 2W3Z, which 
is polysaccharide deacetylase; (3) PgaB from E. coli, strain K12, (codes 3VUS and 
4F9D), which catalyses the N-deacetylation of poly-beta-1,6-N-acetyl-D-
glucosamine (PGA) that is required for a biofilm adhesion; and (4) BaCE4, 
carbohydrate esterase from Bacillus anthracis (PDB code 2J13), which is a putative 
peptidoglycan deacetylase. These homologous proteins are representatives of the 
esterase family CE4 (Blair et al., 2005a; Deng et al., 2009).   
 
2.4.4.1. T-Coffee alignments   
 
These homologous proteins above (SpPgdA, SmPgdA, PgaB and BaCE4 ) were 
aligned with query A6QKG9 protein sequence to determine if query sequence 
conserved that unique arrangement of the CE4 motifs (MT1-MT5). These motifs 
form the active site for enzymatic activity (Little et al., 2012).	Superposition of the 
A6QKG9 and other proteins, especially SpPgdA, active sites (Fig. 2.8.) reveal that 
the sequence of A6QKG9 has elements from each of the five motifs with seven 
significant differences compared with SpPgdA. A6QKG9 has the canonical motifs 
(MT1 and MT2) similar to other CE4 members (Fig. 2.8.). MT1 includes two 
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aspartic acids, the catalytic base (Asp-139) and the metal-coordinating residue (Asp-
140), whereas, MT2 contains two histidines, the metal-coordinating residues. His-
251 and His-255.  Interestingly the MT1 of BaCE4 lacks the second aspartic acid, 
which is replaced with asparagine (N), whereas the MT2 of PgaB has extra residues 
between its two histidines, as opposed to a three residues spacer as presented in other 
CE4 members, including A6QKG9 (Fig. 2.8.). The MT3 is also well conserved with 
exception that the arginine (Arg) is replaced by histidine (His-291). However, Arg-
333 found later in the sequence could be an alternative, since it appears in the cleft of 
the model structure of A6QKG9 close by the catalytic base, Asp-139 (Fig. 2.10A). 
Similarly, MT3 of PgaB lacks its arginine. MT4 and MT5 have the most significant 
differences. The tryptophan (Trp) and aspartic acid (Asp) residues are absent in MT4 
of A6QKG9. However, Trp-85 and Asp-337 respectively could be alternatives, since 
both are located on the side of the active site cleft of A6QKG9 model structure, close 
by His-62 (Fig. 2.10A). Both leucine (Leu) and histidine (His) are missing in MT5 of 
both A6QKG9 and PgaB. However, Leu-208 and His-62/ His-291 presented in the 
sequence of A6QKG9 and very well located in active site could be alternatives. The 
differences in MT4 and MT5 were previously reported in CE4 members, PgaB and 
SmPgdA (Deng et al., 2009; Little et al., 2012).  Finally, a lipobox motif, responsible 
for anchoring the protein to the bacterial surface, is located in the N-terminal of 
A6QKG9 sequence but is not found in the sequences of other CE4 members (Fig. 
2.8). 
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Fig. 2.8. S. aureus A6QKG9 aligned with three described de-N-acetylases. 
Proteins, SmPgdA, PgaB, BaCE4 and SpPgdA are compared with A6QKG9.	The 
number located in the top of alignment is referred to A6QKG9 sequence. The 
important metalloenzyme catalytic site of two metal-binding residues; His-251 and 
His-255 in motif (MT2) plus Asp-139 and Asp-140 in motif (MT1) are conserved in 
the A6QKG9 sequence and other homologues, which indicated (black line) in the top 
of the alignment. Other residues, His-58, His-62, His-291; Asp-332, Asp-337, Arg-
333 and Trp-84 are conserved (red triangle), and expected to be contributed for 
enzymatic activity. These catalytic residues assemble on the cleft of A6QKG9 model 
structure (Fig. 2.9). The alignment was performed using the T-coffee programme. 
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2.4.4.2 Modeling the structure of A6QKG9- overall structure and 
comparison 
 
Although significant motifs and residues were detected in the A6QKG9 sequence, no 
structural data exist. Therefore, Modeller was used to make a model structure for 
A6QKG9; using the Streptococcus pneumonia PgdA protein (SpPgdA) structure as 
template structure and its sequence identity ≥ 27%. The quality of a model structure 
can be approximately predicted from the sequence similarity between the target and 
template. A comparison with the pneumococcal SpPgdA structure revealed that the 
metalloenzyme catalytic site was conserved, whereby a His-His-Asp zinc- binding 
triad with a nearby Asp and His forms the catalytic site. This metalloenzyme 
mechanism is shared throughout the carbohydrate esterase family CE4 (Blair et al., 
2005b). The model structural data in combination with alignments reveal that 
A6QKG9 enzyme consists of a single domain, which uses a His251-His255- Asp140 
zinc- binding triad associated with the conserved catalytic acid (histidine; His-
62/His-291) and base (aspartic acid; Asp139) to carry out base/acid catalysis as 
explained by other study such as, PgdA protein (SpPgdA) of S. pneumonia PgdA 
protein (SpPgdA) (Blair et al., 2005a).   
 
The first structure of a carbohydrate esterase family CE4 member, that of the 
Bacillus subtilis peptidoglycan (PG) deacetylase (PdaA, also named as BaPdaA or 
BaCE4), visualised a substrate-binding cleft, used for binding PG N-acetyl muramic 
acid residues. A more recent structure study of SpPgdA indicates that its catalytic 
domain exhibits the same conserved cleft but with a zinc ion coordinated by zinc-
binding triad comprising of His-His-Asp (Blair et al., 2006; Blair et al., 2005a).  The 
active site of A6QKG9 displays a conserved metal-binding triad. The catalytic 
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subsite contains a zinc-binding triad (as His-His-Asp) comprising of two-histidine 
(His251, His255) from motif 2 and one aspartic acid (Asp140) from motif 1. This 
metal-binding triad (His-His-Asp) is generally conserved throughout the CE4 family 
members such as CICDA and SpPgdA, but exceptions include BaCE4, which only 
has two metal histidine (motif 2) coordinating residues but no aspartic acid from 
motif 1 as explained by (Blair et al., 2006; Blair et al., 2005a), and (Fig. 2.8.) The 
model structure of A6QKG9 also contains Asp139, from motif 1 in a position similar 
to that observed in structure of SpPgdA, which server as an acetate ion as discussed 
by (Blair et al., 2006). The authors concluded that the zinc ion is coordinated by two-
histidine (motif 2), an aspartic acid (from motif 1), and a water (H2O), which 
interacted with the acetate molecule. One of acetate oxygen interacts with an aspartic 
acid (Asp from motif 1), which in turn is linked by a buried arginine (Arg from motif 
3). The same oxygen also binds Histidine (His, from motif 5) and interact with 
aspartic acid (Asp from motif 4) (Blair et al., 2006). Thus, from alignments and 
model structure, A6QGK9 has three motifs (MT1, MT2 and MT3), while other 
missing residues from MT4 and MT5 were observed in different location on 
A6QKG9, but they are in the right place at the cleft of its model structure, possibly 
participating in enzymatic activity (Fig. 2.9 & 2.10). Thus, A6QKG9 protein is a 
member of carbohydrate esterase family CE4 and shares a number of sequence 
motifs, including conserved aspartic acid and histidine residues that possibly indicate 
a function as deacetylase such as, de-N-acetylation of GlcNAc sugars in 
peptidoglycan of S. aureus, similar to SpPgdA enzyme activity. It would be useful to 
determine a A6QKG9 crystal structure for further analysis and in order to determine 
the reaction mechanism.  
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2.4.4.3. Meta-PPISP. 
 
Meta-PPISP was used to analyse the template structure and indicated that 48 residues 
(data not shown) located to in to the top an area of a cleft (Fig. 2.9C), suggesting 
these amino acids might participate in protein-protein interactions. In addition, 
electrostatics of A6QGK9 model structure was generated by PyMOL programme to 
analyse the surface and indicated that the catalytic site is located in a region that has 
a negative electrostatic potential (Fig. 2.9A), which potentially functions to interact 
with a positively charged substrate. 
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Fig.2.9. Visualisation of modelling structure of A6QKG9, using PyMol methods. 
A, B shows the cleft on the surface. This cleft (circled in black) shows a negative 
charge (A) and harbours the proposed catalytic residues of the CE-4 family of 
esterases, including five His, four Asp and and Arg on the surface of the cleft (B). 
Forty-eight residues identified using Meta-PPISP form an area at the top of the cleft 
(yellow colour), and might participate in protein-protein interactions.	
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Conclusion 
 
A comparison of the S. aureus secreted protein A6QKG9 model structure with the 
SpPgdA and SmPgdA structures revealed that the metalloenzyme catalytic site was 
conserved in A6QKG9, whereby a His-His-Asp zinc-binding triad with nearby Asp 
and His residues collectively forms the catalytic site. This metalloenzyme 
mechanism is shared with the carbohydrate esterase family CE4 (Blair et al., 2005a; 
Deng et al., 2009), and was located together with known catalytic residues belonging 
to CE4 family in the S. aureus A6QKG9 query sequence. 
 
Deletion of the gene pgdA encoding SpPgdA protein in Streptococcus pneumoniae 
produced hypersensitivity to lysozyme and reduced virulence in a mouse model of 
infection (Blair et al., 2005a). This SpPgdA protein is a member of the CE-4 family 
and its crystal structure indicates all of the catalytic residues also present in the 
A6QKG9 sequence.   
 
SmPgdA shares homology with a described polysaccharide deacetylase domain and 
catalytic domains of peptidoglycan GlcNAc de-N-acetylase of Listeria 
monocytogenes and Streptococcus pneumoniae. Inactivation of the gene encoding 
SmPgdA protein in Strep. mutans led to altered colony texture and a slightly 
increased cell surface hydrophobicity (Deng et al., 2009). The crystal structure of S. 
mutans smPgdA protein shows the characteristic carbohydrate esterase fold, 
described above, but no peptidoglycan-specific activity was observed. Instead, it 
might act on a polysaccharide at the bacterial cell surface where the mutant has 
significantly increased aggregation/agglutination with salivary agglutinin (SAG) 
(Deng et al., 2009). 
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From this analysis data, it appears that A6QKG9 protein contains all catalytic 
residues required for peptidoglycan deacetylase of an unknown substrate yet. From 
the comparative analysis with the other proteins described here it was determined 
that A6QKG9 protein is a Pgd-like protein and will be named as such going forward 
in this study.  
 
2.4.5. Further proteins of unknown function  
 
During this research study the catalytic functions of two of the three chosen proteins 
were described or identified. Consequently, as insurance moving forward, two 
further proteins were targeted for functional studies as possible replacement targets.  
These proteins, named in the Uniprot database as AOAOH3K682 and SA2061, were 
analyzed during this study (Some data is not shown below, as it was not fully 
completed). Both AOAOH3K682 and Sa2061 genes were inactivated, but not 
investigated further. SA2061 protein is still at unknown function, especially in S. 
aureus. However, by analysis its sequence, this protein was not matched homologous 
protein, and therefore it needs more investigation in future work. 
 
The most interesting is the function of AOAOH3K682 protein in S. aureus, which 
had not yet been determined. However, HH-Suite analysis revealed that its sequence 
had around 30% identity with another protein from Streptococcus pyogenes called 
myosin-cross-reactive antigen (McrA) with size 67 kDa. A McrA of Strep. pyogenes 
was reported to be a fatty acid hydratase, acting on the double bound of an 
unsaturated fatty acid to generate a saturated fatty acid. The protein activity is 
achieved by a motif sequence GXGXXGX, which detoxifies antimicrobial fatty 
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acids (AFAs), such as linoleic and oleic acids (Volkov et al., 2010). The active site 
residues (motif) of McrA were observed in the S. aureus AOAOH3K682 sequence as 
well as other motifs contributing to activity against AFAs. This study suggests that 
AOAOH3K682 may act as McrA of Strep. pyogenes, and therefore this protein needs 
more investigation.  
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Fig. 2.10. Overview of the S. aureus Pgd (A6QKG9) model structure. (A) a zoom of 
Fig.2.9B to show active site and its residues. (B) Scheme for the possibly active site residues 
on A6QKG9 of S. aureus. It is expected that the Zinc ion (red circle) bind residues (H-251 
and H-255) and an aspartic acid (D-140) in this area.  Other residues; histidine (H-58, H-62, 
291), aspartic acids (D-139, D-332 and D-337) and arginine (R-333) are indicated and may 
be involved in this active site. (C) A6QKG9 surface shows the cleft and the location of 
residues that are indicated in (A). The model structure of pgd compared with overall 
structure of the spPgd and smPgd structures (Deng et al., 2009). 
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2.4.6. Future focus of this study   
 
The identification of a S. aureus protein with homology to N-deacetylases using 
homology searching and structural prediction/modeling produced a focus for future 
research to determine whether this predicted function was correct. Given the 
potential importance of the protein in cell wall surface regulation, the study focused 
intensively to study its role using a molecular genetic and functional genomics 
approach.  
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CHAPTER 3 
3. Materials and Methods  
3. 1. Materials  
 
3.1.1. Reagents. 	
All chemical reagents were obtained from Bioline (Meridian Life Science, UK), 
Fisher Scientific (Germany) and Sigma-Aldrich, unless otherwise stated. The 
preparation and storage of reagents was performed according to manufacturer’s 
instructions. Water (ddH2O) was deionised using a reverse osmosis purification 
system.  
 
3.1.2. Bacterial strains and plasmids 	
Bacteria, plasmids and antibiotics that were used for this study are listed in Table 
3.2. E. coli Top10 was used as a general cloning host via the production of 
competent cells for transformation with plasmids constructed by ligation of PCR-
amplified genes. The pMUTIN4 vector was used for creating S. aureus mutants by 
allelic replacement, following resolution of integrated plasmid intermediates by 
using phage transduction. The low copy number pSK5632 plasmid was used for 
complementation of gene mutants in S. aureus strains. S. aureus strain RN4220, a 
methylation-positive, restriction-negative host strain, was used as a cloning 
intermediate for construction of desired strains. The plasmids PTB361 and PET 24d+ 
were used as vectors to clone genes for overexpression studies and both contain a T7 
promoter for expression by induction of T7 RNA polymerase. 
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Table 3.1. Genes included in this study to determine their functions.  
Gene 
name 
*ID 
gene 
Size 
(bp.) 
*ID 
Protein 
Size 
(a.a) 
Mass 
(Da) 
Bioinformatics 
analysis results 
a6qe24 NWMN_0336 855 A6QE26 284 32.24 Iron uptake  
a6qd62 NWMN_0022 2319 A6QD62 772 83.42 Nucleotidase 
activity or 
hydrolysis of 
UDP-sugar.  
pgd NWMN_2579 1125 A6QKG9 374 43.55 Deacetylase of 
peptidoglycan or 
polysaccharide.  
mcrA NWMN_0050 1776 A6QD90  
 
591 67.64 Detoxification of 
oleaic acid, 
hydratase. 
SA2061 SA2061 1212 Q7A443 403 43.92 MFS transporter 
capable of 
transporting small 
solutes in 
response to 
chemiosmotic ion 
gradients 
*Sequences and data were obtained from NCBI and Uniprot databases. 
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Table 3.2. Bacterial strains and plasmids used in this study. Antibiotics (Sigma) are as 
follows: ampicillin (Ap), 100 µg ml-1; kanamycin (Kan), 50 µg ml-1; erythromycin (Ery), 
25 µg ml-1; chloramphenicol (Cm), 10 µg ml-1; tetracycline (Tet), 12.5 µg ml-1 with E. coli 
strains and 5 µg ml-1 with S. aureus strains. 
Strains Description Lab ID Reference/Source 
S. aureus 
Newman Wild-type LIV028 (Duthie and Lorenz, 
1952) 
SH1000 Wild-type strain, rsbU repaired strain of 
S. aureus 8325-4 
LIV023 (Horsburgh et al., 
2002a) 
SF8300 Clinical isolate (USA300) LIV1138 (Montgomery et al., 
2009) 
BHICC MRSA clinical isolate. SCCmec type II, 
Biofilm positive. 
LIV1175 (O'Neill et al., 2007) 
RN4220 Intermediate cloning host restriction 
negative, methylation-positive 
LIV124 (Novick, 1991) 
Newman 
atl 
atl insertional inactivation mutant, Ery LIV232 (Foster, 1995) 
SA113 Wild-type strain LIV1142 (Bera et al., 2005) 
SA113 
oatA 
Single-deletion mutant (oatA:: kan), 
lacks MurNac O-acetylation 
LIV1144 (Bera et al., 2005) 
SA113 
tagO 
Single-deletion mutant (tagO::ermB), 
lacks MurNac WTA 
LIV1143 (Bera et al., 2007) 
SA113 
oatA, 
tagO. 
Double-deletion mutant (oatA:: kan 
tagO::ermB), lacks both MurNac WTA 
and O-acetylation  
LIV1145 (Bera et al., 2007) 
Escherichia coli and plasmids used in this study  
Top10  Chemically competent cell, cloning host. LIV131 Lab stock 
pMutin4 Suicide vector for allelic replacements 
containing lacZ. Ap, E. coli; Ery, S. 
aureus. 
LIV697 (Vagner et al., 1998) 
pET24d+ Vector for overexpressing proteins with 
His6 tag. T7 promoter. Kan, E. coli. 
LIV849 Lab stock  
pTB361 Vector for overexpressing proteins. Tet, 
E. coli. 
LIV713 Lab stock  
pSK5632 Shuttle vector used for complementation. 
Ap, E. coli; Cm, S. aureus 
 LIV711 (Grkovic et al., 
2003) 
pLysS  E. coli BL21 (DE3)  LIV036 Lab stock  
pDG1513 pMTL22 derivative, containing the 
tetracycline resistance cassette 
 (Guerout-Fleury et 
al., 1995) 
pDG792 Plasmid pML22, containing the 
kanamycin resistance cassette 
 (Guerout-Fleury et 
al., 1995) 				
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S. aureus strains (created during in this study)  
 
Newman pgd Newman pgd::tet. Tet. LIV3005 This study 
Newman pJAL- 
pgd 
Newman containing pSK5632+pgd. Cm. LIV3018 This study 
Newman pgd 
pJAL- pgd 
Complemented strain. Newman pgd 
containing pSK5632+pgd. Cm.  
LIV3021 This study 
SF8300 pgd SF8300 pgd::tet. Tet. LIV3017 This study 
SF8300 pJAL- 
pgd 
SF8300 containing pSK5632+pgd. Cm. LIV3020 This study 
SF8300 pgd 
pJAL- pgd 
Complemented strain. SF8300 pgd 
containing pSK5632+pgd. Cm. 
LIV3023 This study 
SH1000 pgd SH1000 pgd::tet. Tet. LIV3000 This study 
SH1000 pJAL- 
pgd 
SH1000 containing pSK5632+pgd. Cm. LIV3019 This study 
SH1000 pgd 
pJAL- pgd 
Complemented strain. SH1000 pgd 
containing pSK5632+pgd. Cm. 
LIV3022 This study 
BH1CC pgd BHICC pgd::tet. Tet. LIV3043 This study 
BH1CC pJAL- 
pgd 
BHICC containing pSK5632+pgd. Cm. LIV3045 This study 
BH1CC pgd 
pJAL-pgd 
Complemented strain. BHICC pgd 
containing pSK5632+pgd. Cm. 
LIV3044 This study  
Newman oatA Newman oatA::kan. Kan LIV1187 This study 
Newman tagO Newman tagO::erm. LIV1189 This study 
Newman oatA 
tagO 
Newman oatA::kan tagO::erm. Kan  LIV1205 This study 
Newman pgd oatA Newman pgd::tet oatA::kan. Tet,Kan LIV1190 This study 
Newman pgd tagO Newman pgd::tet tagO::erm. Tet, Erm LIV1203 This study 
SA113 pgd SA113 pgd::tet. Tet LIV1184 This study 
SA113 pgd oatA SA113 pgd::tet oatA::kan. Tet, Kan LIV1186 This study 
SA113 pgd oatA 
tagO 
SA113 pgd::tet oatA::kan tagO::erm LIV1207 This study 
SF8300 oatA SF8300 oatA::kan. Kan LIV1192 This study 
SF8300 pgd oatA SF8300 pgd::tet oatA::kan. Tet, Kan LIV1180 This study 
Newman mcrA Newman mcrA::tet. Tet. LIV3004 This study 
SH1000 mcrA SH1000 mcrA::tet. Tet. LIV2002 This study 
Newman a6qd62 Newman a6qd62::tet. Tet. LIV2995 This study 
SH1000 a6qd62 SH1000 a6qd62::tet. Tet. LIV2992 This study 
Newman SA2061  Newman SA2061::tet. Tet. LIV3012 This study 
SH1000 SA2061 SH1000 SA2061::tet. Tet. LIV3015 This study 
RN4220 mcrA 
pSK5632-mcrA 
RN4220 mcrA containing PSK5632+ 
mcrA. Cm. 
LIV1162 
 
This study 				
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Plasmids generated in this study for the complementation 
pJAL pSK5632 containing cloned pgd gene 
plus tet cassette 
LIV1141 This study 
pMcrA pSK5632 containing mcrA plus cm 
cassette 
LIV1142 This study 
pSA2061 pSK5632 containing sa2061plus cm 
cassette 
LIV1170 This study 
pA6QD62 pSK5632 containing a6qd62 plus cm 
cassette 
LIV1171 This study 
Plasmids generated in this study for overexpression  
PJamal-PCR2 PET24d + pgd. Kan LIV1132 This study 
PJamal-PCR2 E. coli BL21 (DE3) pLysS with 
pET24d + pgd. Kan 
LIV1132-
A 
This study 
EX-A6QD62 PET24d + a6qd62. Kan LIV1131 This study 
EX-MCRA PET24d + mcrA. Kan LIV1134 This study 
EX-SA2061 PET24d + SA2061. Kan LIV1147 This study 	
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Table 3.3. Oligonucleotide primers designed for PCR amplification. The 
sequence of the restriction enzyme (RE) site is underlined. 
Gene 
ID Purpose DNA Primer Sequence 5’ → 3’ RE  
a6
qe
26
 
(N
W
M
N
_0
33
6)
 
  
K
no
ck
 o
ut
 
(K
O
) 
F1
 ACATGAATTCTGCAACTGAGCAACCATCAG EcoRI 
R
1 CCGGTACCTGCTTCTGCAACTGGTTCAG KpnI 
F2
 ATAACTGCGGCCGCGTGATGATATCCAAATGAAC NotI 
R
2 CGACGGATCCAACGGTGCACCACTATGTCGT BamHI 
C
om
pl
em
en
ta
tio
n 
(C
O
) 
F 
CGACGGATCCGAGAAGGTATGTTACGTGAC BamHI 
R
 
TTATAAAGCTTGGCACCGCCAATACCTAACA HindIII 
O
ve
re
xp
re
ss
io
n 
(E
X
) 
F 
GTATACCATGGGCATCAACGTTATTAATTGCT NcoI 
R
 
TTATACTCGAGTTCAGTAATCACAGCCAT XhoI 
a6
qd
62
 
(N
W
M
N
_0
02
2)
 
K
no
ck
 o
ut
 
(K
O
) 
F1
 
ACAT GAATTC TTG CAC TGA TGT ATA TTG CA EcoRI 
R
1 CC GGTACC GAT GGT GCG TTG GAT GTT AC KpnI 
F2
 ATAACT GCGGCCGC ACT GTA TCA AGC AAG 
AGT GG 
NotI 
R
2 CGAC GGATCC TCT TAT ATA TTG AAT GAA CG BamHI 
C
om
pl
em
en
ta
tio
n 
(C
O
) 
F TTAC AGATCT ACG CCA ATA TAT ACA ATA TAA BgIII 
R
 TTAC GTCGAC TTA TCA ACG GTT ATC GCT Sall 
O
ve
re
xp
re
ss
io
n 
(E
X
) 
F GTATA CATATG ACA AGT GTA TGG CTC GTT Ndel 
R
 TTATA CTCGAG GCT AGC TTT TCT ACG TCG TAC XhoI 
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Gene 
ID 
 Purpose DNA Primer Sequence 5’ → 3’ RE  
pg
d 
(N
W
M
N
_2
57
9)
 
  
K
no
ck
 o
ut
 
(K
O
) 
F1
 
ACAT GAATTC GTA CTG CTA TGG AGT TAA GAC EcoRI 
R
1 CC GGTACC TAC AGT AAT CAT CCA ATC AT KpnI 
F2
 ATAACT GCGGCCGC TAC AGA TAT ATC AGC 
AAC GA 
NotI 
R
2 CGAC GGATCC TGG CTG CGC AGT AAT ATC TAA BamHI 
C
om
pl
em
en
ta
tio
n 
(C
O
) 
F CGAC GGATCC GAC GAT ACT ATG GAC GAC ATT BamHI 
R
 TTATA AAGCTT CTT GCA CAT ATT GTC CTT GCC HindIII 
O
ve
re
xp
re
ss
io
n 
(E
X
) 
F ATT CCATGG AAAATAAATCTGTTAATCCA NcoI 
R
 TTATA CTCGAG TTC TTC ATA ATC CCG ATT CC XhoI 
m
cr
A 
 
(N
W
M
N
_0
05
0)
 
 
K
no
ck
 o
ut
 
(K
O
) 
F1
 ACATGAATTCGGAATTGGTTAAGTTCACTC EcoRI 
R
1 CCGGTACCAGAACTCATCTAATA CAGAC KpnI 
F2
 ATAACTGCGGCCGCTGTATCACTTAGGTGTATCA NotI 
R
2 CGACGGATCCTCCAGCTGTTACCAGTCCGA BamHI 
C
om
pl
em
en
ta
tio
n 
(C
O
) 
F 
TTACGGATCCTTAAGTAACTTCTTTCAA BamHI 
R
 
TTATAAAGCTTACATCATTTCTGTCCCAG HindIII 
O
ve
re
xp
re
ss
io
n 
(E
X
) 
F 
GTATACATATGTATTACAGTTATGGAAAT Ndel 
R
 
TTATACTCGAGTAACAATTTGTGTTCTTT XhoI 
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Gene 
ID 
 Purpose DNA Primer Sequence 5’ → 3’ RE  
SA
20
61
 
K
no
ck
 o
ut
 
(K
O
) 
F1
 
ACATGAATTCTTGAGTACGCATGGAATCACTT 
EcoRI 
R
1 
CCGGTACCGATCAACTGCAGTTGCGATAC KpnI 
F2
 
ATAACTGCGGCCGCACTGTTGGTCTAGATG 
NotI 
R
2 CGACGGATCCTCTCAACACAGAAGCTGACA BamHI 
C
om
pl
em
en
ta
tio
n 
(C
O
) 
F 
TTACAGATCTACGCACATAGACGTGCAATTG 
BgIII 
R
 
TTACGTCGACTTG TGCCAATCAGTACATCA 
SalI 
T
et
ra
cy
cl
in
e 
( t
et
B 
) 
A
m
pl
ify
 te
t f
ro
m
 
pD
G
15
13
  F 
ATAACTGCGGCCGCGGCGGATTTTATGACCGAT
GAAG NotI 
R
 
CCGGTACCTTAGAAATCCCTTTGAGAATGTTT 
KpnI 
K
an
am
yc
in
 
(k
an
) 
Is
ol
at
e 
ka
n 
fr
om
 
pD
G
79
2 
 F
 ACAGGTACCGAAAACCCAGGACAATAACC KpnI 
 
ACAGGTACCCTCGGGACCCCTATCTAG 
KpnI 
 
 	
 M
13
 
F 
GTAAAACGACGGCCAG  
R 
CAGGAAACAGCTATGAC 
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3.1.3. Protein purification buffers  
 
Lysis buffer  (for 1 litre) 
50mM NaH2PO4  
300mM NaCl  
10mM imidazole  
Adjust pH to 8.0 
 
Washing buffer (for 1 litre) 
50mM NaH2PO4  
300mM NaCl  
20-60mM imidazole  (the concentration of imidazole required for elution is protein 
dependent) 
 
Adjust pH to 8.0 
 
Elution buffer (for 1 litre) 
50mM NaH2PO4  
300mM NaCl  
250mM imidazole  
Adjust pH to 8.0 
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(A) Separating gel 10% (for one gel) 
dH2O 1.75 ml 
30% acrylamide 2.5 ml 
3M Tris-HCl/SDS, pH 8.45 2.5 ml 
Glycerol 0.75 ml 
30% APS (Ammonium persulfate) 7µL 
TEMED 7µL 
 
(B) Separating gel 4% (for one gel) 
dH2O 1.95 ml 
30% acrylamide 0.4 ml 
3M Tris-HCl/SDS, pH 8.45 0.775 ml 
30% APS (Ammonium persulfate) 7µL 
TEMED 7µL 
 
SOC media for 1	litre  
20 g Tryptone 
5 g Yeast extract  
0.186 g KCl 
0.5 g NaCl 
2.4 g MgSO4, anhydrous 
4 g Glucose 
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3.2.  Methods  
 
3.2.1.  Bacterial culture  	
Broth and agar media were prepared according to the manufacturer’s instructions 
using distilled water and sterilised by autoclaving at 121oC for 15 min. E. coli strains 
were routinely grown overnight in Luria-Bertani (LB) medium (LAB M, Quest Park, 
Lancashire, UK) at 37oC with shaking at 250 rpm and supplemented, as appropriate, 
with antibiotics: 12.5 µg ml-1 tetracycline (Tet), 50 µg ml-1 kanamycin (Kan) and 100 
µg ml-1 ampicillin (Amp).  
 
S. aureus strains (Newman, SF8300, SH1000 and BHICC) including their mutants 
and their complemented counterparts were typically cultured in brain heart infusion 
(BHI) (LAB M, Quest Park, Lancashire, UK) at 37oC with shaking at 250 rpm. The 
supplementation of media with antibiotics is listed for relevant strains in Tables 3.1 
and 3.2.  
 
 3.2.2. Preparation of competent cells  	
 3.2.2.1. Chemically competent cells of E. coli Top10. 	
Chemically competent E. coli Top10 were prepared according to the Hanahan 
method (Hanahan et al., 1991). A frozen stock of E. coli Top10 (LIV131; Table 3. 
2.) was streaked onto an LB plate and incubated overnight at 37oC. Next, several 
colonies were aseptically transferred to a 500 ml flask containing 100 ml of SOB 
media and incubated at 37oC, with shaking at 225 rpm until the OD600 nm reached 
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0.5. The culture was chilled on ice for 20 min and then cells were harvested by 
centrifugation at 3,220 rcf for 10 min. The pellet was resuspended gently in 25 ml of 
cold FSB buffer and incubated on ice for 15 min. Next, the cells were harvested 
again as described and resuspended in 8 ml of cold FSB buffer. Subsequently, 280 µl 
of DMSO (99.7 % dimethyl sulphoxide, Fisher Scientific) was added to the mixture 
and incubated for a further 10 min on ice. Finally, the cells were aliquoted and frozen 
using dry ice with 100% ethanol, prior to storage at -80oC until use. A 200µl aliquot 
of the competent cells was assessed for its effectiveness by transformation with 100 
ng of pMUTIN4 to ensure numbers of colonies yielded on an LB ampicillin plate 
were greater than 108 colonies per µg DNA. 
 
3.2.2.2. Electrocompetent cells of S. aureus RN4220.  	
The strain S. aureus RN4220 (LIV124) was used as an intermediate cloning host and 
electrocompetent cells were prepared according to a commonly used method (Schenk 
and Laddaga, 1992).  Strain RN4220 was grown overnight in 10 ml B2 broth at 
37oC. Following this, 2 ml of overnight culture was added to 1 litre of fresh B2 and 
cultured under the same conditions until growth reached mid-log phase (OD600 nm 
~ 0.8). Cells were harvested by centrifugation at 1500 rcf for 10 min at 4oC. The 
pellet was washed three times by resuspension in 300 ml sterile cold-water and 
harvested by centrifugation at 1500 rcf for 10 min, followed by three washes with 
100 ml, 50 ml and 25 ml of 10 % (v/v) ice-cold glycerol, respectively. Cells were 
harvested and resuspended in 1.25 ml of ice-cold glycerol, then aliquoted in 200 µl 
batches in sterile 2 ml eppendorfs and frozen using dry ice with 100% ethanol and 
then stored at -80oC until use. 
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3.2.3. Bacterial storage   	
All bacterial strains used in this project were stored as resuspended cells in LB 
medium containing 15% (v/v) glycerol, and stored at -80 OC.  
 
3.2.4. Genomic DNA extraction 	
Genomic DNA from S. aureus was extracted with a DNeasy Blood & Tissue kit 
(QIAGEN) using a modified protocol. One or several colonies were transferred to 10 
ml BHI media with culture overnight at 37oC, shaking at 225 rpm. Cells were 
harvested from overnight culture by centrifuging for 10 min at 1500 rcf. 
Subsequently, supernatant was discarded and the cells were completely resuspended 
in 180 µl enzymatic lysis buffer (180 µl ELB buffer plus 2 µl lysostaphin [5 µg ml-1] 
and 20 µl lysozyme [1 mg ml-1]). After mixing, the cells were incubated for 1 h at 
37oC to ensure lysis then 25 µl proteinase K and 200 µl AL buffer were added 
consecutively, with mixing between, to the lysed cells and mixed before incubating 
at 56oC for 30 min. Next, 200 µl of 99% (v/v) ethanol was added to the mixture and 
vortexed before pipetting onto the Mini spin column, which was centrifuged at 6030 
rcf for 1 the min. The flow-through was discarded from the collection tube and 500 
µl AW1 buffer was added onto the spin column, followed by centrifuging at 6030 rcf 
for 1 min and again discarding the flow-through. AW2 buffer (500 µl) was added to 
the column and centrifuged at 6030 rcf for 1 min, followed by discarding the flow-
through and replacing the collection tube. A 2 min centrifuge cycle was used to dry 
the membrane of the column. Finally, the DNA was collected into a sterile 1.5 ml 
tube by pipetting 50µl ddH2O directly onto the spin column membrane followed by 
centrifugation at 18400 rcf for 1 min. The DNA quality and concentration was 
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measured using a NanoDrop-1000 (Thermo Scientific) then stored at -20 oC until 
use.  
 
3.2.5. Plasmid extraction from bacteria 	
Plasmids and their respective host E. coli strains used during this study are listed in 
(Table 3. 2.). E. coli strains containing the desired plasmid were grown in LB broth 
with selective concentrations of antibiotic (Table 3. 2) at 37 oC with shaking at 200 
rpm for overnight. Plasmids from the host cells were harvested with the Isolate II 
Plasmid Mini Kit (BioLine). Briefly, 10 ml of overnight culture was centrifuged at 
18400 rcf for 10 min and the supernatant discarded. The pellet was resuspended in 
250 µl resuspension buffer P1 (containing RNase A) and mixed by pipetting up and 
down to fully resuspend clumps. Subsequently, 250 µl lysis buffer P2 was added to 
the mixture and mixed gently by inverting the tube 6-8 times, to avoid shearing 
genomic DNA and contaminating the plasmid, followed by incubating at room 
temperature for 5 min. Afterwards, 350 µl neutralization buffer P3 was added to the 
mixture to neutralise the NaOH present in buffer P2 and mixed gently prior to 
centrifuging at 21200 rcf for 10 min. The clarified supernatant phase was transferred 
to a spin column, placed in a 2 ml collection tube and then centrifuged at 13500 rcf 
for 1 min. The filtrate was discarded each time and the collection tube reused. Next, 
500 µl wash buffer PW1 was added directly onto the membrane column then 
centrifuged at 13500 rcf for 1 min prior to adding 600 µl wash buffer PW2 and 
centrifuging again at 13500 rcf for 1 min. The filtrate was discarded and the silica 
membrane dried by centrifuging the spin column once more at 13500 rcf for 2 min. 
Finally, the DNA was collected into a sterile 1.5 ml tube by pipetting 50 µl ddH2O 
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directly onto the spin column membrane then centrifuging at 18400 rcf for 1 min. 5 
µl of the plasmid DNA was tested using a single restriction enzyme digest followed 
by agarose gel electrophoresis to confirm the size of plasmid.   The quality and 
concentration of extracted plasmid was determined by NanoDrop-1000 (Thermo 
Scientific) and DNA was stored at -20 oC until use. 
 
3.2.6. DNA manipulations. 	
3.2.6.1. Oligonucleotide primers. 	
Oligonucleotide primers for amplification of each gene of interest are outlined in 
Table 3.3. Custom oligonucleotide primers were designed with the following criteria; 
each primer was typically between 18 to 26 bases. The 5’ end of each primer for 
cloning consisted of a specific restriction site for ligation; all primers were selected 
with a GC content of approximately 50%; the calculation of annealing temperature 
(Tm) of these primers was between 55oC and 65oC. All primers were purchased from 
Eurofins Genomics, Germany and were dissolved in Milli-Q water and stored at -
20oC. 
  
3.2.6.2. Polymerase Chain reaction (PCR)  	
Dependent on their purpose, three different groups of primers were designed in this 
study (Table 3.3). 
Group one were designed for creating gene mutants: four primers were designed and 
used to amplify two flanking regions of the target gene [left arm (LA) and right arm 
(RA)] from the genome of S. aureus Newman. These LA and RA regions, around 1 
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kb in length, were amplified from the genome of S. aureus and coligated with tet or 
kan resistance cassettes to generate disrupted alleles in shuttle vector pMUTIN4. 
This pMUTIN4 construct was used as a suicide vector for the allelic replacement of 
the target gene (Fig. 3. 1.). The tetracycline gene (tet) was isolated from the 
pDG1513 vector, while kanamycin (kan) was amplified from pDG782 vector 
(Guerout-Fleury et al., 1995).  
 
Group two primers were designed for gene complementation studies: a pair of 
primers were designed to amplify the full-length target gene (including potential 
promoter and terminator sequences upstream ~200bp and downstream ~50bp) from 
S. aureus Newman strain for cloning into the complementation vector pSK5632.  
 
Group three primers were designed for generating overexpression plasmids: primers 
were synthesised to amplify the full-length sequence of a target gene (excluding the 
5’ N-terminal signal peptide and 3’ stop codon sequences) from S. aureus Newman 
genomic DNA.  The amplified and digested DNA was cloned into pET24d+, which 
was used for the overexpression of the target gene using the E. coli BL21 (DE3) 
strain. This is discussed further in (section 4.3.3.2). The PCR parameters, reaction 
mixture and quantities are outlined (Table 3.4-5).  
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Table 3.4.  PCR amplification cycle parameters 
Step Cycle TM Time 
1 Primary denaturation 95 oC 3 min 
2 Denaturation 95 oC 20 s 
3 Annealing 55 oC 30 s 
4 Extension 72 oC 1 min per kb 
 Step 2-4 repeated for 30 cycles 
5 Final Extension 72 oC 3-10 min 
6 Hold sample 4 oC As required 
 
3.2.6.3. Agarose gel electrophoresis  
Agarose gel electrophoresis is a common method used for separating and identifying 
DNA based upon its size from the rate of movement through an agarose gel with an 
applied potential difference. PCR amplicons and restriction enzyme digests were 
routinely separated on a 1% (w/v) agarose gel for up to 1 h at 90 V (or until DNA 
species resolution was optimal). Agarose gels were prepared by heating a mixture of 
1x TAE buffer and agarose (Sigma Ultra). Next Midori green DNA Stain was added 
to the gel mixture (2µl/100ml) and mixed gently. Subsequently, the mixture was 
cooled to 50 OC and poured into the gel tray. After resolution, DNA bands were cut 
from gels visualised using a UV transilluminator set with a long wavelength, 365 nm 
(UV-P, USA), to minimise damage (Fig. 4.2). Finally, DNA was extracted using the 
manufacturer’s protocol for the Isolate II PCR and Gel kit (Bioline, A Meridian Life 
Science, UK). Extracted DNA was measured by NanoDrop and stored at -20 oC until 
use.  
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Table 3. 5. PCR mixture for a typical 50 µ l reaction volume.  
 
Reagent Volume Final concentration 
BioMix Red  (Bioline) 25 µl 
2X reaction mix (stable 
Taq polymerase, buffer 
and loading dye) 
Template DNA 1.5 µL ~2.5 ng template DNA 
Primer Forward 1.5  µl 100 pmol µL-1 
Primer Reverse 1.5  µl 100 pmol µL-1 
ddH2O 20.5 µl Up to 50 µL 
Accuzyme  (BIOLINE) 1 µl 2.5 U µL-1 
 Final 50 µL  				
3.2.6.4. DNA quantification 	
DNA concentration was routinely quantified prior to each cloning step. A NanoDrop 
-1000 system (Thermo Fisher scientific, Germany) was used for measuring the DNA 
concentration and quality. The sample in ddH2O was applied to the instrument 
pedestal and the absorbance was read at 260 nm. 
 
3.2.6.5. Restriction enzyme digests.    	
All restriction enzymes (Table 3.6) were obtained from Thermo Scientific and DNA 
digests were achieved as recommended in the manufacturer’s guidance (Thermo 
Scientific). In general, both insert and plasmid DNAs were digested in 50 µl 
reactions including 2-8 units of restriction enzyme per 1 µg of DNA, 5 µl of 
appropriate 10x buffer (dependent on the recommendation) and water up to 50 µl. 
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DNA digestion was performed for 1-2 h at 37oC. For verification of the digest and 
gel extraction of desired DNA portions, 5x loading buffer was mixed with the digest 
mixture followed by separation with electrophoresis on 1% (w/v) agarose for 1 h (or 
as required for resolution) at 90 V. DNA was extracted from agarose as described 
above and stored at –20 oC until required. 
 
3.2.6.6. DNA Ligation.  	
Ligation of digested insert and plasmid DNA fragments using T4 DNA ligase with 
ligase buffer was achieved as recommended using manufacturer’s instructions 
(Thermo Scientific). Briefly, the reactions occurred in a 20 µl volume, including 1 µl 
of T4 DNA ligase (~3 Weiss units), 2 µl of 10x buffer, made up with dH2O. Insert 
and plasmid DNA were quantified to establish the volumes required for fragment to 
vector ratios of 4:1. The DNA ligation reaction was incubated overnight at 4OC 
before transforming E. coli TOP10 competent cells.   
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Table 3. 6. Features of restriction enzyme (RE) digests and cloning purpose.  
DNA amplicons and RE sites 
for each gene: 
 
Antibiotic 
cassette 
and RE 
sites 
Plasmid and 
RE sites 
Cloning Purpose 
Genes:  a6qe26, a6qd62 
               pgd 
              mcrA  
              SA2061 
tet cassette: 
NotI & KpnI 
pMUTIN4:  
 
 
EcoRI & BamHI 
For creating gene 
mutants by allelic 
replacement 
LA fragment  
EcoRI & 
KpnI 
RA fragment  
NotI & 
BamHI 
 
Genes:  a6qd62 & SA2061 
 
 
 
 
pSK5632:  
 
 
BglII & SalI 
For gene 
complementation in 
mutant strains and 
control in wild-type 
 
 
Target gene with  
200 bp upstream and 
50 bp downstream 
BglII & 
SalI 
Genes: a6qe26 
             pgd 
             mcrA   
pSK5632: 
BamHI & HindIII 
 
Target gene with 200 
bp upstream and 50 
bp downstream 
BamHI & 
HindIII 
 
Gene name:  a6qd62 
Gene name:  mcrA 
 
 
None 
PET24d+ with: 
 
 
NdeI & XhoI 
For target gene 
overexpression in 
E. coli BL21 (DE3)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Target gene 
excluding the 5’ 
signal peptide and 3’ 
stop codon sequence  
NdeI & 
XhoI 
Gene name: a6qe26 
Gene name: pgd 
 
 
 
 
 
NcoI & XhoI 
Target gene 
excluding the 5’ 
signal peptide and 3’ 
stop codon sequence  
 
 
NcoI & 
XhoI 
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3.2.7. E. coli transformation  	
Chemically competent cells of E. coli were prepared using the Hanahan method 
(Hanahan et al., 1991) For transformation, 5µl of a ligation was mixed with 100 µl of 
competent cells in a 2 ml Eppendorf tube and then incubated on wet ice for 30 min. 
Next, the cells were subjected to heat shock by transferring the tube from wet ice to a 
37 OC water bath with incubation for 90 s; this facilitates internalisation of DNA. 
Afterwards the transformation was returned to wet ice for 3 min. Next, 900 µl of LB 
medium was added to the cells and incubated at 37 OC with shaking for 1 h. 
Subsequently, 50-100 µl of cells were spread onto LB plates containing the 
appropriate antibiotics and incubated at 37 OC overnight or up to 48 h. Empty vector 
was used as the control for transformations. Features of the relevant plasmids are 
presented in Table 3.7. 
 
Table 3. 7.  Plasmid features relevant to cloning strategies 
Constructed 
plasmid Purpose Resistant gene 
pMUTIN4 Suicide vector for allelic replacement of 
target genes. Replication proficient in E. coli 
(Vagner et al., 1998).	
 
amp for E. coli 
erm for S. aureus 
tet insert in mutant 
alleles  
pSK5632 E. coli/S. aureus low copy number shuttle 
vector suitable for gene complementation 
studies in S. aureus (Grkovic et al., 2003). 
amp for E. coli 
cm for S. aureus 
pET24d+ Vector for protein overexpression studies in 
E. coli. T7 promoter and His-tag sequences 
kan for E. coli 
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3.2.8. Clone selection strategies following transformation  	
Following transformation of competent cells of E. coli TOP10 the resulting colonies 
were cultured on selective agar plates. Around 20 colonies were selected from each 
transformation and isolated on selective plates containing appropriate antibiotics, as 
described above, and incubated at 37 OC overnight. Subsequently, 10 ml of fresh LB 
broth with any selective supplements was inoculated with a chosen colony and 
incubated at 37OC for overnight. The recombinant plasmids were extracted from 
overnight cultures using Isolate II Plasmid Mini Kit (BioLine), as described 
previously, followed by screening to ensure correct cloning using the appropriate 
restriction enzymes with discrimination of inserts after gel electrophoresis as 
described above (Fig. 4.3. and 4.4). Verified transformant clones were stored with 
15% glycerol at - 80oC until use.  
 
3.2.9. Preparation of S. aureus for transformation   	
Transformation of S. aureus RN4220 strains was performed as described previously 
(Schenk and Laddaga, 1992).  Prior to transformation of S. aureus plasmids were 
concentrated by precipitation.  Typically, 200 µL of DNA sample was mixed with an 
equal volume of isopropanol plus 20 µL of 3M sodium acetate (pH 5.2). The mixture 
was incubated at room temperature for 1 min and centrifuged for 20 min at 21200 rcf 
to pellet the DNA.  The DNA was washed with 500 µL of 70 % (v/v) ethanol then 
centrifuged at 21200 rcf for 5 min. The DNA pellet was vacuum-dried at 40oC for 5 
min, followed by adding up to 50 µL of ddH2O then stored at -20 oC.   
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3.2.9.1 Transformation of S. aureus by electroporation  	
Aliquots (200 µL) of RN4220 competent cells were mixed gently with 2 µL  (200 
ng/µl) of plasmid DNA in chilled electroporation cuvettes, 0.1 cm gap (Cell projects, 
UK) and kept on wet ice for 20 min. Competent cells alone served as a plasmid 
negative control. For transformation the cells/DNA mixture was mixed again gently 
and using an electroporator (Gene PulserTM ,Bio-Rad) it was pulsed with the 
following parameters:  capacitance 25 µF, resistance 100 Ω and 1.6 kV. 
 
Immediately following electroporation the mixtures were replaced on ice for 3 min 
and the contents transferred to a chilled 1.5 ml Eppendorf tubes containing 800 µl of 
recovery media (SOC) and incubated at 37oC for 1 h. Cells were plated onto 
selective agar containing either tetracycline for cells transformed with constructs of 
pMUTIN4 or chloramphenicol for cells transformed with constructs of pSK5632, 
with incubation overnight at 37oC. Selected and culture isolated colonies of RN4220 
were tested by PCR using the primer pair F-M13 and R-M13 (Table 3. 3) to identify 
the presence of cloned inserts.  
 
3.2.9.3. Phage transduction  	
Of the target genes a6qe62, pgd, mcrA and SA2061 each were selected as their 
cognate integrated pMutin4 and/or pSK5632 constructs in RN4220. From this 
intermediate cloning strain, bacteriophage ∅11 lysates were prepared to transduce 
desired alleles to strains SH1000, Newman, SF8300 and BH1CC, using SH1000 ∅11 
mediated genetic transduction. RN4220 donor strains were infected with ϕ11 to 
obtain high titre (~1010 pfu ml) phage lysates. These strains were cultured in LK 
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medium at 37OC overnight. A mixture comprised of 5 ml LK broth (1% w/v 
tryptone, 0.5% w/v yeast and 0.7% w/v KCl), 5ml phage buffer (1mM MgSO4, 4mM 
CaCl2, 50mM Tris-HCl pH7.8, 5.9 g/L NaCl and 1 g/L gelatin) and 200 µl ϕ11 
phage was mixed with 300 µl of donor culture and incubated at room temperature 
overnight until completely lysed. Next, lysates were filtered by using sterile syringe 
filters (0.22 µm MILLEX®GP) and stored at 4 OC.  
 
 For transduction of S. aureus SH1000, Newman, SF8300 or BH1CC strains 
(recipient strains) cells were infected with ϕ11 lysates of the RN4220 donor strains. 
Recipient strains were grown in 20 ml LK broth at 37 OC overnight then centrifuged 
at 1500 rcf for 10 min. The pellet was resuspended in 1 ml LK broth, then 500 µl of 
the recipient cell suspension was added to 1 ml LK with 10 mM CaCl2 plus 500 µl of 
ϕ11 lysate then incubated stationary at 37OC for 25 min followed by 15 min with 
shaking at 250 rpm. Afterwards, 1 ml ice-cold 0.02 M sodium citrate was added to 
the mixture and incubated on ice for 5 min prior to centrifuging again. Next, the 
pellet was resuspended in 1 ml of 0.02 M Na citrate and incubating on ice for 1 h. 
Finally, cell suspensions were plated onto LK plates containing 0.05 % w/v Na 
citrate and incubated for 1 h at 37C. Cells were then overlaid with top agar 
containing appropriate selective antibiotics and incubated for 24-48 h at 37 oC.  
Clones were picked and cultured on selective agar prior to colonies being screened 
by PCR. Correct clones were stored at -80 OC with 15% v/v/ glycerol. 
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CHAPTER 4 
 
4. Molecular investigation of gene function of S. aureus 
 
4.1. Introduction 	
Generally, the principles that support using genetic manipulation to characterise gene 
function in pathogenic bacteria are best summarised by Stanley Falkow’s molecular 
update of Koch’s Postulates (Falkow, 1988). More precisely, genetic manipulation of 
target genes that encode putative virulence proteins is used to produce inactivated or 
modified alleles that can subsequently be examined for loss of contribution to 
virulence, either in vitro or preferably in vivo. With this approach, it is important to 
demonstrate that gene complementation restores the virulence back to near wild-type 
levels.  
 Early studies of bacteriophages revealed that certain bacterial strains presented 
resistance for phage infection but were infected by phage when either the titer was 
greatly raised (Rountree, 1956) or the recipient strains were previously heat-shocked. 
This indicated that the infection barrier system could be overwhelmed by transient 
inactivation (Asheshov and Jevons, 1963). The majority of Staphylococcus aureus 
isolates have an effective, robust barrier which hinders DNA exchange. In the 
laboratory, this can be seen to prevent the transformation of plasmid vectors into the 
bacterial cell because by virtue of this system called  a restriction-modification 
barrier (RM). Consequently, genetic researchers have focused on the use certain lab 
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strains of transformable  S. aureus, particularly the strain RN4220 (Baba et al., 2008; 
O'Neill, 2010; Voyich et al., 2005).  
Three out of four known types of R-M system are known in staphylococci and 
recently described in detail (Monk and Foster, 2012). A type I R-M system (SauI) 
includes genes encoding a host specificity of DNA (hsd) component, a modification 
protein (HsdM), a specifity protein (HsdS) and a restriction endonuclease protein 
(HsdR). These gene products combine to form a complex of either HsdSHsdM2 or 
HsdSHsdM2HsdR2. The HsdSHsdM2 complex protects target DNA sequences from 
restriction by catalysing the transfer of a methyl from S-adenosylmethionine to 
adenine residues within the target DNA sequence, while the complex of 
HsdSHsdM2HsdR2 functions as a restriction endonuclease, which can recognise and 
cleave unmethylated target DNA sequence. The S. aureus RN4220 strain that was 
obtained by UV and chemical mutagenesis of strain NCTC8325-4 carries a nonsense 
mutation in the hsdR gene, making this strain deficient for restriction and an 
important intermediate cloning host for S. aureus strain construction (Nair et al., 
2011; Waldron and Lindsay, 2006).  
Certain type II R-M systems are widely used by molecular biologists, with their 
restriction endonuclease enzymes making for effective reagents for recombinant 
studies. Type II R-M systems are used for digesting nucleic acid at specific 
sequences for cloning. The cleavage of the target DNA sequence can be prevented by 
the DNA methylation status. In S. aureus, Sau3AI was the first type II R-M system 
that was described in detail, but this system is uncommon in isolates of S. aureus 
(Stobberingh et al., 1977; Waldron and Lindsay, 2006).   
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Type IV R-M systems are known to be the simplest form of restriction system, which 
includes a single protein with the ability to detect the methylation status in order to 
hinder uptake of foreign DNA (Corvaglia et al., 2010; Kelleher and Raleigh, 1991). 
The SauUSI gene was classified as a type IV R-M system in the majority of S. 
aureus, and it requires dATP or ATP for endonuclease activity of  foreign DNA (Xu 
et al., 2011b). The motif recognised by SauUSI is identified by cytosine methylation. 
The E. coli strains widely used for cloning, such as TOP10 and DH10B are able to 
methylate both cytosine and adenine. Consequently the plasmid isolated from these 
E.coli strains can be readily degraded by SauUSI (Monk and Foster, 2012). In order 
to avoid this restriction barrier of type IV in S. aureus, the plasmid should be isolated 
from an E. coli strain that is defective in methylation of cytosine (Monk and Foster, 
2012). Analysis of the SauUSI gene in RN4220 revealed a nonsense mutation in the 
middle of the sequence, making it  able to modify foreign DNA but not restrict it 
(Monk et al., 2012). 
 
4.1.1. Heterologous expression of proteins 	
The T7-directed protein expression system is one of the most commonly used for the 
overexpression of target DNA in E. coli and derives from T7 bacteriophage 
replication life-cycle components. The utility of the expression system arises from 
the high degree of specificity that the phage T7 RNA polymerase has for cognate 
promoter sequences. The polymerase recognises only the T7 bacteriophage promoter 
sequences and not those of E. coli, leading to selective transcription of large amounts 
of RNA. The pET24d+ plasmid is one of a series plasmid vectors designed for gene 
cloning and protein overexpression from target DNA sequences when ligated 
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downstream from the T7 promoter (Studier et al., 1990). The E. coli lysogen BL21 
(λDE3) strain was originally developed as a host for expressing genes and was 
engineered with the lacUV5 promoter providing IPTG-inducible expression of the 
polymerase (Studier et al., 1990). The pET24d+ plasmid contains a T7 promoter 
located 5’ of a multiple cloning site, and there is a T7lac promoter controlling LacI 
repressor expression to modulate the IPTG-dependent regulation. In addition, this 
plasmid has a C-terminal hexa-histidine tag, which facilitates purification of the 
target protein, and an N-terminal T7 tag. This plasmid has a kanamycin resistance 
gene for selection during growth. Two host E. coli B strains are commonly used for 
the expression:  BL21 (λDE3) and BL21 (λDE3) pLysS. The latter strain contains 
pLysS vector which has a T7 lysozyme gene.  This phage lysozyme is a natural life-
cycle antagonist of T7 RNA polymerase and is used to decrease the basal level 
expression of protein that might be toxic to the host cell (Moffatt and Studier, 1988).  
 
4.2 Chapter Aims  
In the previous chapter five genes were analysed variously using bioinformatics 
methods to establish predicted functions (Table 3.1).  The aim of this chapter was 
therefore to generate strains to enable functional studies of each of the target genes 
(a6qe26, a6qd62, pgd, mcrA and SA2061 genes). As a basis to study gene functions the 
production of three strains was attempted: an allelic replacement mutant; a 
complementation strain, and a protein overexpression strain. 
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Firstly, creating the mutant strain was based on allelic replacement using a suicide 
vector that when resolved will disrupt the target gene on the chromosome with a 
selectable marker cassette.. Secondly, creation of the complementation strain was 
made using the low copy shuttle vector PSK5632 carrying the target gene for 
subsequent transformation of the respective gene mutant strain (additionally the 
plasmid would be used to transform the isogenic wild-type as a control strain). 
Finally, attempts would be made to create an E. coli protein overexpression strain 
with a plasmid carrying the target gene. These aim being that these strains would aid 
subsequent studies of target gene function. 
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4.3. Results and Discussion 
 
Inactivation and complementation strain construction 
4.3.1. Creation of gene mutant strains by allelic replacement. 
 
The process of allelic replacement for mutagenesis used the suicide vector 
pMUTIN4 vector followed by transductional outcross as presented in (Fig. 4. 1). 
Allelic replacement of a6qe26, a6qd62, pgd, mcrA and SA2061 genes was carried 
out by amplifying two 1 kb flanking regions to the left and right of the target using 
primers pairs F1/R1 and F2/R2 respectively. A tetracycline cassette gene was 
amplified in addition; all primers are listed in (Table 3.3). These three fragments 
were digested with specific restriction enzymes EcoRI/KpnI, NotI/BamHI and 
NotI/KpnI, respectively. Subsequently, these digested fragments were co-ligated into 
pMUTIN4 vector digested with EcoRI and BamHI. The resulting recombinant 
plasmid ligations for each target gene were used to transform E. coli TOP10. 
Identification of tetracycline-resistant colonies was followed by extracting the 
plasmids confirm the presence of desired fragments. 
 
4.3.1.1. Screening and confirming successful transformants 
  
Prospective correctly cloned plasmids were extracted and digested with various 
combinations of restriction enzymes. Each plasmid was digested with separate 
enzyme combinations to release four fragments as following: BamHI/KpnI (~2600 
bp includes right flank plus tet), NotI/EcoRI (~2600 bp includes left flank plus tet), 
BamHI/EcoR1 (~3600 bp includes both flanks plus tet) and NotI/KpnI (~1600 bp, 
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tet) (Fig. 4. 3.). Identification of each fragment indicated that the production of the 
recombinant suicide allelic replacement constructs was achieved successfully.   
 
4.3.1.2. Transformation and transduction of S. aureus strains 	
The constructed plasmids were precipitated prior to electroporation of S. aureus 
RN4220 strains. Colonies growing on the selective media with tetracycline were 
confirmed with acid formation on mannitol agar and PCR using forward and reverse 
M13 primers. Next, phage ϕ11 lysates of the clones were prepared and used to infect 
S. aureus strains Newman, SF8300, SH1000 and BH1CC. Correct allelic 
replacement via transduction outcross was achieved with selection for tetracycline-
resistant, erythromycin-sensitive clones (Section 3.2.8). Despite several attempts the 
mutant of a6qe24 failed due to problems with transduction of S. aureus but 
importantly, a paper was published that described the function of protein A6QE26 as 
FepA (Turlin et al., 2013), and involved in heme iron utilisation as predicted by 
bioinformatics methods in this study.  Work on this gene was discontinued. Correct 
allelic replacements of the a6qd62, pgd, mcrA and sa2061 genes were confirmed by 
PCR using the external primer pair (Table 3. 3.). 
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Fig. 4.1. Schematic of allelic replacement construction in S. aureus. (A) Allelic 
replacement of pgd gene in the genome of S. aureus using the suicide plasmid 
pMutin4 by homologous recombination of the cloned pgd gene regions where the 
tetB cassette replaces pgd. The left-hand flanking region upstream of pgd was 
amplified by primer 1 with an EcoRI sequence and primer 2 with KpnI (red arrows), 
while the right-hand region downstream was amplified with primers 3 and 4 bearing 
a NotI and BamHI site respectively (red arrows). In the isogenic mutant pgd::tetB, 
the tetB contains its own promoter and is in the opposite orientation to pgd in wild 
type. (B) The map of the complementation vector PJAL (pSK5632-pgd). Only 
relevant part of the complementation vector pJAL is shown. The pgd gene with its 
translational signal sequence was cloned into the multiple cloning sitee of pSK5632 
by using BglII and HindIII restriction sequences.   
!
Downstream+ Target+gene+ Upstream+Region+!!!!!!!!!!!!
1kb++++++ 1.5kb+ 1kb+!!!!!!!!!!!
!
+ Gene+A+!tetB$
pgd$ Gene+A+!Gene+C+
pMUTIN4ΔgeneB+
Newman+genome++
Newman+geneB::tetB$!
lacZ+
Gene+A+!+tetB$Gene+C++
FIG. 4.1 Processes of Allelic replacement for making the mutagenesis vector (constructed 
plasmid). Allelic replacement of gene B in the genome of S. aure  Newman (A) and m p 
of the complementation vector pSK5632pgd (B). (A) A plasmid relay on the shuttle 
vector pMutin4 that permitted replacement of ext3 gene by tetB cassette through 
homologous recombination sequence was constructed. The flanking region (LA) upstream 
of ext3 amplified by primer 1 contains EcoRI and primer 2 with KpnI (red arrows), while 
region downstream amplified by primers 3 contains NotI and primer 4 with BamHI (red 
arrows). In the isogenic mutant ext3::tetB, the tetB contains its own promoter and is in the 
opposite orientation to ext3 gene in wild type. (B) Only relevant part of the 
complementation vector pSK5632ext3 is shown. The ext3 gene with its translational 
signal sequence was cloned into multiply cloning sites of the pSK5632 plasmid by using 
BglII and HindIII restriction sites (Dependent on the REs sites were designed). ApR is 
blaM gene of E.coli for β-lactamase, CoIE1HCori is E.coli High-copy-number plasmid 
origins of replication, lacZα gene encoding LacZα for blue/white selection colons in E. 
coli and cmR gene encoding CmR chloramphenicol acetyltransferase.   
 
pgd$
+
ApR+! ColE1HCori$! lacZ$ cmR$ pSK5632geneB$!
Gene+C+
$
A+
B+
3++NotI+ 1+++EcoRI+
2+++KpnI+4+++BamHI+
KpnI+NotI+
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Fig. 4.2. PCR-amplified flanking sequence and tet cassette of gene mutants from 
mutant construction confirmation. Lanes 1,2: left (LA) and right (RA) sequences 
of a6qe26 gene plus tet (~1000 bp and 1100 bp); Lanes 3,4: LHS and RHS flanking 
fragments of a6qd62 gene plus tet (~1400 bp and 1200 bp); Lanes 5,6: left and right 
fragments of pgd gene plus tet (~1100 bp and 1200 bp) and lanes 7,8: left and right 
fragments of mcrA gene plus tet (~1000 bp) and 1000 bp). A DNA size marker is 
shown for reference. 
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Fig. 4.3. Restriction digest analysis of allelic replacement construct plasmids. 
Purified pMUTIN4 vector constructs from transformants were digested to produce 
three fragments; RHS, tet and LHS. and separated by gel electrophoresis alongside a 
DNA size ladder. The corresponding digest fragments belonging to a6qe26 gene (A), 
a6qd62 (B), pgd gene (C) and mcrA gene (D). Restriction enzymes fragments of 
expected sizes as follows; Lane 1: BamHI/KpnI (RHS plus tet), (2) NotI/EcoRI (LHS 
plus tet), (3) BamHI/EcoR1 (RHS plus tet) and (4) NotI/KpnI LHS plus tet). 
 
4.3.2. Construction of pSK5632 complementation plasmids  	
The low-copy number vector pSK5632 was used for complementation analysis, into 
which a copy of each target gene was cloned. The full length of each target gene 
(a6qe26, a6qd62, pdg and mcrA) plus a 200-bp sequence upstream and 50-bp 
downstream of the open frame was amplified using forward and reverse primers 
designed for each gene (Table 3.3). Next, the PCR fragment of each gene 
(a6qe26,pgd and mcrA) was digested and cloned as a BamHI/HindIII fragment into 
pSK5632, while the fragments of a6qd62 and SA2061 genes were cloned after 
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FIG.3.1: Double digestion analysis with BgIII and HindIII enzymes 
carried out in 3h and then subjected to electrophoresis on 1% agarose 
at 90V/45 min to confirm the size of insert and linear plasmid 
(PSK5632) of constructed Psk5632 isolated from the transformants 
strains. (A) Only Psk5632 plasmid, (B,C&D) constructed Psk5632 of 
ext1, ext3 and ext4 transformants respectively. Three extracted 
plasmids for each transformant.   
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FIG.3.1: Double digestion analysis of the recombination plasmid 
pMUTIN4. Each plasmid cut digested with different with BgIII and 
HindIII enzymes during incubation 37oC for 3h and then subjected to 
electrophoresis on 1% agarose at 90V/45 min to confirm the size of 
insert and linear plasmid (PSK5632) of constructed Psk5632 isolated 
from the transformants strains. (A) Only Psk5632 plasmid, (B,C&D) 
constructed Psk5632 of ext , ext3 and ext4 transformants respectively. 
Thr e extracted plasmids for each transformant.   
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BgIII/SalI digest.  After E. coli transformation with ligations, colonies were grown 
on selective agar plate with ampicillin.  Clones were selected and extracted plasmids 
were confirmed by enzyme digestion (Fig. 4.4.). The five resulting constructs 
produced were: pE26, pD62, pJAL-pgd, pMcrA, and pSA respectively. These 
correctly cloned complementation vectors, plus pSK5632 as a control, were used to 
transform S. aureus RN4220 then transduced using phage ϕ11 into strains Newman, 
SF8300, SH1000 and BH1CC.  
 
 
Fig. 4.4. Confirmatory restriction digestion analysis of pSK5632 plasmids 
bearing cloned fragments. Lanes (A), pSK5632 (undigested control); (B) a6qe26 
gene fragments: (C) pgd gene fragments; (D) mcrA gene fragments.  The upper band 
represents plasmid with the insert gene below. Three constructed plasmids were 
digested for each transformants and indicated as (1, 2 & 3).  The size of the BamHI 
and HindIII cloned inserts are: a6qe26, 1162bp, pgd, 1384bp and mcrA, 2062bp.  	
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4.3.3. Pgd Overexpression  
4.3.3.1. Preparation of competent expression host cells 	
The host strains, E. coli BL21 (λDE3) and BL21 (λDE3) pLysS were made 
chemically-competent by using CaCl2 standard treatment methods (Park and Batt, 
2004).	  A single colony of each strain was cultured in 10 ml Luria-Bertani (LB) 
without antibiotic for E. coli BL21 (λDE3) or with 25 µg ml-1 chloramphenicol for 
BL21(λDE3) pLysS, and incubated at 37OC overnight. Next, 2ml of culture was 
transferred into 200 ml fresh LB in a l l flask and cells grown at 37°C with shaking 
(250 rpm) until OD600 reached around 0.5 (~ 3 h). Subsequently, the culture was 
transferred into centrifuge tubes and chilled on wet ice for 20 min. After, the tubes 
were centrifuged at 3000 g for 10 min at 4OC, followed by discarding the 
supernatants prior to cell suspension in 100 mL of cold 0.1 M CaCl2. The cells were 
then transferred into 50 ml polypropylene falcon tubes and incubated on wet ice for 
30 min followed by repeat centrifugation. Next, the supernatants were discarded and 
cells resuspended gently in 4 mL cold 0.1M CaCl2 contained 15% (v/v) glycerol. 
Finally, 200 µL cells were transferred into 1.5 mL Eppendorf tubes and the aliquots 
were stored at -80 OC until use.  
 
4.3.3.2. Cloning of S. aureus pgd in pET24d+ expression plasmid 	
The plasmid pET24d+ was purified from E. coli (Table 3.2) using an Isolate II 
Plasmid Mini Kit (BioLine) (Section 3.8.). For gene amplification, the pgd specific 
forward (F) and reverse (R) primer sequences (Table 3.3) were designed by 
incorporating a NcoI restriction site (CCATGG) at the 5’ end of the forward primer 
(F) and XhoI restriction site (CTCGAG) at the 5’ end of the reverse primer (R) that 
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excluded the stop codon sequence from the 3’ end of pgd. The gene was PCR-
amplified in triplicate reactions from the genome of S. aureus Newman with these 
primers. This multiple amplification was done to limit subsequent cloning of pgd 
sequences containing PCR enzyme fidelity errors and thereby ensure at least one 
correct gene sequence for overexpression analysis. The three amplicons of the pgd 
gene were labelled as pgdPCR1, pgdPCR2 and pgdPCR3 and were cloned into 
vector pET24d+ at the multi-cloning site. For this, the purified DNAs, pgdPCR1, 
pgdPCR2 and pgdPCR3 and pET24d+ plasmid, were restriction digested with NcoI 
and XhoI as described previously (Section 3.2.6.5) and purified prior to their ligation 
as described previously (Section 3.2.6.6). The recombinant pgd plasmids created this 
cloning were named pJAMAL1, pJAMAL2 and pJAMAL3 (Table 3.2) for the three 
pgd amplicons from distinct PCR reactions, respectively. 
 
4.3.3.3. Transformation of E. coli Top10 with pET24d+ ligations 	
Transformation of E. coli Top10 was achieved using the Hanahan method (Section 
3.14) and colonies were grown on selective agar plates containing kanamycin.  From 
the transformation plates, single colonies (5-12) were selected from each of the three 
independent ligation sets and transferred to fresh agar plates for subsequent analysis. 
The recombinant plasmids were isolated using the Isolate II Plasmid Mini Kit 
(BioLine) (Section 3.8.) and colony PCR was performed using forward (F) and 
reverse (R) primers for the overexpression PCR of pgd (Table 3. 2.) The presence of 
inserts was determined by separation of PCR products on 1% (w/v) agarose gels. 
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4.3.3.4. Analysis of plasmid clones by restriction enzyme digestion 	
For confirmation of DNA cloning, the extracted recombinant plasmids were digested 
with NcoI and XhoI restriction enzymes under the same conditions described above.  
The presence of both the 5.3 kb plasmid and ~1.1 kb pgd insert was confirmed for 
multiple clones (Fig. 4.5) indicating there was correct cloning. 
 
 
Fig. 4.5. Plasmid digestion of pgd clones in pET24d+.  Double digestion of 
purified plasmids using NcoI and XhoI of clones from pgdPCR2 (lanes 1 to 3) and 
pgdPCR3 (lanes 4 to 7), indicating pET 24d(+) (~ 5300bp) and inserts (~ 1124bp).  	
4.3.3.5. DNA sequencing to confirm correct amplification 	
To verify that the cloned insert pgd sequences matched the original sequence of the 
pgd gene from S. aureus Newman, two constructed plasmids: pJAMAL2 and 
pJAMAL3 bearing pgdPCR2 and pgdPCR3 PCR products were sequenced.  The 
plasmids were extracted, as described above, and sent for sequence determination by 
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GATC Biotech (Germany); specifically, 20 µl (~50ng) of each plasmid was 
sequenced with specific forward (F of pgd; (Table 3. 3.) and the plasmid-specific T7 
reverse primers (M13). Analysis of sequence data indicated that the cloned pgdPCR2 
sequence contained three errors resulting in three different amino acids.  In contrast, 
the pgdPCR3 sequence was identical to the original S. aureus Newman pgd sequence 
(Fig. 4A); Appendix). Thus, pJAMAL3 plasmid has correct pgd sequence and was 
used for expression studies with pJAMAL2 plasmid included only as a comparator.  
 
4.3.3.6. Transformation and overexpression of Pgd 	
With the aim of testing Pgd protein expression from the cloned gene copies, the pgd 
containing pET24d+ plasmids pJAMAL2 and pJAMAL3 were introduced into 
expression host strains. Transformation of E. coli BL21 (λDE3) and BL21 (λDE3) 
pLysS strains (Section 4.3.3.) was performed with the transformants used 
immediately for expression analysis, as described below.  
 
A single colony from each of the transformation plates was used to inoculate 10 mL 
LB containing 10 µg ml-1 kanamycin. Cultures were grown overnight at 37°C with 
shaking at 225 rpm. Next, 1 mL of overnight culture was transferred into 50 mL LB 
in a 250 mL flask containing 50 µg ml-1 kanamycin, and incubated with the same 
conditions.  Once the OD600 of cultures reached ~0.5, protein expression was induced 
by adding isopropyl- β-D-1-thiogalactopyranoside (filter-sterilised) to a final 
concentration of 1 mM, and the cells were grown for 3 h at 37°C with shaking at 225 
rpm. Subsequently, cells were collected by centrifugation at 1500 rcf for 10 min at 
4°C and used immediately or stored briefly at -20°C. 
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4.3.3.7. Optimisation of Pgd induction  	
 For the optimisation of Pgd induction duration, the cells were grown, as described 
above, until the OD600 of cultures reached  ~0.5 when the target protein was induced 
by the addition of 1 mM ITPG as final concentration. At defined time points (0, 1, 2, 
3 and 4 h), samples were taken from cultures and measured their OD600. SDS 
sample buffer was used for disrupting cells and solubilising proteins at 80°C for 5 
min. Proteins were separated by SDS-PAGE and the total cell proteins of each 
sample were compared with controls of both E. coli BL21 (λDE3) cells and E. coli 
BL21(λDE3) cells transformed with plasmid pET24d(+) to examine the 
effectiveness of overexpression conditions.  
 
The Pgd target protein was clearly expressed after 2 h post-induction, but in only 
certain clones.   From three independent experiments, it was evident that both clones 
tested that were transformed with pJAMAL3 plasmid did not express Pgd protein, 
whereas, the strains with pJAMAL2 expressed the target Pgd (Fig. 4.7.), with a 
protein band migrating to ~43 kDa (Fig. 4.8.). From these experiments and the 
sequencing it appeared that the pgdPCR3 gene copy, that has the correct sequence, 
might not be expressed due to toxicity to E. coli. 
 
4.3.3.8. Purification of Pgd using His-Trap FF columns  	
Although the expressed Pgd protein did not have the correct primary sequence due to 
PCR errors, it was nonetheless expressed and purified for potential production of 
antibodies targeting the protein in future studies. 
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4.3.3.8.1. Cell lysis  
 
The bacterial cells from induction with IPTG were lysed using sonication. First, the 
cells were resuspended in 10 mL lysis buffer per 500 ml of culture and incubated on 
wet-ice for 30 min. Next, the cells were sonicated 6 times with 10 s pulses at 200 W 
to disrupt the cells completely and samples of cell lysates from both the 
overexpression strain and control E. coli BL21 (lDE3) with empty vector were 
separated by 10 % SDS-PAGE and compared.  
 
4.3.3.8.2. Purification of Pgd protein  	
Pgd protein was purified by two different methods, manually using Mastereflex 
Pumps and/or AKTA pure chromatography systems (Fig. 4. 6-8). In both methods, 
1ml HisTrap FF columns (GE healthcare Life Sciences) were used.  First, cells were 
lysed as mentioned above and subsequently the cells suspension (lysed) was 
centrifuged at 15900 rcf for 30 min at 4OC and the supernatant or soluble protein was 
used. The target protein pgd was captured on 1 ml HisTrap FF columns (GE 
healthcare Life Sciences) and eluted with a linear gradient imidazole to determine the 
best concentration of imidazole. First, the HisTrap column was washed with 5 ml 
dH2O to remove all 20% (v/v) ethanol, followed by two washes with 5 ml lysis 
buffer in 10 mM imidazole pH 8.0. Next, 10 mL of the supernatant lysate was added 
into the column to bind a target protein to the column and the unbound proteins were 
collected in the tube as washes. With the manual pump, the column was washed with 
5 mL of increasing concentrations of imidazole (a stepped gradient of imidazole 
starting from 20, then 30, 50 and 60 mM imidazole PH 8.0) and followed by washing 
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with 5mL elution buffer (250 mM imidazole pH 8.0). Each wash was collected and 
the samples were tested by SDS-PAGE (Fig. 4.7). 
 
 
 
Fig. 4.6. Chromatogram of Pgd purification using the AKTA system. The 
different steps of the purification are indicated; (1) equilibration, (2) loading of 
sample, (3) washing column with imidazole, (4) elution of protein and (5) re-
generation. 100 mM Imidazole, pH 8 was used as 100% eluting solution. 
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Fig. 4.7. 10% SDS PAGE of Pgd purification from E. coli BL21(DE3) 
pJAMAL2. Lanes: (1) Molecular weight marker (Fermentas), (2) cell lysate, (3) 
flow through, (4-8) column washes from a linear gradient of imidazole buffer 
starting from 20, 30, 50, 60 and 250 mM imidazole pH 8.0, respectively.  	
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Fig. 4.8. SDS electrophoresis of Pgd protein expressed from pJAMAL2. The 
total cell proteins of strains are as follows: E. coli BL21 (λDE3) strain without 
pET24d+ as control (lane 2), or with pET 24d + with no insert as control (lane 3), or 
bearing pJAMAL2 (lanes 4 to 7), Lanes 4-7 represent samples after 1,2,3 and 4 h of 
induction with IPTG, respectively. Arrow indicates the location of the expressed Pgd 
protein. The size of Pgd protein is 43 KDa. Lane 1 and 8, Molecular weight marker 
kDa (Fermentas). 
 
4.3.3.9. Protein toxicity assay 	
In order to assess whether the pgdPCR3 clone from pJAMAL3transformation, 
representing the correct pgd gene sequence, is cytotoxic to host E. coli BL21(λDE3), 
a previously described protocol was used (pET System Manual for toxicity assay - 
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8th ed, 1999, Novagen). The toxicity assay consists of plating the bacterial cells 
transformed with either constructed plasmid, pJAMAL2 or pJAMAL3, LB plates in 
the absence or presence of 1 mM IPTG and kanamycin, with LB plates with or 
without kanamycin serving as plating controls.  
 
Based upon this protocol, it is expected that most cells can form colonies on LB-
plates without supplementation. Toxic proteins will result in more than 2% colonies 
on plates containing 1mM IPTG and more than 0.01% on plates containing both 
kanamycin and IPTG. Toxicity of a target protein can cause the accumulation of cells 
in the culture, which no longer maintain or expression. This is because of the likely 
for loss of constructed plasmid in culture immediately before induction as described 
by manufacture of pET plasmid (pET System Manual for toxicity assay - 8th ed, 
1999, Novagen). The experiment using the described protocol (Table 4.1) revealed 
that E. coli BL21 (λDE3) pJAMAL2 plated at 5% forming colonies on kanamycin 
plus IPTG or IPTG alone. In contrast, the pJAMAL3 bearing clone formed nil or 
~0.1% colonies, respectively. From these results there is confirmation that Pgd is 
possibly cytotoxic via this expression system at the levels achieved in E. coli BL21 
(λDE3). 
 
Therefore, this study so far suggests that the pgd gene was not expressed because this 
gene encodes an enzyme activity that may be toxic to E. coli. The proposed 
peptidoglycan deacetylase function might interfere with the pathways of GlcNAc 
metabolism inside the cell and limit proliferation of the host cell causing growth 
limitations and a lower capability to form colonies (Rosano and Ceccarelli, 2014). 
For future work, this gene needs to be cloned into different plasmids and expressed 
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in different bacteria to obtain the result, which can confirm or reject the result of this 
study.  
 
Table 4. 1. Plasmid stability-toxicity assay 
E. coli 
BL21(λDE3) 
with plasmid: 
Colonies 
(%) on LB 
Colonies 
(%) on LB, 
Km,  
Colonies 
(%)  
on IPTG 
Colonies (%) 
on Km, IPTG 
pJAMAL3 3014 (100%) 2838 (44%) 3 (0.09%) Zero (0%) 
pJAMAL3 1698 (100%) 760 (46%) 2 (0.11%) Zero (0%) 
pJAMAL2 3308 (100%) 2747 (83%) 160 (5%) 158 (5%) 
pJAMAL2 1588 (100%) 660 (41%) 130 (8%) 106 (7%) 
Experiments were performed in triplicate and the average is indicated for each 
strain.  
 
 
Summary. 
To conclude this chapter, the correct cloning of vector constructs for the genetic 
study of the pgd, mcrA and a6qe26 genes was achieved by producing allelic 
replacement, complementation and overexpression constructs. However, only Pgd 
expression was achieved in this study and it was revealed that the T7 overexpression 
system was not optimal for production of the protein due to cytotoxicity, however a 
gene mutant, PCR2 pgd (pJAMAL2), that was inadvertently produced during 
amplification was overexpressed and could be used for future antibody production. 
 
		 129	
CHAPTER 5  	
5. Physiological analysis of Staphylococcus aureus mutants. 
5. 1. Introduction 	
 Bacterial lipoproteins are secreted and localised to the cell wall during exponential 
growth phase. These lipoproteins can play critical physiological roles at the cell 
surface, such as transport, ligand binding, resistance to antimicrobials, signaling and 
protein folding (Hutchings et al., 2009; Sutcliffe and Russell, 1995). Roles have also 
been described in virulence including host invasion, immunomodulation and 
adhesion (Kovacs-Simon et al., 2011; Nakayama et al., 2012). S. aureus has the 
capability to adhere and colonise different synthetic materials by forming a biofilm. 
These structures are important in the lifestyle of bacterial communities and develop 
from a coordinated sequence of events, including initial attachment, microcolony 
formation, maturation and detachment. The formation of biofilm provides significant 
protection from host defences and antibiotics during colonisation and pathogenesis. 
Most commonly, S. aureus infections that are described as biofilm-associated include 
nosocomial infections arising from medical devices, such as heart valves, bone 
prostheses, or implanted catheters (Otto, 2013). 
 
Peptidoglycan (PG) has key roles in bacterial growth, morphogenesis and separation, 
pathogenesis, interaction with the environment, biofilm formation and homeostasis 
(Sharif et al., 2009; Typas et al., 2012). Modification of the PG structure is important 
for its biosynthesis, maintenance and degradation and this is controlled by different 
sets of secreted enzymes, which are tethered or ionically attached to the PG.  For 
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example, peptidoglycan deacetylases (Pgd) of Listeria monocytogenes and 
Streptococcus pneumoniae, which belong to the carbohydrate esterase family 4 
enzymes (CE4), can modify peptidoglycan (PG) by removing N-acetyl groups from 
N-acetylglucosamine.  This role is known to contribute to the bacterial defence from 
human and animal mucosal lysozyme (Blair et al., 2005a; Popowska et al., 2009).  
 
This study identified that Pgd of S. aureus is a lipoprotein that harbours a catalytic 
domain that is predicted to function as a de-N-acetylase of N-acetylglucosamine or 
another acetyl group in peptidoglycan, similar to function of the homologous Pgd 
protein of Streptococcus pneumoniae. The research described in this chapter 
therefore aimed at examining S. aureus pgd mutants through a range of different 
assays to identify phenotypic differences compared with their parent strains. 
5.2. Materials and Methods 	
5.2.1. Bacterial strains and their culture 	
For the study of Pgd function, the allelic replacement pgd mutation was transduced 
to a set of S. aureus host strains.  The use of a single S. aureus strain to study the 
species is increasingly discredited, due to the possibility of revealing only strain-
specific effects.  Consequently, this study generated pgd mutants with complemented 
variants of the strains Newman, SF8300, SH1000, BH1CC and SA113.  Some of 
these choices were also a consequence of the phenotypes observed for the mutation, 
where greater clarity of the observed phenotype was needed.  For example, in 
addition to Newman pgd, SF8300 pgd, SH1000 pgd, BH1CC pgd and SA113 pgd, an 
oatA (MurNAc O-acetyl transferase) mutant was combined with the pgd mutation to 
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observe the phenotype of single compared with double mutants for the study of 
lysozyme resistance and biofilm formation. The full details of strains are listed in 
Table 3.1 and 3.2. 
 
The genotypes of mutant strains after transduction were confirmed by PCR, with 
sequencing where necessary, as discussed in Chapter 3. Briefly, DNA was released 
from bacteria using lysis buffer and purified with a DNeasy Blood & Tissue kit 
(QIAGEN). Extracted DNA was used as template for PCR using primers specific to 
the downstream and upstream regions of the gene of interest (Table 3.3; 3.4: 3.5). 
Transduction of mutant alleles was confirmed after separating the PCR products with 
1% (w/v) agarose gels to reveal that the size of the amplified insert matched the 
expected size for the modified allele.  
 
Antibiotic resistance testing was also used to confirm the selectable phenotype of the 
marked allele moved by transduction. Plates were prepared with appropriate 
antibiotic concentrations and a single colony was inoculated and incubated overnight 
at 37 OC as described in Chapter 3. 
 
5.2.2. Cell growth curve 	
Phenotypes of isogenic strain sets of S. aureus Newman, SH1000, SF8300, and 
BH1CC, comprising: wild-type; pgd mutant; wild-type plus pJAL-pgd; and pgd 
mutant plus pJAL-pgd, were compared by culture in defined conditions. Growth 
curves of each strain were determined with culture in 50 mL BHI broth, either alone 
or supplemented with sterile filtered 1% (w/v) glucose. Culture was performed in 
250 mL conical flasks with triplicate assays and inoculation was performed using 
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overnight cultures (section 5.2.1) adjusted to OD600=0.05 as the starting value. 
Cultures were incubated at 37 OC in a water bath with shaking at 250 rpm and the 
turbidity was measured hourly at OD600 nm. 
 
5.2.3. Staphyloxanthin pigment assay 
 
S. aureus strains were assayed for their production of the carotenoid pigment 
staphyloxanthin using a modified protocol from a previous study (Liu et al., 2005). 
Overnight culture was used to inoculate 10 mL BHI broth in sterile 50 mL centrifuge 
tubes (Fisher Scientific) to OD600=0.05. Cells were incubated to allow aeration at 37 
OC with shaking at 250 rpm for 24 h. Next, cells were harvested by centrifugation at 
1500 rcf for 10 min then washed twice with 1x PBS (pH 7.2). The cell pellet was 
suspended with 1 mL of 100% (v/v) methanol and mixed thoroughly before 
incubating stationary at 37OC for 2 h. Subsequently, the mixture was centrifuged at 
15900 rcf for 5 min and 200 µL of supernatant was transferred in triplicate into a 
polystyrene 96-well plate for measuring the absorbance spectrum between 350-550 
nm using a FLUOstar Omega plate reader.  
 
5.2.4. Hydrophobicity assay 	
The microbial adherence to hydrocarbon (MATH) assay was used to determine the 
relative ability of S. aureus strains to adhere to the surface of hexadecane. 
Hexadecane (Sigma) was stored in the dark at 25 OC until use and a previously 
described experimental protocol was modified for the assay (Beck et al., 1988).  A 
single S. aureus colony was inoculated into 10 mL BHI broth in a 50 mL falcon tube 
and incubated overnight at 37OC with shaking at 250 rpm (section: 5.2.2.). The 
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overnight culture was then sub-cultured into 50 mL BHI broth to inoculate at OD600 
of 0.05; cultures were incubated overnight at 37OC with shaking at 250 rpm. After 
growth, the cells were harvested by centrifugation at 15900 rcf for 10 min and 
washed twice with PBS buffer, pH 7.2.  Next, cells were suspended in PBS buffer 
(pH 7.2) and the OD450 of each sample was adjusted to between 0.9-1.0 (initial 
reading). A 3 mL portion of each cell suspension sample was transferred into 15 mL 
Falcon conical tubes (Sigma) and 300 µL of hexadecane was added. The mixture 
was vortexed for 2 min and then left at RT for phases to separate for exactly 2 min. 
Subsequently, the lower aqueous phase was collected and the turbidity was measured 
at OD450 (final reading). The difference between the turbidity of the initial and final 
readings was taken as a measure of cell hydrophobicity and calculated as a 
percentage. This experiment was repeated at least 3 times. 
 
5.2.5. Autolysis assays 	
Autolysis rates were investigated after challenge with penicillin-G and triton X-100 
(Sigma) as alternative inducers of autolysis.  The protocol was modified from 
previous studies (Bose et al., 2012; Ingavale et al., 2003). Separate assays were 
performed with S. aureus strains Newman, SF8300, SH1000 and BHICC, including 
their isogenic pgd mutants, and plasmid complemented variants (section: 5.2.2.).  An 
atl insertional inactivation strain served as an autolysis control with it having greatly 
reduced autolysis. Overnight cultures (section: 5.2.2.) were used to inoculate 50 ml 
TSB broth in a 250 mL flask to an OD600 of 0.05 for each strain. Cultures were 
incubated in a water bath at 37OC with shaking at 250 rpm until cell OD600 reached 
~0.5. Next, cells were harvested by centrifugation at 1500 rcf for 10 min, then 
washed with 10 ml sterile PBS (pH 7.2). Subsequently, cells were suspended in 50 
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mL sterile PBS, pH 7.2 containing either 0.1 mg ml-1 penicillin G (Sigma) or 0.1% 
(v/v) triton X-100 (Sigma) then incubated at 37 OC with shaking at 250 rpm. Lysis of 
cells was monitored by measuring half-hourly the OD600 turbidity changes.  
 
5.2.6. Lysozyme survival assays. 	
5.2.6.1. Lysozyme disc diffusion assay  
 
S. aureus strains were grown overnight in tryptic soy broth (TSB, LAB M) at 37OC 
with shaking at 250 rpm, including selective concentrations of antibiotic as 
appropriate (Table 3.2).  These cultures were diluted in molten soft TSB agar at 50 
OC to final OD600 0.05 and immediately poured onto TSA plates. After 10-15 min, a 
sterile 6 mm paper disc prepared with 20 mg mL-1 lysozyme (hen egg-white, Sigma) 
was placed gently on the agar surface; all plates were incubated at 37OC overnight. 
5.2.6.2. Cell lysis after lysozyme challenge 	
S. aureus strains were cultured in TSB overnight, as described above, then this was 
used to inoculate 50 mL TSB cells for around 5 h growth (until end of exponential 
phase) at 37OC with shaking. This was followed by adding sterile lysozyme to a final 
concentration of 30 mg mL-1 and measuring optical density hourly at OD600 to 
monitor cell lysis. 
 
5.2.7. Biofilm formation assays. 
 
A range of diverse assays were used within this study to evaluate biofilm formation 
and development over time in BHI broth, with or without added 1% (w/v) glucose or 
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4% (w/v) NaCl. Various types and brands of polystyrene plates were tested to 
monitor biofilm formation, mostly polystyrene plates that were untreated 
(hydrophobic) or that had been plasma-treated (‘tc-treated’) to generate a hydrophilic 
surface. Static conditions for biofilm formation were used with overnight growth of 
cultures without movement across the surface. In contrast to this static assay, 
measurement of biofilm formation was examined using a Bioflux assay device 
whereby biofilms were formed in the presence of a hydrodynamic flow.  
 
5.2.7.1. Static conditions for biofilm formation  
5.2.7.1.1. Biofilm formation on untreated polystyrene plate surfaces 	
Biomass of individual biofilms formed by strains was quantified using the commonly 
used microtitre plate method (Christensen et al., 1985), which was modified in this 
study. S. aureus strains were tested for biofilm formation on polystyrene with culture 
using BHI broth in the absence or presence of 1% (w/v) glucose. Experiments were 
performed using untreated 96-well polystyrene plates, which are deemed to have a 
hydrophobic surface presentation, as described by the manufacturer (greinter bio one, 
Germany).   
 
After incubation the plates were washed three time in distilled water (dH2O) to 
remove excess cells that were unattached, followed by incubation of the plate at 
60OC for 1 h to fix cells onto the surface of plate. Next, 200 µL of crystal violet was 
added into each well, including broth only controls, and incubated at RT for 20 min 
to stain cells in the biofilm. After this, the excess dye was removed using at least 
three washes with dH2O and the plate was incubated at 37OC for an hour to dry. 
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Subsequently, the crystal violet dye was solubilised by adding 160 µL of 33% (v/v) 
glacial acetic acid (Emsure, USA). The OD490 of each well was measured by using a 
FLUOstar Omega plate reader (BMG Labtech). At least three biological replicates of 
each sample with 3-8 technical replicates per plate were performed for each sample 
in an assay. The mean values were determined for each strain tested, together with 
their standard deviation and standard error. The statistical significance of differences 
between samples was analysed using student’s t-test. 
 
5.2.7.1.2. Biofilm formation on plasma-treated surfaces 	
Biofilm growth of S. aureus strains on plasma-treated (tc-treated) surfaces and its 
measurement with crystal violet dye was performed as described in the previous 
section, except that the plates were exchanged for Nunclon plastic. Plasma treatment 
produces a hydrophilic surface as indicated by the manufacturer.  
 
5.2.7.2. Imaging of biofilm formation with confocal microscopy 	
Confocal laser scanning microscopy (CLSM) was used to visualise biofilm formation 
and cell viability in conjunction with vitality stains.  
Overnight cultures of S. aureus strains were diluted with BHI broth to obtain 
OD600=0.05. Sterile 12 mm diameter glass coverslips (coated with poly-D-lysine, 
positively charged, neuVitro, USA) were placed into 12-well polystyrene plates 
(untreated, Greiner bio-one, Germany) prior to adding 300 µL of culture.  Biofilm 
was allowed to develop over 24 h of incubation at 37OC. Biofilm production and cell 
viability were evaluated using a BacLight live/dead kit, which contains SYTO9 and 
propidium iodide stains (L-7007, Molecular Probes, Invitrogen), following the 
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manufacturer’s instructions and a previously described method (Bauer et al., 2013). 
The BacLight dye was prepared by mixing 5 µL of component A (1.67 mM 
propidium iodide) and 4 µL of component B (1.67 mM SYTO 9) into 1 mL of 
distilled water. At the end of the incubation time, excess culture was removed 
carefully from each well-contained coverslip which were then washed twice with 
dH2O. Next, 300 µL of mixture dye was added into the well and the plate was 
incubated at RT for 30 min in the absence of light. Afterwards, wells were washed 
twice more to remove excess dye. The coverslips were removed and inverted upon a 
microscope slide, followed by direct observation using confocal scanning laser 
microscopy (CSLM) (LSM-510, Zeiss), with the excitation/emission measured at 
480/500 nm for SYTO-9 dye and 490/635 nm for propidium iodide (a dual-band 
emission filter at 500-550 nm/598-660 nm). The imaging was detected by LSM 
software and presented by image J software. 
 
5.2.7.3. Hydrodynamic flow biofilm formation  	
Hydrodynamic flow biofilm formation using a BioFlux system was done in 
collaboration with Nikki Black at the University of Galway, who performed the 
assay and supplied raw data.  The method used was a modification of a published 
protocol [Moormeier and Bayles, 2014]. The BioFlux 1000z microfluidic system 
(Fluxion Biosciences Inc., San Francisco, CA) was used to evaluate biofilm 
formation under shear flow conditions using BHI as growth medium with or without 
the addition of 1% (w/v) glucose.  For cell growth, 200 µl of media was added to the 
output wells of a 48-well plate and the channels were primed for 5 min at 5.0 
dynes/cm2.  After priming, the media was aspirated from the output wells and 
replaced with a 50 µl media suspension of cells grown to early exponential growth 
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phase and adjusted to an OD600 = 0.8. A further 50 µl of media was added to the 
input wells and the channels were seeded by pumping from the output wells to the 
input wells for 3-5 seconds at a speed of 3 dynes/cm2. Bacterial cells were allowed to 
attach to the surface of the plate for 1 h at 37°C. Excess inoculum solution was 
aspirated from the output wells and a further 1.2 ml of media was added to the input 
wells. The flow rate was set at 0.6 dyne/cm2 for 18 h (equivalent to 64 µl/hour). 
Bright field images were captured every 5 min at 10X magnification. A total of 217 
images were captured over 18 h. The gain and exposure settings remained constant 
over the 18-hour period for all images. 
 
5.2.8. Alamar Blue assays. 	
Culture of strain and metabolism was examined with Alamar blue stain (Invitrogen); 
the stain substrate is a water-soluble tetrazolium salt that consists of both resorufin 
and resazurin as oxidation-reduction (redox) indicators that yield a fluorescent signal 
and colorimetric change in response to the metabolic activity of cells. A blue colour 
with non-fluorescence reports oxidation, while a pink colour with fluorescence 
reports reduction (Byth et al., 2001). S. aureus strains were grown at 37OC in BHI 
broth with shaking overnight, as described previously. Cells were harvested by 
centrifugation at 1500 rcf for 10 min and then suspended in 50 mL fresh BHI broth 
(pH7.2) until the OD600 reached 0.05. Cultures were incubated at 37OC with shaking 
until the OD reached OD600 of 0.5. Following this, 10 mL BHI broth (pH 7.2) was 
inoculated and the OD was adjusted to 0.5 nm to ensure that the number of cells was 
closely matched based upon turbidity, prior to adding Alamar Blue; 200 µL of 
suspended cells were transferred into sterile 96-well polystyrene plates followed 
immediately by adding 20 µL (1/10) of Alamar Blue with stationary incubation at 
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37OC in the dark, as recommended by the manufacturer. A negative control 
comprised BHI plus Alamar Blue. Changes in absorbance were measured at 
wavelengths 570 nm and 600 nm using a FLUOstar Omega plate reader. 
Experiments were repeated at least 3 times and the mean value was determined. 
 
5.3. Results and Discussion 	
5.3.1. Growth analysis of a S. aureus pgd mutant  	
The growth rate and yield of the pgd mutant was examined by comparative culture 
with the wild-type strains.  The aim was to determine the role of the pgd gene in S. 
aureus physiology with respect to whether it is required for normal growth of S. 
aureus by examining the mutant and its isogenic wild type strain with their 
respective complementation plasmid variants across all four strains backgrounds, 
SH1000, Newman, SF8300 and BH1CC.  
 
Relative turbidity measurements indicated that the pgd mutants exhibited a delay 
during the lag phase. This delay was significantly observed in three strain 
backgrounds (Newman, SF8300 and SH1000), but was more clearly observed with 
the isogenic pgd mutant of SF8300, when cultured in both BHI and BHI 
supplemented with 1% (w/v) glucose (Fig. 5.1; 5.2). The growth rate of pgd mutants 
and plasmid complementation variants was unaffected during exponential growth 
phase, with each sharing similar growth rates (rate data not shown); strains also 
reached similar post-exponential growth phase yields, compared with their parent 
strains; an exception was strain SF8300 pgd with a reduced yield in stationary phase.  
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The reason for the elongated lag phase in pgd mutants is unclear, as is the variation 
between strain backgrounds (e.g. compare SF8300 with BH1CC). Since the proposed 
role of Pgd is associated with cell wall metabolism and synthesis, the deletion of pgd 
in several S. aureus strains has an impact on a particular growth phase that might 
relate to growth ability, but nothing more definite can be stated. The lag phase is 
important for synthesising and secreting essential surface proteins to be used for cell 
growth (Harris et al., 2002).  The observations of altered growth in S. aureus have 
some similarities with the growth of a pgdA mutant of S. pneumoniae, but for this 
species mutation reduces growth during exponential phase when compared with the 
parental strain (Vollmer and Tomasz, 2000). 
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Fig. 5.1. Growth curves of S. aureus strains cultured in BHI medium. Growth of 
(A1) Newman, (B1) SF8300, (C1) SH1000 and (D1) BH1CC strains. Wild-type 
(empty triangle), pgd mutant (solid triangle), wild-type with pJAL-pgd plasmid 
(empty circle) and pgd mutant with pgd complementation plasmid (solid circle) at 
37OC. A minimum of triplicate experiments was performed. Standard errors were 
always within 0.70% of total mean.  
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Fig. 5.2. Growth curves of S. aureus strains cultured in BHI medium plus 
glucose. Growth of (A2) Newman (B2) SF8300 (C2) SH1000 and (D2) BH1CC 
strains; Wild-type (empty triangle), pgd mutant (solid triangle), wild-type with 
pJAAL-pgd plasmid (empty circle) and pgd mutant with pgd complementation 
plasmid (solid circle) at 37OC. A minimum of triplicate experiments was performed. 
Standard errors were always within 1.2 % of total mean. 
 
5.3.2. Staphyloxanthin production 	
Since altered growth of the pgd mutant was observed across several strain 
backgrounds, together with visual differences in colony appearance (data not shown), 
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expression of the carotenoid staphyloxanthin was measured. For the assay of pigment 
production, each of the S. aureus strain backgrounds were cultured for 24 h to 
compare the wild-type and pgd mutant with their pgd complementation plasmid 
variants (section: 5.2.3). Methanol extraction was performed with suspended cell 
pellets to extract pigment.  
 
Deletion of the pgd gene decreased staphyloxanthin pigment production in a S. 
aureus Newman pgd mutant, but did not with mutation of pgd in the SF8300, 
SH1000 or BH1CC strain backgrounds. This was clearly visualised from comparison 
of cell pellets with their respective parent strains (Fig 5.3.). The observed differences 
were confirmed by comparing the spectral profiles of extracted staphyloxanthin from 
both parent and pgd mutant, together with the pJAL-pgd (pSK5632 plus pgd gene) 
plasmid containing strains. The S. aureus Newman pgd mutant staphyloxanthin 
absorbance spectrum shows characteristic peaks at 430, 462 and 491 nm that were 
absent in the wild-type parent strain profile. Complementation of Newman pgd with 
pJAL-pgd did not fully restore pigmentation to wild-type levels (Fig. 5.3A1; B1). In 
two different strain backgrounds, mutant complementation decreased pigmentation 
(SF8300 pgd pJAL-pgd and SH1000 pgd pJAL-pgd) and the strains lacked the 
absorbance peaks (430, 462 and 491 nm) characteristic of staphyloxanthin (Katzif et 
al., 2005) when compared with spectral profiles of their parent strains (Fig 5.3).  
 
The incomplete complementation of staphyloxanthin expression could relate to the 
gene sequence cloned with respect to its regulatory sequences or due to gene dosage 
arising from the construction and copy number of the pJAL-pgd vector.  The plasmid 
was assembled by cloning the full pgd transcriptional unit sequence, including a 
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candidate promoter located ~170 bp of DNA upstream of the start codon.  In addition 
~50 bp of sequence located 3’ of the termination codon was cloned, which was 
predicted to include a terminator sequence.  The plasmid used for complementation, 
pSK5632 (Grkovic et al., 2003) replicates and maintains a copy number of ~10 per 
cell, at least under conditions of testing in S. aureus RN4220.  While at the lower end 
of copy numbers for complementation plasmids used in staphylococcal studies, the 
vector will still result in multiple copies of both the pgd gene and its regulatory 
sequences present in the cloned promoter region.  While the mechanism of regulation 
of pgd expression in S. aureus is unknown, there is a likelihood of the MgrA 
transcriptional repressor being a contributory element from available transcriptional 
data and there could be an activator modulating transcription. The gene copy number 
could titrate two component system regulatory proteins e.g. WalKR, LytSR known to 
control autolysis and cell surface decoration producing consequential phenotypes 
(section 1.1.14.5. and 1.1.14.6.).  
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Fig 5.3.  The effect of pgd on pigment production in S. aureus strains. Cell pellets after 
culture of (A1) Newman, (A2) SF8300, (A3) SH1000 and (A4) BHICC. Tubes numbered 1, 
2, 3 and 4 represent wild type, pgd, and complementation strains wild-type plus pJAL-pgd 
and pgd plus pJAL-pgd, respectively.  Strains were grown in 50 ml BHI (v/v) at 37OC with 
shaking.  After 24 h, cells were centrifuged and washed three times with PBS. Absorbance 
spectra (A350-550) of strains: (B1) Newman, (B2) SF8300, (B3) SH1000 and (B4) BHICC. 
Lines coloured blue, red, green and purple correspond to wild type; pgd; wild-type plus 
pJAL-pgd; and pgd plus pJAL-pgd, respectively. The absorbance spectrum of each 
supernatant was measured. Experiments were repeated on three separate occasions and 
representative data of one experiment is shown. 
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Staphyloxanthin is a membrane-bound carotenoid of S. aureus. Most S. aureus 
clinical isolates produce the carotenoid pigment, though the expression levels vary 
widely, ranging from pale yellowish to bright orange after aerobic overnight culture 
on solid medium (Duthie and Lorenz, 1952).  The levels of staphyloxanthin in the 
cell membrane are linked with increased bacterial survival from reactive oxygen 
species since the pigment has antioxidant properties (Chamberlain et al., 1991; Dye 
and Kapral, 1980; Giachino et al., 2001; Grinsted and Lacey, 1973; Lee and 
Bergdoll, 1985; Pelz et al., 2005).  The pigment contributes to S. aureus virulence 
and was demonstrated to increase the severity of skin abscess infections by 
comparison of wild-type and crt gene mutants (Liu et al., 2005). Staphyloxanthin 
impairs the antimicrobial action of neutrophil ROS by virtue of its antioxidant roles 
(Clauditz et al., 2006; Liu et al., 2005; Olivier et al., 2009).  The carotenoid pigment 
also functions to modulate membrane fluidity to increase stiffness, which imparts 
resistance to cationic antimicrobial peptides. The proposed mechanism that directs 
this is unknown, though it was determined that neither phospholipid composition, 
surface charge, the complement of fatty acids or cell wall thickness wall appear to 
differ in a S. aureus mutant overexpressing crtMN of the crtOPQMN operon (Mishra 
et al., 2011).  
 
The yellow and orange carotenoid pigments of S. aureus are synthesised via a C30 
triterpenoid biosynthetic pathway (Marshall and Wilmoth, 1981). The yellow 
pigment of carotenoid corresponds to 4,4’-diaponeurosporene which is converted to 
an orange pigment called staphyloxanthin as the pathway end product. 	 The	
crtOPQMN	operon encodes the biosynthetic enzymes for staphyloxanthin and crtM 
is responsible for the first step of carotenoid production, encoding dehydrosqualene 
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synthase. CrtM combines two farnesyl pyrophosphate molecules to create a 4,4’-
diapophytoene. Subsequently, this molecule undergoes three cycles of 
dehydrogenation catalysed by CrtN, a 4,4’-diapophytoene desaturase, to produce the 
yellow pigment 4,4’-diaponeurosporene (Raisig and Sandmann, 1999). Following 
dehydrogenation the yellow pigment is converted to the orange pigment 
staphyloxanthin via the activities of CrtO, CrtP and CrtQ. Staphyloxanthin is 
regulated by the rsbUVWsigB operon (Giachino et al., 2001; Horsburgh et al., 
2002b; Kullik et al., 1998; Morikawa et al., 2001; Palma and Cheung, 2001), with 
the alternative sigma factor SigB solely directing transcription of the crtOPQMN 
operon (Bischoff et al., 2004). In addition, there are several reported genetic factors 
that modulate expression, including a cold shock gene, cspA, which was reported to 
modulate pigment production in S. aureus via a SigB-dependent pathway (Katzif et 
al., 2005).  
 
The data presented here indicates that deletion of pgd and changes to its expression 
can lead to altered pigment levels in certain strains, and needs more investigation but 
this must be influenced by other factors given the strain variation that is evident. 
Regardless of this, there would appear to be potentially undescribed pathways 
leading to altered pigment expression; this could be related to a potential cell wall 
activity.  
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5.3.3 Contribution of Pgd to cell surface properties 	
5.3.3.1. Cell surface hydrophobicity 	
To determine whether Pgd has a role in modifying properties of the S. aureus cell 
surface the hydrophobicity of cells was assayed. The previously described set of 
strains were cultured overnight, then washed and suspended in PBS buffer, pH 7.2. 
Each strain suspension was tested for microbial adhesion to hydrocarbon (MATH 
test) using hexadecane as the hydrophobic organic solvent (Section 5.2.4). The 
difference between the turbidity prior to and subsequent to mixing with hexadecane 
was used to determine adhesion (cell hydrophobicity). The experiment was 
performed with triplicate biological samples and the results expressed as percentage 
hydrophobicity for each individual strain (Fig. 5.4.). 
 
The results clearly identified that in three strain backgrounds: Newman; SF8300; and 
BH1CC, mutation of pgd significantly lowers adhesion to hexadecane (P < 0.01). 
This phenotype is shown by the increased absorbance of the buffer phase for each 
mutants compared with their respective parent strains.  These data indicate decreased 
hydrophobicity of the pgd mutant cell surface. In contrast, the SH1000 pgd mutant 
revealed the opposite phenotype with an increased hydrophobicity of its cell surface. 
In each case, the pgd mutant phenotypes were restored to similar hydrophobicity 
levels as their parent strains. 
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Fig. 5.4. Hydrophobicity of S. aureus cell surface based on adhesion to 
hexadecane. Cell surface hydrophobicity was evaluated by reduction in absorbance 
(OD450 nm) of the aqueous phase once separated from hydrocarbon. Strains: wild-
type (black), ∆pgd (white), wild-type plus pJAL-pgd [WT + pgd] (dark grey) and 
complementation strain pgd plus pJAL-pgd (∆pgd + pgd) (light grey). A minimum 
of triplicate experiments were performed and error bars represent standard deviation, 
using 2-tailed Student t-test, ** indicates P<0.005 value.  
 
These data obtained from the MATH test clearly indicate that pgd contributes to 
hydrophobicity of the S. aureus cell surface. The phenotype is similar to that of a S. 
mutans pgd strain, where reduced hydrophobicity was observed (Deng et al., 2009). 
S. aureus cells are typically hydrophobic and when examined in other studies for the 
contributing factors by gene deletion, it was identified that mutants that lacked 
protein A, teichoic acid or coagulase remained hydrophobic. However, 
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peptidoglycan extracted from different S. aureus strains is hydrophilic, indicating 
that there is likely to be one or more protein-associated molecule, presumably 
localised at the cell membrane or cell wall, capable of changing hydrophobicity of 
the cell surface (Reifsteck et al., 1987). Hydrophobicity and charge of the S. aureus 
cell surface have been investigated across growth phases. Hydrophobicity was 
significantly increased during exponential phase and greatest in stationary phase, 
however, surface charge decreased during exponential phase yet significantly 
increased in stationary phase. These changes support different structures in S. aureus 
contributing to changing both charge and hydrophobicity of the cell surface during 
growth (Beck et al., 1988).  
 
The PgdA protein of S. mutans strain shares homology with Pgd proteins from L. 
monocytogenes and S. pneumoniae with each possessing catalytic domains 
corresponding to peptidoglycan N-acetylglucosamine deacetylase. Deletion of pgdA 
in S. mutans was reported to only slightly affect hydrophobicity and the mutant 
exhibited a dissimilar colony texture to the wild-type. These features were not 
reported for the pgd mutants of either L. monocytogenes or S. pneumoniae, and 
furthermore S. mutans pgd was not hypersensitive to lysozyme which was reported 
as a key phenotype of both S. pneumoniae and L. monocytogenes mutants (Deng et 
al., 2009).  
 
Based on the protein homology between the S. aureus candidate Pgd and the other 
species’ Pgd proteins, plus the findings of altered hydrophobicity and pigmentation 
there is supporting evidence that the pgd gene contributes to cell surface properties.  
The protein is proposed from the structural work in chapter 3 to be a peptidoglycan 
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N-acetylglucosamine deacetylase.  This enzyme activity can lead to a change of nett 
positive charge on the cell surface due to increased acetyl groups and this might be 
an explanation for the observations described above. A reduced level of positively 
charged peptidoglycan associated with the S. aureus pgd mutant surface, if verified, 
might lead to altered properties essential for normal cell growth. Decreasing the cell 
wall surface positive charge might be expected to alter resistance to cationic 
antimicrobial peptides, which are essential elements produced during innate immune 
system (Peschel, 2002). Modification of cell surface charge to change peptidoglycan 
properties might also be expected to alter the activity of peptidoglycan synthesis 
enzymes, particularly the activity of hydrolases, and in this respect altered lysozyme 
resistance is reported as a phenotype of pgd mutants of several species.  
 
5.3.4. Autolysis.  	
Experiments were designed to examine the relative level of autolysis for the S. 
aureus pgd mutant compared with isogenic wild type and complementation control 
strains described above, but without study of BH1CC strains because this strain was 
incorporated into the study after these experiments were performed. Within these 
assays an atl mutant was included as an autolysis reference strain to provide a control 
for challenged cells. Briefly, harvested cells were washed and suspended in 50 mL 
sterile PBS containing either 0.1 mg ml-1 Penicillin-G or 0.1 % (v/v) Triton X-100. 
After addition of these autolysis trigger molecules, the mixture was incubated at 
37OC with shaking and lysis of cells was monitored by spectrophotometry (Fig. 5.5.) 
The extent of autolysis due to pgd mutation of both Newman and SF8300 strain 
backgrounds was clearly increased compared with wild-type, following challenge 
with Triton X-100 and Penicillin-G.  Similar rates of autolysis were observed with 
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both strain Newman pgd and SF8300 pgd. In contrast, SH1000 pgd did not exhibit 
altered autolysis in either condition compared with its parental strain.  Notably there 
was no complementation of the pgd mutation in this experiment with no explanation 
yet and the pgd complementation strains of Newman and SF8300 had higher 
autolysis rates than their isogenic parents and rates similar to Newman pgd and 
SF8300 pgd. These data do identify that the pgd mutation can be assigned with 
multiple phenotypes relating to the cell surface and autolysis, similar to pgdA 
inactivation of L. monocytogenes (Popowska et al., 2009).  
 
In bacteria, autolysins are peptidoglycan (murein) hydrolases that have specific 
hydrolytic activities for different components of peptidoglycan structure (Ingavale et 
al., 2003). Autolysins control turnover, maturation and degradation of peptidoglycan 
(Bose et al., 2012) meaning they play important roles in critical biological processes 
such as growth, cell wall synthesis, cell division, and peptidoglycan recycling 
(Fujimoto and Bayles, 1998). Biosynthesis of peptidoglycan in staphylococci, as in 
other bacteria, is a multistep process occurring across three different subcellular 
compartments; the cytoplasm, cell membrane and cell wall.  UDP-MurNAc-
pentapeptide is a final product of the cell wall biosynthetic pathway, which is 
transferred to the lipid membrane and modified by addition of GlcNAc residues and 
a peptidoglycan-bridge; this structure is translocated to the outer surface of the 
membrane (Ingavale et al., 2003). Peptidoglycan assembly is catalysed by 
transpeptidases and carboxypeptidases, such as penicillin-binding proteins (Navarre 
and Schneewind, 1999). The staphylococcal peptidoglycan hydrolases include N-
acetyl glucosaminidase, N-acetyl muramidase, endopeptidase, and N-acetylmuramyl-
L-alanine amidase activities (Ramadurai et al., 1999; Sugai et al., 1995). Due to their 
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cell wall enzymatic activity, they are tightly regulated to prevent autolysin-mediated 
lysis. Previous studies demonstrated that autolysis enzymes are controlled 
transcriptionally (Fujimoto and Bayles, 1998) and indicated that multiple regulators 
including, SarA, LytSR, AgrCA, ArlRS and MgrA (Rot) affect autolysin expression 
in S. aureus (Ingavale et al., 2003). Mutation of S. aureus agr leads to a decreased 
autolysis rate, while inactivation of several Sar-family genes results in an increased 
autolysis rate (Fujimoto and Bayles, 1998). Atl is the major autolysin activity of S. 
aureus and this enzyme contains two domains; amidase (AM) and glucosaminidase 
(GL), which must both be catalytically active for a bacterium to form a biofilm.  Atl 
is the key enzyme activity associated with autolysis and a gene mutant has majorly 
reduced autolysis (see Fig 5.6) (Bose et al., 2012). 
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Fig. 5.5. Autolysis of S. aureus pgd mutants compared with isogenic strains. 
Autolysis was induced in mid-exponential growth phase cells after adding Triton-X-100 
[0.1% (v/v)] or Penicillin-G [0.1 mg ml-1] in 50 mL PBS. Comparison are made with S. 
aureus wild-type strains (empty triangle), atl (solid square), ∆pgd (solid triangle), wild-type 
with pJAL-pgd plasmid (empty circle) and ∆pgd complemented with pJAL-pgd (solid 
circle). Strains Newman, SF8300 and SH1000 were challenged with (A1, B1, C1) Penicillin 
G or (A2, B2, C2) Triton-X-100, respectively.  Data represents the mean of triplicate 
biological samples with standard deviation shown. In both experiments, statistically 
significant differences (*) between WT and ∆pgd are indicated (p<0.05) and determined 
using student’s t-test 
5.3.5. The role of Pgd in lysozyme resistance 		
Two separate experiments were performed to test the contribution of Pgd to 
lysozyme resistance of S. aureus.  The assay approaches included: disc-diffusion of 
lysozyme (20 mg mL-1) on agar; or challenge of planktonic post-exponential growth 
phase cells with lysozyme (30 mg mL-1). Isogenic strain sets were assayed: Newman; 
SF8300; and SA113, with each set containing WT, pgd, oatA and double mutant pgd 
oatA (Table 3.2).  In both lysozyme resistance experiments the S. aureus strains were 
grown in TSB medium.  Optimisation of the lysozyme disc-diffusion agar assay was 
performed to determine conditions to compare resistance levels.  This optimisation 
was required because the published assay of Bera et al. (2005) was established with 
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Fig. 5.6. Autolysis of S. aureus pgd mutants and isogenic strains.  
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S. aureus SA113, which was identified here to be markedly less resistant to 
lysozyme than either Newman or SF8300 strains upon inactivation of resistance 
genes.  The optimal test conditions were determined to be a lysozyme disc-diffusion 
agar plate overlaid with 6 mm paper discs prepared with 20 mg mL-1 lysozyme, or 
broth grown post-exponential phase cells challenged with lysozyme added to 30 mg 
mL-1 final concentration. The data from both optimised experiments is presented in 
Fig. 5.6.  
 
As expected, each wild-type strain (Newman, SF8300 and SA113) was completely 
resistant to lysozyme (Fig.5.6 A3, B3, C3). Further, it was determined that all pgd	
mutants remained resistant and their growth was unaffected on lysozyme disc-
diffusion agar plates and by lysozyme challenge in broth, even at the highest 
concentrations tested >30 mg mL-1 in the assays (Fig 5.7). The mutant Newman oatA 
was lysozyme sensitive at a level similar to that of SA113 oatA described by Bera et 
al., (2005). In sharp contrast and without explanation, SF8300 oatA was not 
lysozyme sensitive in either assay.  
 
Newman pgd oatA and SA113 pgd oatA double mutant strains exhibited a reduced 
zone (~50%) of clearing on lysozyme diffusion agar plates.  This is reduction in 
resistance was demonstrated more clearly in the broth lysozyme challenge assays 
with an increased lysozyme resistance of a pgd oatA double mutant compared with 
oatA mutation alone in the same strain backgrounds (Fig.5.6).  From these data it is 
evident that Pgd contributes to lysozyme resistance and raises questions about 
whether there is coordinated OatA expression given potential compensatory roles. 
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Fig. 5.6. The role of pgd in S. aureus resistance to lysozyme. Growth inhibition 
from lysozyme was assessed on TSA plates. Overnight cultures were diluted 10-fold 
in soft agar and poured onto plates. A paper disc (6 mm) containing lysozyme (20 
mg) was placed on the plates and incubated at 37OC overnight. Growth of S. aureus 
strains; SA113 oatA (A1), SA113 oatA pgd (A2), Newman oatA (B1), Newman oatA 
pgd (B2) and SF8300 oatA (C1) and SF8300 oatA pgd (C2). Cultures of SA113, 
Newman and SF8300 strains (A3, B3, C3) were challenged with lysozyme during 
late exponential growth phase in TSB after addition of 30mg ml-1 lysozyme (arrow). 
Wild-type (empty triangle), pgd (solid triangle), oatA (empty squares) and oatApgd 
(solid squares). 
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Many bacterial pathogens display resistance activity for bactericidal components 
produced by host tissues, including antimicrobial peptides and enzymes. This 
resistance frequently results from structural properties of the cell surface and the 
modification of these. For example, in S. aureus D-alanine is incorporated into 
teichoic acids by the DltA enzyme (Peschel et al., 1999), O-acetylation of 
peptidoglycan is catalysed by OatA (Bera et al., 2005) and MprF adds lysine to 
phosphatidylglycerol (Staubitz et al., 2004); each modification contributes to surface 
defences to a range of molecules, including antimicrobial peptides. Thus, mutation in 
one of these genes was shown to decrease virulence. In addition to these activities, S. 
aureus similar to some other pathogens, has additional regulation of biochemical and 
structural features that increase resistance to host defence from bactericides. 
Lysozyme resistance is part of this defence system, to protect from the enzyme 
activity that cleaves peptidoglycan between the glycosidic beta-1,4-linked of N-
acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)  (Bera et al., 2005).  
 
In this study (Chapter 3), S. aureus Pgd was revealed to show homology with the 
peptidoglycan deacetylation catalytic domains from L. monocytogenes, S. 
pneumoniae and S. mutans, which are members of the carbohydrate esterase family 4 
enzymes (CE4) contributing to defence from human and animal mucosal lysozyme.  
It was reported that pgd mutants in several species lack peptidoglycan (GlcNac) 
deacetylase activity resulting in sensitivity to lysozyme digestion; for example 
mutants of L. monocytogenes (Popowska et al., 2009), S. pneumoniae (Blair et al., 
2005a) and Bacillus cereus (Psylinakis et al., 2005). In contrast, the pgd mutant of S. 
mutans was not sensitive to lysozyme (Deng et al., 2009).  Counter to these studies, 
the S. aureus pgd mutation apparently contributes to lysozyme resistance, which is 
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clearly demonstrated when the mutation is combined with oatA mutation revealing 
the double mutant has increased resistance.  This warrants further investigation to 
identify the interrelationship between the two activities.  Also prime for further 
investigation is the complete lysozyme resistance of the CA-MRSA strain SF8300 
oatA.  The underlying mechanism for this resistance could be a novel aspect or could 
be due to major compensation of absent O-linked acetylation of MurNAc with O-
linked teichoic acid, catalysed by TagO (Bera et al., 2005).  This would represent a 
marked difference in the described extent of the activity of TagO.  Unfortunately, the 
lysozyme resistance in respect of tagO could not be investigated further at this stage 
due to the presence of erm resistance in strain SF8300. 
 
5.3.6. The role of Pgd in biofilm formation 	
S. aureus causes a broad spectrum of infections in humans such as, soft tissue 
diseases and abscesses, endocarditis, and osteomyelitis. These diseases are largely 
due to S. aureus encoding a large set of virulence factors that allow the bacteria to 
infect various tissues within hosts. In addition to these secreted factors, S. aureus has 
the ability to form multicellular structures called biofilm. This biofilm structure is a 
functional multi-layered community with the bacteria attached to a surface and to 
each other while embedded in their synthesised extracellular matrix (O'Toole et al., 
2000). Biofilm formation is known as a form of bacterial protection from influences 
of hostile environments and is observed in many bacteria that infect animal and 
human tissues (O'Toole et al., 2000).  
 
Clinically, biofilm infections are important since bacterial biofilms display 
recalcitrance to antimicrobial peptides and host defence enzymes and immune 
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components and phagocytes. Biofilm development is a complex process and is 
structured, being commonly divided into three phases: initial attachment, 
maturation/accumulation and dispersal/detachment (O'Toole et al., 2000; Otto, 
2013).  
 
The primary attachment phase can occur on biotic or inert surfaces and in 
staphylococcal infections the initial attachment can frequently be to an inert surface 
such as an indwelling medical implant, with colonisation of either a metal surface 
e.g. devices (prosthetic joints) or plastic surfaces e.g. central venous catheters, lines.  
Adherence is reliant on both the chemical characteristics of the material surface and 
bacterial surface components.  The latter components include autolysin, Atl (Houston 
et al., 2011), wall teichoic acid (WTA) and lipoteichoic acid (Gross et al., 2001). For 
example, atl inactivation in several clinical S. aureus strains led to decreases in the 
initial attachment rate and reduced FnBP (fibronectin-binding protein)-dependent 
biofilm formation on hydrophilic polystyrene plates. In contrast, biofilm formation 
developed by FnBP or PIA proteins required atl gene expression on hydrophobic 
polystyrene plates (Houston	 et	 al.,	 2011). The accessory sigma factor B (σB) is 
required for FnBP-mediated biofilm formation, and functions to repress expression 
of RNAIII and protease production. Mutation of sigB reduced initial attachment of 
MRSA strain BHICC during biofilm development due to reduced atl expression (Houston	et	al.,	2011). Extracellular DNA (eDNA) has an important contribution to 
early development steps of FnBP-dependent and Atl-dependent biofilm formation 
(Houston et al., 2011). In S. epidermidis, autolysin AtlE promoted	 lysis	of	 cells	 to	release	eDNA	as	a	component	of	 the	biofilm	matrix	(Qin	et	al.,	2007),	whereas	
		 160	
an	Atl-enhanced	lysis	in	S.	aureus,	leads to release of eDNA during the early steps 
of ica-independent biofilm (Houston et al., 2011).    
 
Primary attachment to a biotic surface, e.g. tissue cells or a synthetic surface coated 
with fibrinogen, fibronectin or vitronectin, is controlled largely by multiple cell wall-
anchored (CWA) proteins including fibrinogen-binding protein (FnbpA), fibronectin-
binding protein (FnbpB) and clumping factors A/B (Vaudaux et al., 1995).  After 
attachment, in both cases, staphylococcal biofilms develop through proliferation and 
production of an extracellular matrix as a scaffold (O'Toole et al., 2000; Otto, 2013).  
 
The extracellular matrix of biofilm is complex. However, until recently, few 
components of this structure were fully described:  poly-N-acetyl-glucosamine 
(PNAG) also termed polysaccharide intercellular adhesin (PIA) (Mack et al., 1996), 
and extracellular DNA (eDNA) (Montanaro et al., 2011) are both recognised as key 
components. Both constituents direct development of the biofilm structure with the 
presence of eDNA being critical for stability. The polysaccharide intercellular 
adhesin (PIA) of S. aureus and S. epidermidis biofilm is encoded by the icaADBC 
locus and, in PIA-dependent biofilms, considered to be the major substance 
connecting cells in the matrix (Montanaro et al., 2011). Aside from the primary 
attachment phase, an additional contribution of CWA proteins is promoting the 
accumulation phase within ica-dependent biofilm (Foster et al., 2014).  Thus, these 
proteins mediate all biofilm phases including intercellular adhesion. Varying 
numbers of different CWA proteins that contribute are present on the cell surface of 
S. aureus, based on growth conditions, but the bacteria can express up to 24 proteins, 
whereas S. epidermidis express a lower number (Foster et al., 2014).   
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The pgd mutant is hypothesised to be incapable of N-acetylglucosamine 
deacetylation, which would lead to a change in the net charge and/or hydrophobicity 
of the surface.   This functional prediction is consistent with the data presented so far 
including protein sequence homology. Hydrophobicity assay indicated that the pgd 
mutant of the three strains tested was significantly less hydrophobic compared with 
their parent strains (Section 5.3.3.1). If the pgd mutant is locked into increased 
acetylation of peptidoglycan producing altered surface properties, what is the role of 
Pgd in the biofilm formation where surface interactions are influenced by cell surface 
charge?  
 
5.6.7. Biofilm formation  	
Various assays and experimental conditions were used in this study to evaluate 
biofilm formation.  The development of biofilm was monitored after growth in BHI 
broth, either alone or supplemented with 1% (w/v) glucose or 4% (w/v) NaCl.  To 
determine the effect of the abiotic surface upon which the biofilm was developing, 
various microtitre plates were used in the experiments: polystyrene plates which 
have a hydrophobic surface; or Nunclon plates that were oxygen plasma-treated, so 
called ‘tc-treated’, which introduces polar groups (e.g. carbonyl and carboxylic acid) 
rendering a hydrophilic surface.   
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5.6.7.1. Microtitre plate assay for biofilm formation  	
5.6.7.1.1. Biofilm formation on untreated polystyrene  	
Given the extent of strain variation observed in previous assays, biofilm formation 
was investigated with all four strains: Newman, SF8300, SH1000 and BHICC; 
testing wild type, pgd, wild type plus pJAL-pgd and the complemented pgd mutant 
with pJAL-pgd (section: 5.2.1.). Biofilm development was examined after culture 
with BHI broth or BHI supplemented with 1% (w/v) glucose. Experiments were 
performed with 96-well microtitre plates composed of polystyrene, an untreated 
surface described by the manufacturer as relatively hydrophobic.  
 
After 24 h of incubation at 37°C, plates were washed and stained with crystal violet 
dye. From these assays, both wild-type strains and their pgd isogenic mutants did not 
form biofilm when cultured in unsupplemented BHI.  However, both the SF8300 and 
Newman wild type strains displayed biofilm formation with 1% (w/v) glucose-
supplemented BHI broth, while their respective pgd mutants did not (Fig.5.7.). 
 
5.6.7.1.2. Biofilm formation on treated polystyrene 	
Biofilm growth followed by staining with crystal violet dye was performed as 
described in the previous section, except the microtitre plates were exchanged for 
Nunclon plates plasma-treated during production. These plates have a surface that is 
considered to be hydrophilic as indicated by the manufacturer.  
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The S. aureus strains were tested for their biofilm development in Nunclon plates 
after culture in BHI broth or BHI supplemented with 1% (w/v) glucose. The 
observed biofilms revealed that there were, again, no difference between wild type 
strains and their isogenic pgd mutants in BHI broth alone (data not shown).  
 
 
Fig. 5.7.  The role of pgd in biofilm formation on a hydrophobic polystyrene 
surface. S. aureus strains: (A) Newman, (B) Newman pgd (C) SF8300 and (D) 
SF8300 pgd were cultured at 37°C for 24 h in BHI supplemented with 1% (w/v) 
glucose. Plates were washed with dH2O before staining with crystal violet dye. The 
experiment displayed is representative of a minimum of triplicate experiments and 
each strain was assayed as three columns of technical replicates as indicated (red 
line).  
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In contrast, when the suite of S. aureus strains were cultured in BHI supplemented 
with 1% glucose, both of the Newman pgd and SF8300 pgd mutants developed 
greater levels of biofilm in comparison with their respective isogenic parents, 
Newman and SF8300 (Fig. 5.8 & 5.9).    These results indicate there is an opposite 
effect of the nature of the polystyrene surface upon biofilm formation depending on 
it being either hydrophobic or hydrophilic in nature. 
 
In comparison, both SH1000 and BHICC strains were examined for biofilm 
formation as described above but both displayed different outcomes for the pgd 
mutation when comparing the wild type and mutant strains (Fig. 5.8). Thus in these 
two strains inactivation of pgd produced no effect upon biofilm formation.  
Additionally, for confirmation, the biofilm was measured for all strains (A490) with 
crystal violet dye-extraction using a FLUOstar Omega plate reader.  From these 
assays it was observed that while biofilm formation of both Newman pgd and 
SF8300 pgd is significantly reduced (p<0.05), the SH1000 pgd and BH1CC pgd 
mutants are not significantly different (p>0.05), when each are compared with their 
respective isogenic parent strains (Fig. 5.10). 
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Fig. 5.8. The role of pgd in biofilm formation on a hydrophophilic (tc-treated) 
polystyrene surface. S. aureus strains: (A) Newman, (B) Newman pgd (C) SF8300 
and (D) SF8300 pgd were cultured at 37°C for 24 h in BHI supplemented with 1% 
(w/v) glucose. Plates were washed with dH2O before staining with crystal violet dye. 
The experiment displayed is representative of a minimum of triplicate experiments 
and each strain was assayed as three columns of technical replicates as indicated (red 
line). 
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Fig. 5.9. S. aureus biofilm formation on a hydrophilic (tc-treated) polystyrene 
surface. S. aureus strains: (A) Newman, (B) SF8300 (C) SH1000 and (D) BH1CC 
were cultured at 37°C for 24 h in BHI supplemented with 1% (w/v) glucose. Plates 
were washed with dH2O before staining with crystal violet dye.  Next, 33% (v/v) 
acetic acid was added to extract the dye and OD490 was measured. Extracted dye 
values are presented for four strains in each graph: wild-type in (black), ∆pgd 
(white), wild-type plus pJAL-pgd [WT + pgd] (dark grey) and complementation 
strain pgd plus pJAL-pgd [∆pgd + pgd] (light grey). A minimum of triplicate 
experiments were performed and error bars represent standard deviation. ** indicates 
P<0.005 value.  Error bars are standard deviation with student’s t-test used for 
statistical analysis. 
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5.6.7.1.3. Biofilm formation images by confocal laser microscopy 
(CLSM) 	
Since there was good evidence for increased biofilm production with Newman and 
SF8300 pgd mutant strains on a hydrophilic polystyrene surface, this was 
investigated further using poly-lysine-coated glass.  The aim was to confirm the 
biofilm phenotype to enable further study using microscopy to examine the nature of 
the biofilm produced. Confocal laser scanning microscopy (CLSM) was combined 
with cell staining to visualise the biofilm, measure its thickness and examine cell 
viability. Paired strains were used in this experiment, Newman and SF8300 plus their 
pgd mutants. After culture of cells, as described above, the slides were washed and 
stained with the Live/Dead viability staining dye mixture (SYTO-9 and propidium 
iodide) and then immediately imaged using CLSM (Fig. 5.10). A greater depth of 
biofilm was produced by both pgd mutants, with a thickness of ~17-20 µm in 
comparison with their parental strains, which exhibited a thickness ~2-4 µm. Similar 
to several previous assays the complemented strains did not fully restore biofilm 
formation to the level of the parental strains but showed an intermediate phenotype. 
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5.6.7.2. Hydrodynamic flow biofilm formation  	
While this study identified a biofilm phenotype for pgd mutation using standard 
methods of static biofilm formation, there has been a recent trend to investigate the 
formation of biofilm on a surface exposed to hydrodynamic flow using microfluidics. 
These conditions subject the forming biofilm to hydrodynamic shear within the 
continuous flow cell where biofilm forms and this can be visualised using light and 
fluorescence microscopy. Since this setup is considered to more closely resemble 
natural conditions under which biofilm assembly occurs it provided an important 
comparator for the previous assays that were performed in the study of Pgd. The 
BioFlux method was developed to be used also as a high-throughput (HTP) method 
for the screening of biofilm formation and viability (Benoit et al., 2010). The surface 
within a bioFlux flow cell is a plate of glass that is plasma-treated to remove organic 
material, causing exposure of carbonyl and acetyl groups that generate a hydrophilic 
surface, but its properties alter to hydrophobic over time, as described by the 
manufacturer http://fluxionbio.com/bioflux/. For the study here, bioFlux flow cell 
biofilms were set up in collaboration with Nikki Black in the laboratory of Infectious 
Disease Microbiology at University of Ireland, Galway.   Given the need to focus on 
one host strain for this part of the study, SF8300 was chosen to compare with its 
isogenic pgd mutant, complemented mutant and SF8300 with the pgd plasmid.  In 
addition the role of oatA deletion in biofilm formation was assessed alone and in 
combination with pgd inactivation (SF8300 oatA; SF8300 pgd oatA).  
 
The bioFlux system records biofilm development with video and from this recording 
still images were taken for each sample at time intervals.   Three different cultural 
conditions were tested to examine biofilm development using the bioFlux system: 
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growth in BHI broth alone; growth in BHI broth supplemented with 1% (w/v) 
glucose; and growth in BHI supplemented with 4% (w/v) NaCl. Images were 
captured over the time-course once flow had begun. 
 
None of the S. aureus SF8300 strains tested were able to form biofilm, neither in 
BHI alone nor supplemented with NaCl (data not shown) Both strains SF8300 (wild 
type) and SF8300 pJAL-pgd strains formed biofilm BHI medium supplemented with 
1% glucose but, the latter strain forms greater amounts of biofilm formation at 18 h 
in comparison with former strain (Fig. 5.11). The wild-type strain, S. aureus SF8300 
exhibits four steps to form biofilm, initial	 attachment	 between	 0.5-1	 h,	
microcolony formation evident at ~3 h, followed by development at (6 h) to fully 
formed biofilm at (12-18 h). Contrastingly, SF8300 pgd and the plasmid 
complementation strain SF8300 pgd pJAL-pgd were unable to form biofilm by 18 h, 
and visually appeared unable to remain attached to the glass in the bioFlux 
microfluidics channel. Complementation of pgd did not restore fully the capability to 
develop biofilm but there was clearly increased adherence to the channel surface 
after 6 h, indicating partially restored function (Fig. 5.11).  
 
An unexpected finding was that both SF8300 oatA and SF8300 oatA pgd mutants 
were unable to form biofilm although their initial adherences appeared similar to 
wild-type. Both strains displayed adherence at 18 h (Fig. 5.11). 
 
Discussion 
Data obtained from the flow biofilm experiments were compared with that from the 
static biofilms and provided some clear contrasts between the same strains that need 
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explained from further study. For example, the SF8300 pgd mutant was able to form 
a biofilm in a tc-treated 96-well microtitre plate (static biofilm), however this mutant 
was not able to form biofilm under flow conditions	 although the media, BHI 
supplemented with 1% glucose, was the same in both experiments. The question 
raised is whether this discrepancy is simply due to material surface properties, such 
as hydrophobicity or charge, or just due to the hydrodynamic shear influencing the 
cells at the surface?  
 
There is a precedent for the difference between the biofilm assay outcomes, where a 
similar situation was reported by Benoit et al., (2010). Their study indicated a similar 
situation where a flow biofilm differed from a static biofilm in the study of rpoS-
deficient E. coli that had impaired biofilm development under flow condition but 
biofilm developed in static conditions to an enhanced extent enhanced compared 
with its isogenic parent (Benoit et al., 2010; Lee et al., 2008). The reasoning 
proposed was that cell signalling is affected by hydrodynamic flow, particularly 
velocity and turbulence of the medium. A further possibility that might explain the 
difference comes from a study by Pozzi et al 2012, which indicated that in relative 
terms the surface of the glass bioFlux channel is more hydrophobic than the highly 
hydrophilic surface of a tc-treated polystyrene plate. In their study, they reported that 
MSSA clinical isolates cultured in BHI supplemented with glucose expressed a 
PNAG-dependent biofilm formation on a hydrophilic surface. In contrast, on a 
hydrophobic surface there formed a PNAG/Atl-dependent or complex biofilm that 
was also dependent on protein adhesins and eDNA (not solely dependent on PNAG). 
Other S. aureus surface proteins are reported to be associated with biofilm formation, 
including protein A, SasC, SasG, and biofilm-associated protein (Bap) in bovine 
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isolates, suggesting functional redundancy within the assortment of cell surface 
proteins contributing to biofilm and surface attachment (Pozzi et al., 2012).  
 
This study confirmed that the activity of S. aureus Pgd contributes to biofilm 
formation and this seems to be an indirect action by altering bacterial surface 
properties. While the consequential effect is unclear it may be due one or more 
factors, including release of eDNA from dead cells, alterations in expression or 
secretion of proteins concerned with biofilm formation and properties of 
peptidoglycan.  The CFU of the pgd mutant, determined when the culture OD600 was 
0.5, indicated that fewer mutant bacteria cultured on agar. The presence of fewer 
viable cells than the parent strain (data not shown), indicated either a plating defect 
or a greater number of dead cells. The latter explanation could implicate that eDNA 
involvement in the complex of biofilm formed by the pgd mutant on a treated plated. 
This could be confirmed by further investigation using DNase and protease to 
examine the biofilm that is formed. 
 
The oatA mutant was shown to be less sensitive to lysozyme when combined with a 
pgd mutation (section 5.3.5). This study identified that oatA and oatA pgd mutants 
were unable to form biofilm on tc-treated plates but showed pronounced adherence 
on the glass of biofilux channel, indicating an important role of these genes in 
surface interaction, presumably arising from their roles in the modification of the 
peptidoglycan surface. Both pgd and oatA mutants need to be investigated further in 
new studies for their clear involvement in surface interactions and biofilm 
development.   
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Fig. 5.11. Biofilm formation and development of S. aureus in bioFlux microfluid 
channel.   Strains: SF8300 (WT) and isogenic mutants pgd, oatA and pgd oatA, 
SF8300+pJAL-pgd and pgd+pJAL-pgd. Cells were grown in BHI supplemented with 
1% glucose. Images were captured over the time course once flow had begun. In 
comparison with the WT strain, initial attachment between 0.5-1 h, microcolony 
formation evident at 3 h, development at 6 h with maximally formed biofilm at (18 
h). Each experiment was repeated with three biological replicates.  
 
5. 6. 8. Alamar Blue assay  	
Alamar blue dye is a proprietary reagent consisting of resazurin, a non-toxic cell 
permeable compound, that is used extensively for assaying cytotoxicity and viability 
of cells, including yeast, fungi, bacteria and mammalian cells. Resazurin is a useful 
indicator to assess both cellular health and metabolic activity of cells, by indicating 
the energy capacity (ATP status) of cells (Rampersad, 2012). Since cell metabolic 
activity can be monitored by Alamar blue, it was used in this study to assess relative 
differences in the viability, cellular health and metabolic status of pgd mutants of 
strains Newman and SF8300 grown in broth media and compared with their parent 
strain. Overnight-cultured cells were harvested and suspended in 10 mL BHI (pH	7.2) broth until the OD600 reached 0.5. Next, 200 µL of cell suspension was mixed 
with 20 µL Alamar blue and incubated at 37 OC in the dark. A negative control (BHI 
plus Alamar blue) was included and for each sample the absorbance was monitored 
by measuring wavelengths	 at	 570	 nm	 and	 600	 nm,	 which	 represents	 the	absorbance	 maxima	 of	 resorufin/resazurin	 (Fig. 5.12). The experiment was 
repeated at least 3 times. 
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The experiment indicated that Alamar blue was rapidly reduced by both wild type 
strains as evidenced by the medium turning pink in colour due to reduction of 
Alamar blue.  In contrast, both pgd mutants were unable to reduce Alamar blue 
within 30 min. In addition, complementation of both the Newman pgd pJAL-pgd and 
SF8300 pgd pJAL-pgd strains fully restored metabolic activity, such that Alamar 
blue was again reduced to pink.   
 
The Alamar blue assays revealed an unexpected alteration in the metabolism of the 
pgd mutants of both strains, Newman and SF8300 during exponential phase.  This 
difference in the capacity for reduction of resazurin in the pgd mutants might explain 
the observed growth lag when the pgd mutants are cultured (section 5.3.1).  The 
metabolism defect was fully complemented indicating the defect might be directly 
linked with Pgd activity. Although, the Alamar blue bioassay measured metabolism 
via the reduction/oxidation (redox) indicator and is used for assessing cellular health 
and metabolic function (Rampersad, 2012), it requires further investigation, 
including cfu quantification, to explain the link between the proposed cell wall 
function of Pgd and the apparent intracellular metabolism differences recorded here. 
A combination of proteomics and metabolomics approaches would be appropriate to 
gain insight. 
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Fig. 5.12. Measurement of cell viability using Alamar blue assay. Overnight 
strains Newman (A-C) and SF8300 (E-G) were cultured to OD600=0.05 in BHI and 
allowed cells to grow until around OD600=0.5 nm. Next, the OD of culture was 
adjusted to OD600=0.05 in BHI and then 10% Alamar blue was added to the culture 
and incubated at 37OC for 30 min. Fig 5.14A- Colour change in response to chemical 
reduction was recorded at A570. Fig 5.14B, Strains (A,E) wild-type; (B,F) pgd; (C,G) 
pgd with pJAL-pgd and (D) Control - BHI broth with 10 % Alamar blue. (D) The 
experiment displayed is representative of a minimum of triplicate experiments as 
indicated.  
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CHAPTER 6  
 
6. Biochemical and biophysical analysis of S. aureus pgd  
6. 1. Introduction 	
A putative S. aureus peptidoglycan deacetylase (Pgd) enzyme sequence belonging to 
the CE-4 esterase family was identified using bioinformatics methods, as described 
in chapter 2. Experiments presented in chapters 4 and 5 reveal that pgd deletion 
produces multiple phenotypes, such as a delay in growth, altered pigmentation, cell 
surface hydrophobicity, increased autolysis and increased resistance to lysozyme. 
Taken together these phenotypes indicate a cell wall modification that affects many 
properties and cell metabolism.  
 
From the bioinformatic data it was predicted that Pgd protein is located at the cell 
surface via a lipobox sequence and may act in concert with other proteins.  Pgd joins 
a set of surface-located protein activities, including TagO and OatA, that are 
responsible for peptidoglycan modification, and whose interaction and activity in 
relation to environmental conditions are incompletely understood. The research in 
this chapter was focused on attempts to investigate both biochemical and biophysical 
effects of pgd mutation to better understand the contribution made by the encoded 
activity in cellular processes and virulence.  
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6. 2. Materials and methods 	
6. 2. 1. Strains and growth condition  
 
The pgd mutants and parent strains used in this chapter were descried previously 
(section 5.2.1). 
6. 2. 2. Transmission electron microscopy (TEM)   	
Samples were prepared for TEM by using a modification of methods described for S. 
aureus (Fischer et al., 2013). Strains were cultured overnight as described (section 
5.2.2.); BHI broth was inoculated from overnight cultures to OD600=0.05. Cultures 
were incubated at 37OC with shaking until OD600 reached 0.2 then cells were 
harvested by centrifugation at 1500 rcf for 10 min. Next, cells were washed with 
PBS (pH 7.2) and then fixed in 2.5% (w/v) glutaraldehyde in 0.1 M cacodylate 
buffer, pH 7.2 for 3 h at RT. Next, cells were washed twice in 0.1 M cacodylate 
buffer, pH 7.2. Subsequently, cells were resuspended in molten 1% agarose (Sigma) 
at 37OC and then agarose was solidified on wet ice for 15 min, followed by cutting 
the agarose contained sample into small pieces 1 mm cube. Next, cubes of agarose 
were treated with 1% (w/v) osmium tetroxide (Agar scientific, Essex) for one hour, 
and washed five times with dH2O, and then treated with 1% (w/v) TAAB EM stain 
(uranyl acetate alternative) for 12 h at 4OC, followed by same washes with dH2O. 
Next, samples were dehydrated in a series of 30%, 60%, 90%, 100% ethanol 
followed by two times cleared in 99.5 % propylene oxide (Aldrich). Cubes of 
agarose containing bacteria were washed again with a resin series dilution of 50%, 
75% and then embedded into 100% resin (TAAB 812 Resin Embedding Kit, TAAB) 
followed by the incubation at RT overnight. Next, resin containing the sample was 
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cut into sections of 75 nm using an ultramicrotome (LEICA EM UC6, Leica). These 
sections were mounted on formvar 200 mesh copper grids (TAAB) coated with 
pioloform (SPI-CHEM, West Chester) and stained again with 4% (w/v) uranyl and 
Reynolds Lead citrate (sodium citrate and lead nitrate) before examining using a 
transmission electron microscope (FEI Tecnai T12 Biotwin -120 kv).    
 
 6.2.2.1. Dimensions and analysis of cells 
  
Cells were randomly chosen and photographed. To determine the observed effects of 
pgd mutation on the cell wall (peptidoglycan) thickness, each cell was measured for 
its dimensions using TEM software (MegaView 3 analySIS). The measurements of a 
single bacterium were taken from the approximated middle of the vertical diameter 
and also for the cell wall thickness. These measurements were performed for n= 25 
cells per strain and analyses were based on a minimum of 6 measurements for each 
cell.  
 
6.2.3. Nuclear Magnetic Resonance spectroscopy (NMR) 	
Nuclear Magnetic Resonance spectroscopy (NMR) is a powerful device used for 
obtaining a wide range of information on the conformation, solvation and electronic 
structure of molecules, including the structure of cell wall peptidoglycan (Lapidot 
and Irving, 1977). In addition, NMR has been used to analysis lipoteichoic acids 
(LTAs), which is able to identify the methine group of the sn-glycerol repeating unit, 
d-alanine (d-Ala), N-acetylglucosamine (NGA), and fatty acids (e.g. CH2 and CH3). 
The average chain length of backbone and the degree of substitution are quantified 
directely by 1H NMR spectrum (Morath et al., 2001). Thus, this study, samples were 
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prepared and purified peptidoglycan from ruptured cells was analysed using NMR by 
Dr. Edwin Yates, Department of Biochemistry, University of Liverpool 
 
6.2.3.1. Peptidoglycan isolation  	
The method used for the purification of PG was described by (Rosenthal and 
Dziarski, 1994).  Two litre volumes of BHI broth were inoculated from overnight 
cultures of wild type S. aureus SF8300 or pgd strains and were grown until OD600 of 
~ 0.8 nm (mid-exponential phase).  Cells were then harvested at 1500 rcf for 10 min 
and washed with sterile PBS, followed by autoclaving for 15 min. The cells were 
then ruptured, using a French pressure cell at 15,000 psi six-times to obtain 
maximum breakage. Broken cells were harvested at 15900 rcf for 10 min and treated 
in SDS buffer, then boiled five times in SDTE buffer for 10 min (each time the pellet 
was collected at 21200 rcf for 10 min).  The final collected pellet was boiled again 
and washed five-times in dH2O. The peptidoglycan layer (PG) appeared as a white 
layer above the yellow cell debris. Peptidoglycan was then collected by gently 
shaking with sterile dH2O followed by harvesting PG by centrifugation at 21200 rcf 
for 10 min and then resuspension in 2 ml sterile dH2O. The turbidity was measured at 
OD660 and PG was stored at - 20 OC until use.  
 
6.2.3.2. Peptidoglycan structural analysis by NMR spectra 	
The method used to digest PG was based on that reported by Eckert (Eckert et al., 
2006). An aliquot of 10 OD600 units of PG was incubated at 37 OC overnight with 45 
µg mutanolysin (Sigma) with 0.1 mM MgCl2 in 1 ml of phosphate buffer (pH 6). The 
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supernatant containing soluble muropeptides was collected after centrifugation at 
21200 rcf for 30 min.  
 
Soluble muropeptides were then freeze dried (LABCONCO) to remove excess water 
and replaced with deuterium oxide (HDO) (Sigma-Aldrich). Next, samples were 
loaded into a NMR tube (Wilmad, LabGlass) and examined by NMR spectroscopy. 
The 1H NMR spectra were recorded on a Bruker Avance DPX300 NMR instrument 
at 300 MHz (300k) referenced to an external standard (TSP). 
 
6.2.4. Pneumonia and bacteraemia infection models 	
6.2.4. 1. Ethics statement 
  
This study was performed with the approval of and in strict accordance with the UK 
Home Office and the University of Liverpool ethics committee (Home Office Project 
License Number 40/3602 to Prof. Aras Kadioglu, University of Liverpool). Every 
effort was made to minimize suffering. All animal experiments were carried out at 
the Universities of Liverpool and handling/procedures were performed by Dr Elaine 
Waters, University of Liverpool. 
 
6.2.4. 2. Infection experiments 	
Female CD1 mice aged 6-8 weeks and age matched (Charles River, UK) were used 
for both pneumonia and bacteraemia models. Bacterial inocula for infections were 
prepared by growing the bacteria in BHI (Oxoid) with shaking until the OD600  
reached 3.0. Cells were harvested, washed in PBS and then adjusted to the 
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appropriate cell numbers for each procedure.  Each experiment was repeated twice 
with 5 mice per group to give a total of 10 per group per time point. Statistical 
analysis was done using 2-tailed Student t-test. 
6.2.4. 2. 1. Pneumonia model 	
For induction of non-lethal pneumonia, mice were anesthetised with a mixture of 
O2 and isofluorane, and then inoculated intranasally (IN) with 2 × 107 CFU S. aureus 
SF8300 or isogenic SF8300 pgd in PBS.   
6.2.4. 2. 2. Bacteraemia model 	
For induction of bactereamia, 5 × 106 CFU were injected into the tail vein (IV). Mice 
did not develop visible signs of disease and were culled at predetermined times post-
infection by cervical dislocation.  
Lungs and nasopharnx were collected for the pneumonia model while kidney, spleen, 
heart and blood were collected for the bacteraemia model.  All organs and 
nasopharnx were homogenised, serially diluted and plated on either mannitol salt 
agar (lungs and nasopharnx) or blood plates. 
 
6. 2. 5. Label free quantitative proteomics analysis  	
Proteomics of S. aureus cells was performed by the Centre for Protein Research at 
the Institute of Integrative Biology, University of Liverpool. S. aureus strains 
SF8300 (wild-type) and SF8300 pgd were cultured overnight as described (section 
5.2.2). BHI broth was inoculated from overnight culture to OD around 0.05 and cells 
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grown until OD600 ~0.5. After, The culture was centrifuged at 1500 rcf for 10 min 
and the pellet washed with sterile PBS. Next, the pellet was resuspended in 100 µl of 
25 mM ammonium bicarbonate (AMBIC).  
  
To analyse for protein content, 0.05% RapiGest™ (Waters, Manchester) in 25 mM 
AMBIC was added and the samples were shaken at 1600 rcf for 10 min at 80°C. The 
samples were then reduced (addition of 10 µl of 60 mM DTT with incubation at 60 
°C for 10 min) and alkylated (addition of 10 µl of 180 mM iodoacetamide with 
incubation at RT for 30 min in the dark).  
 
6. 2. 5. 1. Protein digestion  	
Trypsin (Promega U.K. Ltd., Southampton, proteomics grade) was reconstituted in 
50 mM acetic acid to a concentration of 0.2 µg µl-1 and 10 µL was added to the 
samples prior to overnight incubation at 37 °C. The digestion was terminated and 
RapiGest™ removed by acidification (1 µl of TFA and incubation at 37°C for 45 
min) and centrifugation (15,000 x g for 15 min). To check for complete digestion, 
each sample was analysed pre- and post-acidification by SDS-PAGE. 
 
6. 2. 5. 2. LC-MS/MS analysis 	
For LC-MS/MS analysis, a 2µl (1 µg) injection was analysed using an Ultimate 3000 
RSLC™ nano system (Thermo Scientific, Hemel Hempstead) coupled to a 
QExactiveHF™ mass spectrometer (Thermo Scientific). The samples were loaded 
onto the trapping column (Thermo Scientific, PepMap100, C18, 300µm X 5 mm), 
using partial loop injection, for seven min at a flow rate of 4 µl min-1 with 0.1% (v/v) 
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FA. The samples were resolved on the analytical column (Easy-Spray C18 75 µm x 
500 mm 2 µm column) using a gradient of 97% A (0.1% v/v formic acid) 3% B 
(99.9% v/v ACN 0.1% v/v formic acid) to 70% A: 30% B over 120 min at a flow 
rate of 300 nl min-1. The data-dependent program used for data acquisition consisted 
of a 60,000 resolution full-scan MS scan (AGC set to 3e6 ions with a maximum fill 
time of 100 ms) and the 18 most abundant peaks were selected for MS/MS using a 
30,000 resolution scan (AGC set to 1e5 ions with a maximum fill time of 45 ms) 
with an ion selection window of 1.2 m/z and a normalised collision energy of 28. To 
avoid repeated selection of peptides for MSMS the program used a 30 s dynamic 
exclusion window. 
 
6. 2. 6.  Bradford Assay  
 
The pellet was suspended in 200 µl of 25 mM AMBIC as described before, and then 
sonicated using a Sonics, Vibra Cell (Sonics & Materials, Newtown, USA) with a 
250 µl to 10 ml probe. This was carried out in cycles of 10 s of 30% amplitude in 
each 60 s, to a maximum of 120 joules then stored at -80°C. Further the pellets from 
the wild type and mutant were suspended in 200 µl of 25 mM AMBIC and 10 µl of 
Rapigest detergent and heated to 80°C for 10 min. The protein content of wild type 
and pgd mutant were measured using a Bradford assay and ran 10 µl on PAGE. 
 
The data was searched against S. aureus USA300 database using Mascot (Matrix 
Science, London, UK). A fixed carbamidomethyl modification for cysteine and 
variable oxidation modification for methionine were specified. A precursor mass 
tolerance of 10 ppm and a fragment ion mass tolerance of 0.01 Da were applied. The 
results were then filtered to obtain a peptide false discovery rate of 1%. 
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6. 2. 7.  Complement deposition on S. aureus 	
Immunological assays were performed by Märtje Rujken in the laboratory of Dr 
Suzan Rooijakkers at Utrecht University, The Netherlands.  To analyse C3b 
deposition on the surface of bacteria, S. aureus Newman (WT), Newman pgd and 
Newman pgd pJAL-pgd) were grown overnight in BHI with appropriate antibiotic as 
(section 5.2.2). Next, BHI broth was inoculated from overnight to OD600=0.05, 
followed by allowing cells to grow until OD600=0.5. Subsequently, the cells were 
harvested, washed and adjusted OD600=1.0 in veronal buffer (2.5 mM MgCl2, 0.5 
mM CaCl2) containing 1% (w/v) bovine serum albumin (BSA) to block nonspecific 
hydrophobic binding. Dilute 10x culture in veronal-buffered saline buffer (VBS++ 
1% BSA, and then 50 µL from this dilution bacteria mixed, in 96-well round bottom 
plate, with series dilution of 0.0, 0.03, 0.1, 1, 3, 10 and 30 % serum followed by 
incubating at 37OC for 30 min with shaking to allow complement deposition on the 
surface of the bacteria.  Subsequently, the plates were centrifuged at 1320 rcf for 7 
min and the supernatant removed. Next, 200 µL of 0.1% BSA in PBS was added to 
the cells and mixed followed by removing the supernatant. Afterward, 50 µL 
PBS+0.1% BSA with specific antibody (anti-human-C3 FITC-conjugated goat 
F(ab’)2 1/50, Protos Immunoresearch, Burlingame, CA) added to cells and incubated 
for 30 min with shaking at 4 OC. Next, cells were washed with 0.1% BSA in PBS as 
before and finally 150 µL of this buffer was added to cells. A flow cytometer (FACS 
Verse, BD) was used to measure C3b deposition level on the surface of bacteria.    
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 6. 2. 8. Bacterial killing in serum  	
Strains were grown from overnight cultures in BHI until OD600=0.5 as outlined in 
(section 5.2.2.). Cells (1 ml) were harvested, washed and resuspended in 1ml sterile 
RPMI buffer plus human serum albumin (HSA), followed by diluting cells 104 ml-1. 
Next, 50 µl of bacteria were mixed in an Eppendorf tube with 50 µl RPMI buffer, 
plus either 50% (v/v) normal human serum (NHS), 50% (v/v) heat-inactivated serum 
(HI) that is complement inactived, or NHS plus compstatin (10 µM). The tubes were 
incubated 37 OC with shaking for 60 min. Subsequently, 20 µl of incubated cells 
were mixed with 180 µl PBS in an Eppendorf tube with 50 µl RPMI buffer and 
plated immediately. Viability of strains was assessed by colony enumeration after 
serial dilution.  
 
6. 2. 9. Neutrophil (PMN) killing assay 	
Strains were cultures as per section 5.2.1.2. Next, a culture was grown in BHI to 
OD600=1.5 and then diluted as a starter culture 1:100 in 3 ml BHI in a 10 ml tube. 
Cells were grown to OD600=0.5 nm (~ 2x108 cfu ml-1) at 37OC with shaking at 500 
rpm for about 2 h, followed by the opsonisation of bacteria for 15 min in a FACS 
tube at RT as follows: 175 µl RPMI buffer/HSA, 20 µl pooled human serum and 5 µl 
bacteria of OD600=0.5. Subsequently, PMNs were diluted in RPMI (100 µl of 1E+07 
PMN per ml and 900 µl RPMI-HSA) and added to the FACS tube as follows: 90 µl 
diluted PMN/RPMI buffer (or only RPMI buffer as control) plus 10 µl opsonised 
bacteria. For the zero time-point (pre-incubation), the mixture of cells was plated 
without incubation immediately on THA plates, while other samples were incubated 
at 37 OC with shaking at 500 rpm and the killing/growth was determined at time 
		 189	
points including 0, 30, 60 and 90 min. To stop the reaction, 900 µl/ml ice-cold MQ 
(milliQ water) plus 0.1% (w/v) saponin (S02) was added and incubated for 15 min at 
4 OC, followed by viable counting. Finally, cells were also counted after overnight 
incubation at 37OC. 
 
6.3.  Results and discussions  	
6.3. 1. Transmission electron microscopy (TEM)  	
As described in the previous chapter, this study observed that deletion of the S. 
aureus pgd gene in strains Newman and SF8300 strains led to altered surface 
properties. Pigmentation, hydrophobicity and surface attachment of the pgd mutant 
were affected and the mutation increased autolysis.  
 
To examine further these surface-associated phenotypes, the pgd mutants of strain 
Newman and SF8300 were visualised by transmission electron microscopy (TEM) 
and compared with their isogenic parent strains. Cells were prepared for TEM 
(Section 6.2.2) and measured with the TEM-software Megaview 3 analySIS from 
photographic images at magnification of x60,000 (Section 6.2.2.1). Three 
independent experiments (biological replicates) were performed, with twenty-five 
randomly selected cells from each strain used to measure the cell diameter and the 
thickness of the extracellular cell wall.  
 
The results obtained from TEM indicate that inactivation of pgd in both S. aureus 
Newman and SF8300 led to a decrease peptidoglycan thickness of around 25% 
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compared with parent strains. (Fig.6.1.). Mean peptidoglycan thickness of Newman, 
and SF8300 and Newman pgd, SF8300 pgd were 23.37 nm, 22.49 nm, 34.08 nm and 
33.03 nm, respectively (Table.6.1.).  The differences between cell wall thickness of 
wild type and mutant was statically significant (P< 0.001), using students’ two-tailed 
t-test.  
 
Discussion  
 Given the previously described differences with cell autolysis, there is the 
possibility that pgd mutants of both Newman and SF8300 lysed more rapidly and to 
a greater extent compared with their parent strains due to the reduced peptidoglycan 
thickness. Various relationships between cell wall thickness and autolysis have been 
previously reported.  For example, a correlation between susceptibility of strain 
SF8300 to vancomycin, its cell wall thickness and autolysis was previously reported. 
In one case the vancomycin-sensitive parent strain (MIC 1µg/ml; A1-VSSA) was 
compared with a clone with reduced susceptibility to vancomycin (MIC 8µg/ml; A2 
– VSIA) strains. The A2 –VSIA clone presented a significantly thicker cell wall (~50 
nm) and reduced autolysis following Triton X-100 challenge compared with its 
parent A1-VSSA (cell wall ~ 40 nm) (Passalacqua et al., 2012). In addition, a further 
study compared the VISA strain Mu50 with the heteroresistant hVISA strain Mu3 
indicated that multiple distinct SNPs in the two-component regulator system gene 
graR (up to 16 mutations) and especially that leading to the amino acid change 
(N197S) converted hVISA Mu3 into VISA strain Mu50, in turn producing enhanced 
cell wall thickness and decreased autolysis (Howden et al., 2010). 
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Table. 6. 1. Cell wall dimensions measured using transmission electron 
microscopy (TEM). 
 
Strain Cell diameter (nm)* Cell wall thickness (nm)* 
Newman  
 
1004.71 ± 56.95 34.08 ± 3.62 
Newman pgd   
 
963.87 ± 46.60 23.37 ± 2.63 
SF8300   
 
993.83 ± 51.85 33.03 ± 3.07 
SF8300 pgd  910.61 ± 64.43 22.49 ± 2.44 
*The measurements (nm) are mean ± standard deviations. 
The value for strains Newman	pgd and SF8300 pgd were significantly different (P< 
001) from their isogenic parent strains using Students two-tailed t-test.  
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Fig. 6. 1. Cell dimensions measured by transmission electron microscopy. 
Representative TEM images at x60,000 of mid-exponential growth phase cells from 
strains Newman (A), Newman pgd (B), SF8300 (C) and SF8300 pgd (D). 
Measurements of cell wall thicknesses are given in Table 6.1. 
 
6.3. 2. Nuclear magnetic resonance spectroscopy (NMR) 	
The molecular structure of peptidoglycan was studied by NMR spectroscopy to 
investigate the extent to which the pgd gene contributes to those features that can be 
distinguished using this technique. Samples were prepared and purified 
!
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peptidoglycan from ruptured cells was analysed using NMR by Dr. Edwin Yates, 
Department of Biochemistry, University of Liverpool.   The 1H NMR signals arising 
from 5mg of mutanolysin-digested peptidoglycan were consistent with assignments 
reported in the literature for specific structural component moieties (Morath et al., 
2001). The 1H NMR signals arising from N-acetyl glucosamine (NAG) between 2.0 
and 2.15 ppm were integrated and measured employing iNMR software. The NAG 
signal was twofold increased in the strain SF8300 pgd mutant compared with the 
wild-type SF8300 strain. It was noticeable that other signals were also increased, 
including those corresponding to CH2 at 1.7 ppm and d-Ala at 4.3 ppm, which were 
increased ~1.5 and ~1.75-fold, respectively. Experiments were repeated at least three 
times and the error bars are indicated.  
 
Discussion  
The data obtained from the NMR analysis indicated that pgd deletion led to 
increased acetyl groups on the peptidoglycan and this would be predicted given the 
bioinformatics analysis of the S. aureus Pgd protein sequence (Chapter 2.). Thus, the 
increasing signal of NAG, is a result of overproduction of COCH3 (CH3) in the 
peptidoglycan sample. However, the peptidoglycan structure is composed of two 
sugars; N-acetyl glucosamine (NAG) and N-acetyl muramic acid (NAM), and both 
possess N-acetyl (and hence, CH3) groups. This study suggests that the 
peptidoglycan has been affected through reduction of Pgd-dependent deacetylation, 
but needs further investigation to determine the extent to which the N-acetyl CH3 
group was increased in the peptidoglycan structure. Particularly noticeable is the O-
acetyl group (1.9 ppm), which was shown to be increased twofold and also relevant 
to this analysis is the increased ratio of CH2:CH3 in the pgd mutant. 
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Fig. 6.2. Peptidoglycan structure of S. aureus SF8300 and an isogenic pgd 
mutant using NMR spectroscopic analysis. Experiments were repeated in triplicate 
from individual biological replicates and the mean values (A)	 were determined, 
SF8300 (stippled grey) and SF8300 pgd (grey). The signals 2.0-2.15 ppm are 
assigned to the acetyl group (COCH3) of N-acetyl glucosamine. NMR spectra of 
SF8300 (B) and pgd mutant (C). Error bars are standard deviation. 
 
 
!
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6.3. 3. Investigating the role of Pgd in virulence using infection 
models 	
S. aureus is a pathogen that can cause a wide variety of infections, such as 
pneumonia, sepsis and skin infection. The pathogenicity of this bacterium is 
dependent on multiple virulence factors including cell wall-anchored (CWA) 
proteins, polysaccharide and toxins as discussed in the thesis introduction.  
 
The peptidoglycan analysis of the pgd mutant described in the previous section, 
together with the altered extent of TEM-visible cell wall might indicate that the 
surface protein presentation and thus virulence factor of the strain might be altered, 
To investigate this possibility, the pgd mutant was compared with its isogenic parent 
using pneumonia and bacteraemia infection models, Samples of SF8300 and SF8300 
pgd were prepared and used to inoculate CD1 mice (Table. 6. 1.), by Dr. Elaine 
Waters, Institute of Infection and Global Health, University of Liverpool. 
 
6.3. 3. 1. Pneumonia model of infection 	
CD1 mice were challenged by intranasal (IN) administration with 2x107 CFU S. 
aureus SF8300 or SF8300 pgd. The lungs and nasopharynx were collected after 12 
and 48 h and the viable bacteria counted.  A marginal decrease was determined in the 
CFU of pgd mutant cells in both nasopharynx and lung at 12 h, but this was not 
significant in comparison with parent strain, SF8300 (Fig. 6. 3. 1.). After 48 h, the 
CFU of the pgd mutant was again marginally and non-significantly decreased in the 
nasopharynx.  In contrast, the pgd mutant was significantly decreased in number in 
the lungs after 48 h.  The reason for this is unclear but could relate to differences in 
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cell persistence due to changes in the cell surface and interactions with the host.  
These changes could also impact on survival from the immune system of mouse. 
 
Fig 6.3.1. Bacterial burden after intranasal inoculation with S. aureus SF8300. 
CD1 mice were intranasally inoculated with 2×107 CFU of SF8300 (circle) or 
SF8300 pgd (square). Bacterial numbers in the nasopharynx were determined after 
12 h (A1) and 48 h (A2), and in the lungs after 12 h (B1) and 48 h (B2). Each 
experiment was repeated twice with 5 mice per group to give a total of 10 per group 
per time point. Horizontal lines refer to the mean value for each group and each 
symbol indicates an individual animal. * indicates P< 0.05. 
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6. 3. 3. 2. Bacteraemia (sepsis) model of infection 	
CD1 mice were challenged by intravenous administration with 5x106 CFU of S. 
aureus SF8300 or SF8300 pgd.  Bacteria were recovered from kidney, spleen, heart 
and blood at two time points post-inoculation: 18 h and 7 d, by organ disruption 
followed by enumeration on agar (Fig 6. 3. 2). Across the various organs that were 
harvested it was determined that there was no significant difference in bacterial 
numbers after 18 h with the CFU of the pgd mutant similar to that of the parent.  
After 7 d, however, there were significantly (P<0.05) fewer CFU of the pgd mutant 
recovered from the spleen, but no significant differences in the numbers between the 
pgd mutant and parent for the other organs. 
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Fig. 6.3.2. Bacterial burden after intravenous inoculation with S. aureus SF8300. CD1 
mice were injected into the tail vein with 5×106 CFU of SF8300 (circle) or SF8300 pgd 
(square). Bacteria were enumerated from recovered organs after 18 h (C1-F1) or 7 d (C2-
E2): spleen at 18 h, 7 d (C), kidney 18 h, 7 d (D), heart 18 h, 7 d (E), and blood at 18 h (F1). 
Horizontal lines refer to the mean value for each group and each symbol represents an 
individual mouse. *P<0.05 indicated. 
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Discussion  
There were clear reductions in the survival of the pgd mutant in two of the models of 
infection studied.  The reason for the reduced bacterial numbers recovered with the 
mutant is not clear given the finding of differential survival in the lungs and the 
spleen.  The observed differences in the cell surface that were described above might 
account for the phenotype, but further experiments are necessary to reveal the defects 
encountered with the mutant as they actually relate to these niches.  The necessary 
virulence factors for extended survival at these sites might be reduced on the mutant 
cell surface altering colonisation, immune evasion or replication.  
 
6. 3. 4. The contribution of Pgd to host immune survival.  	
The complement system signals to the innate defence mechanisms that there are 
invading microorganisms like S. aureus present.  The activation of complement leads 
to a labelling of the bacterial cell surface with the opsonins C3b and iC3b, which 
promotes neutrophil phagocytosis.  To investigate whether Pgd has a role in defence 
of S. aureus from opsonophagocytosis, the strains Newman, Newman pgd and 
Newman pgd pJAL-pgd) tested. Three separate experiments were performed in 
collaboration with Dr Suzan H. M. Rooijakkers (Medical Microbiology, University 
Medical Center, Utrecht, the Netherlands: C3b deposition level, S. aureus killing in 
serum and neutrophil (PMN) killing assays.  
6. 3. 4. 1. Complement deposition on S. aureus   	
The immunological study first analysed deposited C3b on the bacterial surface, using 
a specific antibody specific for human C3. Samples were prepared as described 
(section 6.2.7) and the amount of C3b was measured using flow cytometry.  The 
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assay revealed a dose-dependent relationship between the amount of serum and the 
extent of C3b deposition on the cell surface of S. aureus Newman, in which, the level 
of C3b molecules gradually increased with increasing serum levels from 0.03 - 30 % 
(Fig. 6. 4.). It was also determined that the level of C3b on the surface of pgd mutant 
was not statistically significantly different at any serum concentration. 
 
Fig. 6.4. Complement deposition on S. aureus. The levels of C3b deposition on 
strains Newman (circles), Newman pgd (triangles) and Newman pgd pJAL-pgd 
(squares) was measured by flow cytometry after incubation in the absence or 
presence of normal human serum or heat-inactivated (HI) serum. Data represents the 
mean and standard error of three individual experiments. 
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6. 3. 4. 2. S. aureus survival in human serum  	
To evaluate the contribution of Pgd to survival of S. aureus Newman in human 
serum the pgd mutant and complementation strains were compared with their 
isogenic parent.  The relative survival of these strains was determined after 
incubating these strains for 1 h at 37OC with either normal human serum (NHS), 
heat-inactivated (HI) serum or NHS plus compstatin (Fig. 6. 5.).  Viability was 
assessed by the Miles and Misra method, to determine colony forming unit (CFU) 
after overnight incubation at 37OC (section 6.2.8).  
 
Comparable levels survival were observed across all of the strains examined 
revealing that the pgd mutant is not affected by the activity of complement in serum, 
at least under the conditions studied in the described assay.  The presence of the C3 
inhibitor compstatin did not affect relative survival, where this compound was 
included to evaluate if there were complement-independent affects on serum 
survival. 
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Fig. 6.5.  S. aureus survival in the presence of human serum. The viability of S. 
aureus strains was assessed after incubation for 1 h with 50% (v/v) NHS, HI serum 
or NHS + compstatin (10 mM), with serum and incubation controls. Data represents 
the mean CFU ± standard error of the average of three experiments.  
 
6. 3. 4. 3 Neutrophil (PMN) killing assay 	
A further experiment was performed to investigate the effect of Pgd in immune 
survival by testing neutrophil killing in an opsonophagocytosis assay. Freshly 
isolated neutrophils (PMN) from human volunteers were added to NHS-opsonised S. 
aureus strains and the viability of each strain were determined by lysing the 
neutrophils and enumeration using the Miles and Misra method (section 6.2.9). It 
was determined from this assay that S. aureus pgd was killed faster than its isogenic 
Newman parent strain by neutrophils at 60 min and 90 min of incubation (Fig. 6. 6.). 
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students t-test P<0.05. In this assay, as with several other assays, the pgd 
complementation strain did not show restored viability (S. aureus pgd pJAL-pgd). 
 
 
Fig. 6. 6. Neutrophil killing of S. aureus. Bacterial viability (CFU ml-1) was 
assessed for PMN survival at the indicated times with NHS-opsonised S. aureus 
Newman (black), Newman pgd (grey) and Newman pgd pJAL-pgd (white). Assay 
controls, strains incubated with only RPMI buffer are labelled 1, 3 and 5, and those 
incubated with PMN are labelled 2, 4 and 6). Data represents the mean number of 
recovered colonies ± standard error of three separate experiments, using student’s t-
test.  
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Discussion  
C3b molecules can randomly attach via amine group or hydroxyl groups on the cell 
surface, and deposition of C3b is an important part of innate immune defence leading 
to opsonophagocytosis (Berends et al., 2013). In addition to opsonisation from 
activated serum proteins of the complement cascade, neutrophils can recognise 
peptidoglycan (PG) structure by binding via the PGRPb receptor (An et al., 2013; 
Kobayashi et al., 2005; Liu et al., 2000). This study assessed the level of deposition 
of C3b and observed no significant difference between the pgd mutant and parent 
strain, suggesting C3b binding despite the observed differences in structural 
composition by NMR and the reduced cell wall thickness. 
 
The neutrophil killing assay in contrast indicated that pgd mutant was killed more 
rapidy than the wild-type strain which might indicate that either phagocytosis was 
greater with the pgd mutant or that once phagocytosed the bacteria were more 
rapidly killed. Thus, so far, this study suggests that the pgd mutant killing is not 
directly related to opsonisation or serum killing, but could result from increased 
ability of the neutrophils to recognise PG directly e.g. via its PGRPb receptor, 
another serum factor(s) or an increased killing rate after phagocytosis.  Since the pgd 
mutant exhibits less thick PG and lyses faster under stress of Penicillin G and Triton, 
it could be most likely that the mutant is digested by PMN faster than the parent 
strain or killing by antimicrobial molecules that are release from neutrophils 
(granular and/or via NETs) during interactions with bacterium (see section 1.1.2.6.). 
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6. 3. 5. Proteome analysis of S. aureus pgd using label-free 
quantitative analysis 	
The proteome includes all translated proteins and this term was used first by Marc 
Wilkins in 1994 meaning “the protein complement of the genome” (Wasinger et al., 
1995). The term proteomics describes the analysis of proteins on a large scale, being 
a complement derived from a cell fraction, organelle, whole cell or community. 
Global methods for proteomic analysis include gel-free and gel-based techniques. 
The latter method can be used to pre-fractionate, a complex protein mixture by using 
gel electrophoresis.  More recent advances use gel-free techniques and these methods 
now typically employ chromatographic separation after digestion of proteins using 
the protease trypsin. Peptide analysis is achieved by liquid chromatography mass 
spectrometry (LC-MS) that utilises nano-flow liquid chromatography based on 
affinity separation coupled to tandem mass spectrometers (LC-MS/MS). Trypsin is 
used in most mass-spectrometry based proteomics, because of the ease and reliability 
of converting a protein mixture into peptide fragments by C-terminal cleavage of 
peptide bonds between K and R residues (Eng et al., 1994; Olsen et al., 2004). 
 
On the basis that the described results revealed altered peptidoglycan and cell 
metabolism of the pgd mutant, the study aimed to quantify any differences in the 
protein complement of the pgd mutant compared with its parent. It was hypothesised 
that this approach might answer the questions as to what were the underlying bases 
for the metabolic and cell surface changes of the pgd mutant.  
 
The strains SF8300 and SF8300 pgd were cultured and washed and the whole cells 
were trypsin digested and separated using an Ultimate 3000 RSLC system coupled to 
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a QExactiveHF mass spectrometer (section: 6. 2. 5.). This work was performed at 
University of Liverpool in collaboration with Dr. Josephine Moran (Microbiology) 
and Dr. Lynn McLean (Biochemistry) from The Institute of Integrative Biology. Five 
biological samples for each strain were analysed and the differential protein 
abundance was determined.  
 
Bradford assay indicated that the total of protein content of the digest for SF8300 
pgd was 0.126 µg µl-1 and the wild type strain, SF8300 was 0.181 µg µl-1. The 
protein identification based on the peptide analyses using LC-MS/MS methods 
enabled differential protein quantitation between both strains (Table 6. 2.a-b). 
Comparison of the peptide datasets revealed a total of 33 proteins that were 
identified as being differentially expressed; significance was based upon Anova with 
P<0.05 and with a 1.5-fold increase or decrease in expression. 
 
The SF8300 pgd strain dataset revealed that out of the 33 differentially expressed 
proteins 11 were present at increased levels including the cell surface proteins IsaA, 
FnbA and SdrE (Table 6. 2.a.), while 22 proteins were present at decreased number 
including Spa, PBP2a, SarS and Sbi (Table 6. 2.b.).  
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Table 6.2.a. Proteins with increased expression in SF8300 pgd using quantitative 
proteomics. Eleven proteins in the proteome of SF8300 pgd were increased in 
comparison with its isogenic parent, SF8300. Five separate culture samples were 
assayed for each strain with two peptides being the minimum for searching. Values 
are the average between samples and p-value determined using Anova. 
ID Peptides Score P value Fold Protein name 
Q2FDZ7 6 263.19 0.000044 3.19 FeoB 
Q2FHR7 6 356.83 0.00118 2.42 
ArcC1 
Carbamate kinase 
Q2FDL8 2 61.5 0.00417 2.22 PTS IIABC mannose 
Q2FDT8 5 409.01 0.0000453 2.2 IsaA 
Q2FES7 2 56.22 0.00931 2.18 BudA (AlsD) 
Q2FE03 17 1397.52 0.00236 1.96 FnbA 
Q2FHN1 2 48.35 0.03 1.77 Unknown 
Q2FJ77 22 1406.1 0.000205 1.74 SdrE 
Q2FKI1 4 219.36 0.04 1.64 Lipoprotein 
Q2FFB7 2 120.25 0.00609 1.56 RecT recombinase 
Q2FJI3 2 53.61 0.04 1.53 
Sodium-dependent 
transporter 	
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Table 6. 2.b. Proteins with decreased expression in SF8300 pgd using 
quantitative proteomics. Twenty-two proteins in the proteome of SF8300 pgd were 
decreased in comparison with its isogenic parent, SF8300.  
 
ID Peptides Score P value Fold Protein name 
Q2FJH8 3 162.56 0.0000498 3.65 Methionine ABC transport 
protein 
Q2FKD2 6 547.52 0.0000016 3.63 Diacetyl reductase  (ButA) 
Q2FKE8 28 3103.13 0.000105 3.16 Protein A (Spa) 
Q2FG28 7 687.07 0.000155 2.47 Universal stress protein (UspA) 
Q2FK44 33 2787.51 0.0000261 2.41 Acetyltransferase  
(PflB) 
Q2FDV8 20 1247.24 0.02 2.27 Clp protease ATP-binding 
subunit ClpL 
Q2FDZ1 11 654.93 0.00157 2.16 Lantibiotic ABC transporter 
Q2FK74 6 317.87 0.000333 2.02 Pyruvate decarboxylase (IpdC) 
Q2FJ31 14 1234.37 0.00849 1.92 Alcohol dehydrogenase (Adh1) 
Q2FJZ0 21 1441.99 0.000166 1.83 Unknown 
Q2FIN9 5 271.49 0.00223 1.77 Ribosome-associated factor Y 
Q2FDR6 2 77.19 0.00396 1.73 AAA ATPase 
Q2FDG7 2 55.64 0.00151 1.71 2-oxoglutarate translocator 
Q2FHW6 32 1764.34 0.02 1.65 Pyruvate carboxylase (Pyc) 
Q2FKN3 2 111.77 0.00379 1.64 Adenosine synthase (AdsA) 
Q2FK34 3 194.9 0.03 1.61 PrsS protease  (PrsW-like) 
Q2FKM6 13 682.51 0.00815 1.6 Penicillin-binding protein 
(Pbp2a) transpeptidase 
Q2FEH9 2 134.43 0.04 1.6 RpiR 
Q2FDQ7 9 695.29 0.00345 1.53 L-lactate dehydrogenase (Ldh2) 
Q2FHA5 3 232.33 0.04 1.53 Putative homoserine 
dehydrogenase (Hdh) 
Q2FKE7 9 395.85 0.02 1.51 SarS  
Q2FE79 6 357.79 0.00424 1.51 Immunoglobulin-binding 
protein (Sbi) 
 
		 209	
Discussion  
The expression levels of the cell surface proteins, Protein A (Spa) and 
Immunoglobulin-binding protein (Sbi), were decreased in SF8300 pgd mutant 
compared with the parent strain (Table 6. 2.b).  While these proteins are both 
ascribed roles in virulence and immune evasion, they might be implicated in other 
identified phenotypes of the pgd mutant and this is outlined below.  
 
S. aureus binds to numerous serum proteins including, fibronectin, fibrinogen and 
immunoglobulin (IgG).  This binding is widely recognised as contributing to 
protecting the bacterium from innate immune defences of the host (Zhang et al., 
1998) The Spa and Sbi proteins are both immunoglobulin G (IgG)-binding. These 
secreted surface-attached proteins enable S. aureus to bind the Fc region of IgG to 
prevent complement fixation and thus recognition by the neutrophil FcγR receptor to 
inhibit opsonophagocytosis (Smith et al., 2011b). The N-terminus of Sbi protein 
contains two IgG-binding domains in comparison with five consecutive IgG-binding 
domains in the Spa protein sequence. In addition, the C-terminus of Spa comprises a 
proline-rich region followed by a cell wall-anchoring LPXTG motif, which is used to 
covalently link the protein to peptidoglycan. Sbi contains the proline-rich region but 
is not covalently-attached (Smith et al., 2011b; Zhang et al., 1998) meaning that Sbi 
protein is released into supernatant of S. aureus culture in addition to its association 
with the cell wall. Both Spa and Sbi contribute to innate immune defense and their 
expression was found to be affected by the levels of iron in culture medium (Smith et 
al., 2011a).  In a neutrophil killing assay, using whole human blood, the survival of 
spa and sbi mutants was reduced by half in comparison with the parent, in the 
Newman strain (Smith et al., 2011a), implying that these proteins do limit 
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opsonophagocytosis by limiting both complement fixation and interaction with 
neutrophil Fc-binding receptors (Foster, 2005).  
 
The reduced expression of both Spa and Sbi in the pgd mutant in the study described 
here might therefore partly explain the reductions in virulence with the spleen and 
lung organ numbers and reduced survival in lung and spleen assay. Moreover, it 
could also contribute to the increased rate of neutrophil killing observed with the pgd 
mutant in this study. 
 
The SarS transcriptional repressor protein is a member of the SarA-like family and 
its expression is regulated negatively by both agr and sarA regulators. SarS is an 
activator for the transcription of spa by binding directly to the spa promoter region. 
SarS thus functions as an intermediary for the regulation of Spa expression 
controlled by both SarA and agr (Bronner et al., 2004).  
 
In this study, SarS protein levels were reduced ~1.5 fold in the pgd mutant compared 
with the parent strain, suggesting this decrease in the level of SarS is an effector for 
the reduced level of the Spa protein in the pgd mutant. However, in this study, the 
global regulators agr and SarA were not investigated and may also be responsible for 
the observed changes in Spa expression. 
 
SdrE is one of S. aureus’ family of MSCRAMMs (section; 1.1.3.1.), and this 
surface-associated protein contributes to immune defence. Specifically, SdrE was 
reported function similar to complement regulatory protein factor H and when 
expressed it disrupts the alternative pathway of complement fixation by cleaving C3b 
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to iC3b, thereby reducing C3-fragment deposition and in turn reducing C5a 
generation. Furthermore, expression of SdrE in serum was found to provide a 
survival advantage for the bacterium (Foster et al., 2014; Sharp et al., 2012), 
meaning that observed changes in SdrE expression in the pgd mutant might 
contribute to altered survival in the immune evasion and virulence assays . 
 
A noted phenotype of the pgd mutant was the indication of a metabolism alteration 
when the strain was assayed using an Alamar blue viability assay.  Considerable 
insight was provided by the proteomic investigation.  In S. aureus, carbohydrates 
such as glucose are metabolised to pyruvate for subsequent supply to the 
tricarboxylic acid (TCA) or fermentive metabolism pathways (Friedman et al., 
2006), which provides biosynthetic intermediates, ATP, NADH and FADH to drive 
cellular processes (Chaffin et al., 2012). Within the differential protein expression 
data obtained for the pgd mutant there were clearly altered levels of proteins in 
pyruvate and acetoin metabolism plus lower expression of multiple fermentative 
metabolism proteins were reduced. Under excess glucose, the products of the alsSD 
operon converts acetolactate derived from pyruvate metabolism to acetoin.  Acetoin 
produced can also be converted to 2,3-butanediol by acetoin reductase (ButA), which 
could be readily utilised at a later time (Rice and Bayles, 2008). Within the 
differentially expressed proteins of the pgd mutant there was an increased level of 
AlsD (BudA1) and reduced levels of ButA, producing (S)-2-acetoin and (R)-2-
acetoin, respectively, indicating an altered balance of steeorisomers of acetoin, 
although the significance of this is not clear.  The increased expression of AlsD may 
also integrate the observed effects of increased autolysis in this study and suggests 
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that cell viability in post-stationary phase should be examined on the basis of the 
work described by (Yang et al., 2006). 
 
 
Fig. 6. 7.  Pyruvate and acetoin metabolism enzymes with altered expression in 
S. aureus pgd.  Red = increased expression, greeen = decreased expression and no 
shading = change in expression <1.5-fold. 
 
This results and alamar Blue observation (section 5.6.8.), together indicating that pgd 
mutant is indeed affected its metabolic activity and maybe not able to adapt itself 
with environment. 
 
However, in this proteomics study, there are some proteins of known function were 
increased such as, immunodominant staphylococcal antigen A (IsaA), fibronectin-
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binding protein (FnbA) and surface-associated protein (SdrE) with 2.2, 1.96 and 1.74 
fold increased compared to wild type strain (Table 6.3.a), and as described before.  
 
IsaA is an enzyme involved with the metabolism of cell wall. As peptidoglycan of 
bacteria is a dynamic structure, IsaA enzyme has autolytic activity (lytic 
transglycosylase) and able to act on peptidoglycan structure, allowing cell wall of 
bacterium to grow and divide. Moreover, IsaA is located in the cell wall-attached 
with ionically bound. IsaA production can be upregulated by several genes such as, 
sarA, sigB, agrB or saeR but, also was found to be downregulated at anaerobic 
condition, implying the control of IsaA expression is complex (Lorenz et al., 2011; 
Stapleton et al., 2007).  
 
FnbA and FnbB are surface-anchored protein that involved for promoting biofilm 
formation in S. aureus. finbA mutant was less biofilm formation but not substantially 
affected as double mutants finbA finbB (O'Neill et al., 2008). However, deletion of 
finbA in rsp mutant was restored biofilm formation to parent strain level (Lei et al., 
2011).  
 
Thus, deletion pgd gene led to increase the level of these proteins in the surface of 
pgd mutant. Increasing the level of IsaA protein could be affected the cell wall 
peptidoglycan and therefore can lead to increase the autolysis activity, which was 
observed under stresses of penicillin-G and triton X-100 assays (section: 5.3.4). 
Moreover, increasing FnbA maybe related to pgd mutant, while SdrE related to 
improve pgd mutant in serum assay.  
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CHAPTER 7 
7.1. General Discussion  	
At the outset of this study the aim was to identify novel activities of S. aureus 
secreted proteins.  Based upon database and literature searches, modification of 
peptidoglycan by deacetylation in S. aureus has not been reported previously. In this 
regard, the study was successful at identifying a novel function for the species, albeit 
one characterised for a handful of other bacteria.  With the identification of a 
putative deacetylase enzyme, gene mutants were generated to determine the role of 
pgd encoding this activity.  Constructed pgd mutants of S. aureus were studied to 
examine the effect of gene inactivation upon peptidoglycan acetylation as well as 
growth, virulence and survival.  
 
Throughout the study it was clear that there was pronounced strain variation in 
several of the phenotypes.  Particularly, the use of four strain backgrounds (SH1000, 
Newman, BH1CC, SF8300) to study the pgd mutation produced data where one or 
more strain background had a phenotype matching the wild-type or had an opposite 
phenotype as the other pgd mutant strain backgrounds.  This latter effect was 
prominent with the hydrophobicity of SH1000 pgd compared with the other pgd 
mutants of Newman, BH1CC and SF8300. To assess hydrolytic activity of the pgd 
mutant in each strain background the mutants and parent strains were challenged 
with Triton X-100 and penicillin-G in autolysis assays. The pgd mutants of both 
Newman and SF8300 strains exhibited higher autolysis rates compared with the 
parent strains, indicating peptidoglycan or autolysisn levels were altered. Strain, 
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SH1000 pgd exhibited no alteration to autolysis upon challenge with either Triton X-
100 or penicillin, revealing differences between the strains being studied.  
 
Within the research field there is much discussion over the use of more than one 
strain of S. aureus to investigate the effects of gene function to rule out strain-
specific effects. The use of the four strain backgrounds identified variation in cell 
wall properties.  Some of the data presented here certainly suggests differences 
between strains in terms of cell wall charge, hydrophobicity and decoration with 
teichoic acids and acetyl groups (N- and O-linked).  This would be a promising area 
of future study to identify the correlations between gene expression and surface 
properties.  
 
Deletion of pgd in two S. aureus strains, SF8300 and Newman, reduced 
peptidoglycan thickness by 18-25 %, indicating that cell surface PG was affected at a 
gross level.  This phenotype has not been reported in other studies of Pgd homologs. 
Increased acetylation was identified by NMR assay for the PG of the mutant strain 
compared with parent strain relates, however it is not clear how this relates to the cell 
wall thickness phenotype. Perhaps the change in acetylation causes a degree of 
disorder in PG synthesis by altering the localisation of PBPs and/or autolysins during 
biosynthesis, for example.  
 
What could cause reduced peptidoglycan thickness?  From the proteomic analysis of 
the pgd mutant the consequence of increased peptidoglycan N-acetylation was 
altered levels of multiple secreted proteins, including IsaA that has cell wall autolytic 
activity.  This S. aureus protein is one of only nine with peptidoglycan hydrolytic 
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activity (Dubrac and Msadek, 2004) and IsaA functions as a lytic transglycosylase to 
modify peptidoglycan structure (Lorenz et al., 2011; Stapleton et al., 2007). From 
the proteomic data of SF8300 pgd (Table 6.2a), the IsaA protein was increased 2.2-
fold, compared with its parent strain.  This increased level of IsaA has the potential 
to modulate cell wall turnover and cause disorder in PG synthesis.  Tannic acid was 
reported to interfere with biofilm activity and the limiting factor was determined to 
be an elevation of IsaA activity (Payne et al., 2013).  Of particular interest is the link 
between IsaA levels and biofilm formation, since the pgd mutant also exhibited 
altered biofilm phenotypes in this study.  This link needs to be investigated further 
through the use of multiple mutants and to assess the specific consequences of IsaA 
levels upon peptidoglycan structure, which requires closer scrutiny beyond the 
functional determination previously reported (Stapleton et al., 2007). 
 
Lysozyme is an important component of the animal host defense system, and it is 
presumed that many Gram-positive bacteria, including S. aureus are completely 
resistant. Several reports describe that O-acetylation, N-acetylation and N-
deacetylation of peptidoglycan are important processes, conferring intrinsic 
resistance to hydrolysis or autolysis (Dupont and Clarke, 1991; Rae et al., 2011; 
Raymond et al., 2005; Vollmer and Tomasz, 2000).  In Gram-positive bacteria, the 
enzymes responsible for these activities encode peptidoglycan N-acetylglucosamine 
deacetylase (Pgd) and O-acetyltransferase A (OatA).  
 
Mutation of pgd in S. aureus Newman, SF8300 or SA113 did not affect lysozyme 
resistance when assaying cells cultured in broth or agar. Assay of pgd oatA double 
mutants in strains Newman and SA113 revealed that the double mutant was more 
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lysozyme resistant than Newman oatA and SA113 oatA strains. From these data it is 
evident that Pgd contributes to lysozyme resistance and raises questions about the 
potential for coordinated Pgd and OatA expression and compensatory roles in their 
activity.  How this coordination would be regulated requires investigation.  Firstly 
though, the genetic regulation of pgd transcription must be determined and efforts 
towards this aim are ongoing in the Horsburgh lab using promoter fusions combined 
with transposon mutagenesis. In addition genome resequencing of pgd, oatA, 
oatAtagO mutants selected for increased lysozyme resistance is being undertaken to 
identify SNPs contributing to improved growth in high concentrations of lysozyme.  
The pgd promoter contains an inverted repeat sequence that is unique in the genome 
and might indicate the binding site of a novel regulator.  Alternatively, one or more 
of the cell wall regulators, such as WalKR, GraRS, LytRS or MgrA might regulate 
pgd transcription.  Data from the transcriptomic database maintained by the Elasri 
lab (http://www.bioinformatics.org/sammd/) indicates that MgrA might act as either 
a direct or indirect regulator of pgd.  Such regulation would coordinate autolysis 
activity with cell wall modifications; this regulation would fit within the described 
regulatory network encompassing the lytic transglycosylase activity of IsaA. 
 
To further investigate the actions of Pgd and OatA in S. aureus, this study 
characterised the pgd, oatA and double mutants to identify their relative roles in 
resistance to the hydrolytic action of lysozyme. In agreement with previous studies, 
deletion of oatA caused high sensitivity to lysozyme in S. aureus SA113 (Bera et al., 
2005). This phenotype was extended in this study using S. aureus Newman.  
However, in contrast SF8300 oatA was not lysozyme sensitive in either assay.  Since 
SF8300 is a representative of the USA300 strain lineage that has evolved increased 
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virulence as CA-MRSA, this lysozyme resistance phenotype independent of oatA 
warrants further investigation and further highlights the strain differences observed 
with respect cell wall properties.  One explanation for this phenotype is that the 
absence of O-acetyl is fully compensated by the addition of teichoic acid, which is 
competitively added to the same position on MurNAc.  This might indicate that the 
teichoic acid transferase activity (TagO) is higher in this strain or that peptidoglycan 
deacetylase (Pgd) activity is repressed; other possibilities are currently hard to 
envisage. 
 
The proteomics data of the pgd mutant compared with the wild-type SF8300 strain 
indicated that SarS expression was decreased in the pgd mutant.  This decrease is 
likely to be the basis for the decreased levels of protein A (Spa). Since this altered 
Spa expression could be important for immune evasion and biofilm formation, it will 
be important to understand the basis for the pgd mutation leading to the signal 
transduction via SarS.  This SarA-like protein is a member of a suite of purported 
environmental signal-transducing transcriptional repressors, but the actual basis for 
the extracytoplasmic signal transduction leading to altered SarA-like family protein 
activity is mostly incompletely understood, despite many extensive analyses.  The 
data presented here provides another environmental input via N-acetylation changes.  
 
In contrast to S. aureus, mutation of pgd in Streptococcus pneumoniae, Listeria 
monocytogenes and Lactococcus lactis resulted in clear lysozyme sensitivity (Boneca 
et al., 2007; Meyrand et al., 2007; Vollmer and Tomasz, 2000).  Other studies with 
S. mutans and Enterococcus faecalis revealed no difference when comparing parent 
strains with pgd mutants, while with Bacillus anthracis the results were equivocal 
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(Deng et al., 2009; Fukushima et al., 2005; Hebert et al., 2007). Inactivation of oatA, 
pgdA, dltA or sigV encoding the extracytoplasmic sigma factor σV, in E. faecalis had 
no impact on lysozyme resistance levels compared with their parent strain 
(Benachour et al., 2012). Deletion of sigV in B. subtilis increased lysozyme 
sensitivity, while overexpression of oatA in the sigV mutant restored lysozyme 
resistance revealing a contribution of σV to OatA expression (Ho et al., 2011). 
Although S. aureus has no σV homolog, it has an equivalent mechanism of lysozyme 
resistance through increased expression of DltA, which is responsible for addition of 
positively-charged D-alanine to cell wall teichoic acid, plus OatA-mediated MurNAc 
O-acetylation. S. aureus mutated for both genes has a significant increase in 
lysozyme sensitivity.  
 
Compared with their parent strains, pgd mutants of Newman and SF8300 exhibited 
biofilm formation when cultured with 1 % glucose on both plasma-treated plates 
(tissue culture plate) or poly-lysine-coated glass.  These strains did not form biofilm 
on a polystyrene plate, an untreated surface. Additionally, the SF8300 pgd mutant 
was unable to attach and form biofilm within a glass microfluidics channel of 
bioFlux system.	These data reveal a striking contrast between assays when using the 
same material with similar surface properties (treated glass), producing either a 
biofilm or no biofilm.  These experiments raise a question as to whether this 
discrepancy is due to material surface properties (hydrophobicity or charge) 
combined with the increased PG acetylation of the pgd mutant, or simply due to the 
hydrodynamic shear influencing behaviour of cells differently at the surface. 
Nevertheless, it is clear that a pgd mutant has a biofilm phenotype in certain strains 
of S. aureus, and this could be examined further to determine the critical parameters 
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influencing the cell surface/ material surface interaction under hydrodynamic flow 
and static conditions. There is a precedent for the difference between the biofilm 
assay outcomes as reported by (Benoit et al., 2010). Their study indicated a similar 
situation where a flow biofilm differed from a static biofilm in their study of rpoS-
deficient E. coli that had impaired biofilm development under flow condition but 
developed biofilm under static conditions to an enhanced extent when compared with 
its isogenic parent (Benoit et al., 2010; Lee et al., 2008). The reasoning proposed 
was that cell signalling is affected by hydrodynamic flow, particularly due to 
velocity and turbulence of the medium and these conditions altered biofilm 
development. A further possibility that might explain the difference comes from a 
study by Pozzi et al 2012, which indicated that in relative terms the surface of the 
glass bioFlux channel is more hydrophobic than the highly hydrophilic surface of a 
tc-treated polystyrene plate. 
 
In this study Pgd was determined to have roles in the virulence of S. aureus. 
Inactivation of pgd in S. aureus therefore has a similar infection outcome to that seen 
with the reduced in vivo survival of S. pneumoniae pgd and E. faecalis pgd in animal 
models (Blair et al., 2005a; Hebert et al., 2007; Vollmer and Tomasz, 2000).  
Reduced in vitro survival was previously reported for Listeria monocytogenes pgd 
and Shigella flexneri pgd mutants in survival assays with polymorphonuclear 
neutrophils (PMNs) (Rae et al., 2011) which matches the decreased virulence S. 
aureus SF8300 pgd for PMN survival. These in vivo phenotypes of the S. aureus 
mutant may result from the reduced fitness observed in several assays, including 
increased hydrolytic activity that could lead to PG fragments being released to 
activate innate immune pathways. The decreased expression of the surface 
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immunoglobulin G (IgG)-binding proteins protein A (Spa) and Sbi shown in the 
proteomics data (Table 6.2b) may increase complement deposition and recognition 
by the neutrophil (FcyR) receptor to limit their inhibition of opsonophagocytosis 
(Smith et al., 2011b). The decreased virulence of S. aureus SF8300 pgd in the 
infection models could be related to increased IsaA expression, which is highly 
immunogenic meaning it may increase host immune responses.  A higher titre of 
antibody against IsaA was reported as being detected following S. aureus infections 
(Lorenz et al., 2011; Payne et al., 2013). 
 
In summary, many pgd mutant phenotypes were identified in this study and further 
study of the mutant cell wall structure and function will advance our understanding 
of S. aureus as a biofilm-forming pathogen. This increased understanding from 
further such studies will contribute to the long-term objective of new and improved 
antimicrobial therapies.  Pgd of S. aureus may also represent a promising target for 
vaccine design. 
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Fig 4A. Analysis multi-sequence for their similarity, using Clustal Omega 
server. (In the top)  Original S. aureus Newman pgd sequence, (second) cloned 
pgdPCR2 sequence (from pJAMAL2) and (third) cloned pgdPCR3 sequence (from 
pJAMAL2).  Mutation in the sequence compared with original pgd sequence 
indicated by black triangle.  
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